RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Inflammatory Cytokines and Cognition in Alzheimer's Disease and Its Prodrome

Psychiatry Investig 21(10):1054-1064 · 2024 · PMID 39465234

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

3,285편 검색→1,972편 판독→1360편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Inflammatory cytokines such as interleukin-6 and tumor necrosis factor and cognition in Alzheimer disease and mild cognitive impairment (("interleukin-6"[tiab] OR "interleukin 6"[tiab] OR IL-6[tiab] OR "tumor necrosis factor"[tiab] OR TNF[tiab] OR "TNF-alpha"[tiab] OR "inflammatory cytokine*"[tiab]) AND (cognition[tiab] OR cognitive[tiab] OR cognitive function[tiab] OR "cognitive decline"[tiab] OR memory[tiab]) AND ("Alzheimer disease"[tiab] OR "Alzheimer's disease"[tiab] OR "Alzheimer*"[tiab] OR "mild cognitive impairment"[tiab] OR MCI[tiab]))

출판 연도

2020: 33편3320202021: 168편1682022: 203편2032023: 191편1912024: 203편2032025: 300편3002026: 261편2612027: 1편12027

선별된 1360편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01rats · oxidative stress332편

  1. 0.91

    Evaluation of the Anti-Alzheimer Activity of Lycium barbarum Polysaccharide in Abeta(1-42)-Induced Neurotoxicity in Rat Model

    Lu Q, Meng Y, Feng H et al. · Current issues in molecular biology · 2025

  2. 0.87

    Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease

    Siddiqui N, Ali J, Parvez S et al. · Neurochemical research · 2023

  3. 0.86

    Embelin Mitigates Amyloid-beta-Induced Neurotoxicity and Cognitive Impairment in Rats: Potential Therapeutic Implications for Alzheimer's Disease

    Arora R, Deshmukh R · Molecular neurobiology · 2025

  4. 0.86

    The flavonoids of okra insulates against oxidative stress, neuroinflammation and restores BDNF levels in Abeta(1)(-)(42) induced mouse model of Alzheimer's disease

    Yan T, Liu B, Wang N et al. · Experimental gerontology · 2021

  5. 0.86

    Substance P mitigates lipopolysaccharide induced cognitive impairment in rats in a dose dependent manner

    Gurram PC, Manandhar S, Satarker S et al. · Neuropeptides · 2025

  6. 0.86

    Thymoquinone ameliorates cognitive impairment and neuroinflammation in an amyloid-beta-induced rat model of Alzheimer's disease

    Cam Ozunlu SA, Uysal F, Tatli Dogan H et al. · Brain research · 2025

  7. 0.85

    Hentriacontane alleviates streptozotocin-induced Alzheimer's disease-like conditions in rats: In silico and in vivo investigations revealed the unifying principles

    More SA, Sikkalgar A, Chourasiya N et al. · Computers in biology and medicine · 2026

  8. 0.85

    Nattokinase prevents beta-amyloid peptide (Abeta(1-42)) induced neuropsychiatric complications, neuroinflammation and BDNF signalling disruption in mice

    Naik S, Katariya R, Shelke S et al. · European journal of pharmacology · 2023

  9. 0.85

    Clausena Harmandiana root extract attenuated cognitive impairments via reducing amyloid accumulation and neuroinflammation in Abeta(1-42)-induced rats

    Nillert N, Boonyarat C, Welbat JU et al. · BMC complementary medicine and therapies · 2022

  10. 0.85

    Valorization of 2-aminoethoxydiphenyl borate as a neurotherapeutic agent: modulation of calcineurin, TRPC1 and MARK2/GSK-3beta signaling in scopolamine-triggered tauopathy

    Kewal A, Rajput MS, Shah J et al. · Inflammopharmacology · 2026

  11. 0.85

    Tacca chantrieri Andre Rhizome Extract Alleviates Scopolamine-Induced Cognitive Impairment and Neuroinflammation in Rats

    Hawiset T, Sriraksa N, Anukanon S et al. · Advances in pharmacological and pharmaceutical sciences · 2025

  12. 0.85

    Kolaviron neuroprotective effect against okadaic acid-provoked cognitive impairment

    Nazari-Serenjeh M, Baluchnejadmojarad T, Hatami-Morassa M et al. · Heliyon · 2024

  13. 0.84

    Kinetin mitigate neurodegenerative damage of Alzheimer induced by beta-amyloid in male rats by antioxidant and antithrombotic effects

    Movaffagh S, Behzadifard M, Moghaddasi M et al. · Metabolic brain disease · 2026

  14. 0.84

    Plumbagin as a potential therapeutic agent for scopolamine-induced Alzheimer's disease: Mechanistic insights into GSK-3beta inhibition

    Ahsan R, Khan MM, Mishra A et al. · Brain research · 2025

  15. 0.84

    Improvement of cognitive deficit of curcumin on scopolamine-induced Alzheimer's disease models

    Cakmak G, Kaplan DS, Yildirim C et al. · Caspian journal of internal medicine · 2022

  16. 0.84

    Comparative Evaluation of Imatinib and Nilotinib in a Streptozotocin-Induced Rat Model of Alzheimer's Disease : Neuroprotective, Anti-inflammatory, and Cognitive Outcomes

    Gurkan G, Akdag B, Erdogan MA et al. · Journal of Korean Neurosurgical Society · 2026

  17. 0.84

    Effects of inhibiting astrocytes and BET/BRD4 chromatin reader on spatial memory and synaptic proteins in rats with Alzheimer's disease

    Nikkar R, Esmaeili-Bandboni A, Badrikoohi M et al. · Metabolic brain disease · 2022

  18. 0.84

    Cannabidiol prevents cognitive and social deficits in a male rat model of Alzheimer's disease through CB1 activation and inflammation modulation

    Toledano RS, Akirav I · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025

  19. 0.83

    Vigna radiata extracts in pumpkin and soya bean oil: A novel therapeutic approach for Alzheimer's disease

    Amin H, Bukhari SA, Chauhdary Z et al. · PloS one · 2025

  20. 0.83

    Day-night oscillations of cognitive functions, TNF alpha and clock -related factors expression are modified by an intracerebroventricular injection of amyloid beta peptide in rat

    Ledezma C, Coria-Lucero C, Castro A et al. · Neurochemistry international · 2022

  21. 0.83

    Linagliptin, a DPP-4 inhibitor, ameliorates Abeta (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease

    Siddiqui N, Ali J, Parvez S et al. · Neuropharmacology · 2021

  22. 0.83

    Neuroprotective synergy of curcumin and Glycyrrhiza glabra in an alzheimer's model: implications for inflammation and redox pathways

    Liu S, Yan J, Dong J · Frontiers in pharmacology · 2025

  23. 0.83

    Celastrol Attenuates Learning and Memory Deficits in an Alzheimer's Disease Rat Model

    Xiao Y, Wang X, Wang S et al. · BioMed research international · 2021

  24. 0.83

    Sinapic Acid Alleviates Oxidative Stress and Neuro-Inflammatory Changes in Sporadic Model of Alzheimer's Disease in Rats

    Verma V, Singh D, Kh R · Brain sciences · 2020

  25. 0.83

    Zuoguiwan Ameliorates Cognitive Deficits and Neuro-Inflammation in Streptozotocin-Induced Alzheimer's Disease Rats

    Liu H, Zhong L, Dai Q et al. · Neuroimmunomodulation · 2022

  26. 0.83

    Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer's Disease

    Couly S, Denus M, Bouchet M et al. · The international journal of neuropsychopharmacology · 2021

  27. 0.83

    Inhibition of aluminum chloride-induced amyloid Abeta peptide accumulation and brain neurodegeneration by Bougainvillea spectabilis flower decoction

    Abdel-Salam OM, El-Shamarka MES, Youness ER et al. · Iranian journal of basic medical sciences · 2021

  28. 0.82

    A domestic strain of Lactobacillus rhamnosus attenuates cognitive deficit and pro-inflammatory cytokine expression in an animal model of Alzheimer's disease

    Heydari R, Khosravifar M, Abiri S et al. · Behavioural brain research · 2025

  29. 0.82

    Evaluation of Hordenine's Therapeutic Potential in Alzheimer's Disease-Induced Cognitive and Oxidative Impairments

    Agarwal M, Singhal M, Basist P et al. · Recent advances in food, nutrition & agriculture · 2025

  30. 0.82

    Chitosan-curcumin nanoparticles: a potential nano-therapeutic for cognitive restoration in a streptozotocin-induced rat model of Alzheimer's disease

    Khozani MS, Palizvan M, Mosayebi G et al. · Inflammopharmacology · 2026

  31. 0.82

    Lipopolysaccharide-induced Neuroimmune Alteration and Memory Decline in Aging Mice: The Role of Augmented Cellular Senescence

    Nekabari MK, Ben-Azu B, Chijioke BS et al. · Neurotoxicity research · 2026

  32. 0.82

    Fluoxetine ameliorates Alzheimer's disease progression and prevents the exacerbation of cardiovascular dysfunction of socially isolated depressed rats through activation of Nrf2/HO-1 and hindering TLR4/NLRP3 inflammasome signaling pathway

    Abu-Elfotuh K, Al-Najjar AH, Mohammed AA et al. · International immunopharmacology · 2022

  33. 0.82

    Pharmacological Evaluation of Aescin for Neuroprotection in Intracerebroventricular Streptozotocin Model of Alzheimer's Disease in Experimental Rats

    Bhardwaj S, Jindal A, Singh S et al. · Assay and drug development technologies · 2025

  34. 0.82

    Erythrina caffra extract restores memory, modulates cholinergic dysfunction, neuroinflammation, and attenuates oxidative stress in cadmium-induced alzheimer's disease-like pathology in rats

    Ed-Day S, Kacimi FE, El Gui R et al. · Molecular biology reports · 2026

  35. 0.82

    Gentisic acid confers multimodal neuroprotection in experimental Alzheimer's disease by targeting oxidative stress, neuroinflammation, and protein aggregation

    Soni U, Pujari R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026

  36. 0.82

    The protective role of melatonin on the brain in a rat model of Alzheimer's disease

    Mostafa SS, Mohammed RA, Abbas AY et al. · Metabolic brain disease · 2026

  37. 0.82

    Melatonin improves cognitive dysfunction and decreases gliosis in the streptozotocin-induced rat model of sporadic Alzheimer's disease

    Gall Z, Boros B, Kelemen K et al. · Frontiers in pharmacology · 2024

  38. 0.82

    The Neuroprotective Impact of Agomelatine in Preserving Brain Tissue Molecular Structure Against Alzheimer's Disease Etiology

    Amin S, Qusti S, Al-Otaibi WA et al. · Neurochemical research · 2025

  39. 0.81

    Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease

    Kumar R, Kumar R, Sharma N et al. · Neurotoxicology · 2022

  40. 0.81

    Alantolactone improves cognitive impairment in rats with Porphyromonas gingivalis infection by inhibiting neuroinflammation, oxidative stress, and reducing Abeta levels

    Chen S, Han C, Wang X et al. · Brain research · 2024

  41. 0.81

    Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer's disease

    Alavi MS, Fanoudi S, Hosseini M et al. · Metabolic brain disease · 2022

  42. 0.81

    Attenuation of Spatial Memory in 5xFAD Mice by Halting Cholinesterases, Oxidative Stress and Neuroinflammation Using a Cyclopentanone Derivative

    Ullah R, Ali G, Ahmad N et al. · Pharmaceuticals (Basel, Switzerland) · 2020

  43. 0.81

    Rosa x damascena Herrm. and Commiphora wightii (Arn.) Bhandari. combination therapy ameliorates cognitive, neurobehavioral and metabolic impairments in a rat model of Alzheimer's disease through restoration of mitochondrial functions, regulation of neurotransmitter balance and attenuation of pro-inflammatory cytokine levels

    Chauhan P, Wadhwa K, Singh G · Journal of ethnopharmacology · 2026

  44. 0.81

    Chemical components and against alzheimer's disease effects of the calyxes of Physalis alkekengi L. var. franchetii (Mast.) Makino

    Teng Y, Gao J, Tan T et al. · Journal of chemical neuroanatomy · 2024

  45. 0.81

    Neuroprotective Effects of Sulforaphane in a rat model of Alzheimer's Disease induced by Abeta (1-42) peptides

    Khan WU, Salman M, Ali M et al. · Neurochemistry international · 2024

  46. 0.81

    alpha7nAChR activation protects against oxidative stress, neuroinflammation and central insulin resistance in ICV-STZ induced sporadic Alzheimer's disease

    Yamini P, Ray RS, Yadav S et al. · Pharmacology, biochemistry, and behavior · 2022

  47. 0.81

    Standardization and Ameliorative effect of Kalyanaka ghrita in beta-amyloid induced memory impairment in wistar rats

    Diddi S, Lohidasan S, Arulmozhi S et al. · Journal of ethnopharmacology · 2023

  48. 0.81

    Protective effects of curcumin and Ginkgo biloba extract combination on a new model of Alzheimer's disease

    Assi AA, Farrag MMY, Badary DM et al. · Inflammopharmacology · 2023

  49. 0.81

    Pharmacological investigation of oxadiazole derivatives in Alzheimer's disease: Modulation of oxidative stress, neuroinflammation, and iNOS signaling

    Minhas AM, Khan AU, Gul Qazi N et al. · Iranian journal of basic medical sciences · 2026

  50. 0.81

    Dose-dependent neuroprotective effects of adipose-derived mesenchymal stem cells on amyloid beta-induced Alzheimer's disease in rats

    Babaei H, Kheirollah A, Ranjbaran M et al. · Biochemical and biophysical research communications · 2023

  51. 0.81

    Celastrol attenuates Alzheimer's disease-mediated learning and memory impairment by inhibiting endoplasmic reticulum stress-induced inflammation and oxidative stress

    Cao F, Xu L, He X et al. · Archives of medical science : AMS · 2025

  52. 0.81

    Myco-fabricated ZnO nanoparticles ameliorate neurotoxicity in mice model of Alzheimer's disease via acetylcholinesterase inhibition and oxidative stress reduction

    Abd Elmonem HA, Morsi RM, Mansour DS et al. · Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023

  53. 0.81

    Neuroprotective Effects of Amifostine in Mouse Model of Alzheimer's Disease

    Alwaeli NLW, Al-Zubaidy AAK · Clinical laboratory · 2024

  54. 0.81

    Treatment with Blackberry Extract and Metformin in Sporadic Alzheimer's Disease Model: Impact on Memory, Inflammation, Redox Status, Phosphorylated Tau Protein and Insulin Signaling

    de Mello JE, Teixeira FC, Dos Santos A et al. · Molecular neurobiology · 2024

  55. 0.81

    Neuroprotective Effect of Fucoxanthin against Intracerebroventricular Streptozotocin (ICV-STZ) Induced Cognitive Impairment in Experimental Rats

    Dhami M, Raj K, Singh S · Current Alzheimer research · 2021

  56. 0.81

    Polysaccharides extracted from common buckwheat (Fagopyrum esculentum) attenuate cognitive impairment via suppressing RAGE/p38/NF-kappaB signaling and dysbiosis in AlCl(3)-treated rats

    Liu YC, Chen SY, Chen YY et al. · International journal of biological macromolecules · 2024

  57. 0.80

    Geraniol and Z-guggulsterone co-treatment attenuates Alzheimer's disease in adult zebrafish by targeting oxidative damage, neuroinflammation, mitochondrial stress, and synaptic dysfunction

    Chauhan P, Wadhwa K, Singh G · Inflammopharmacology · 2026

  58. 0.80

    Ameliorative effect of myrcene in mouse model of Alzheimer's disease

    Kumar R, Kumar R, Sharma N et al. · European journal of pharmacology · 2021

  59. 0.80

    Protective Effects of Bacillus coagulans JA845 against D-Galactose/AlCl(3)-Induced Cognitive Decline, Oxidative Stress and Neuroinflammation

    Song X, Zhao Z, Zhao Y et al. · Journal of microbiology and biotechnology · 2022

  60. 0.80

    Increased type 3 deiodinase reduces hippocampal T3 signaling and is associated with cognitive impairment in a sporadic Alzheimer's disease animal model

    Marschner RA, Ribeiro RT, Gayger-Dias V et al. · Scientific reports · 2026

  61. 0.80

    Acori Tatarinowii Rhizoma inhibited neuroinflammation in Alzheimer's disease rats by modulating the intestinal flora

    Liu L, Jiang M, Zhang Y et al. · Brain research · 2025

  62. 0.80

    Pharmacological Screening of Viola odorata L. for Memory-Enhancing Effect via Modulation of Oxidative Stress and Inflammatory Biomarkers

    Saleem U, Hira S, Anwar F et al. · Frontiers in pharmacology · 2021

  63. 0.80

    beta-Caryophyllene Ameliorates STZ-Induced Alzheimer's Disease-Like Conditions in Rats via Modulation of Brain-Derived Neurotrophic Factor, Synaptic Plasticity, and Neuroinflammation

    Rathod SS, Agrawal YO · The European journal of neuroscience · 2025

  64. 0.80

    Neuroprotective mechanism of trans,trans-Farnesol in an ICV-STZ-induced rat model of Alzheimer's pathology

    Kadian M, Saini N, Khera A et al. · Inflammopharmacology · 2024

  65. 0.80

    Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer's disease: the role of TNF-alpha/NF-kappaB/IL-1beta axis inhibition

    Nafea M, Elharoun M, Abd-Alhaseeb MM et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2023

  66. 0.80

    Thyroid Hormone Supplementation Restores Cognitive Deficit, Insulin Signaling, and Neuroinflammation in the Hippocampus of a Sporadic Alzheimer's-like Disease Rat Model

    Sepulveda P, Ferreira AFF, Sandoval C et al. · Cells · 2024

  67. 0.80

    Xinnaoxin capsule alleviates neuropathological changes and cognitive deficits in Alzheimer's disease mouse model induced by D-galactose and aluminum chloride via reducing neuroinflammation and protecting synaptic proteins

    Wu X, Qiu X, Wang S et al. · Journal of ethnopharmacology · 2025

  68. 0.80

    Paeonol Ameliorates Cognitive Deficits in Streptozotocin Murine Model of Sporadic Alzheimer's Disease via Attenuation of Oxidative Stress, Inflammation, and Mitochondrial Dysfunction

    Tayanloo-Beik A, Kiasalari Z, Roghani M · Journal of molecular neuroscience : MN · 2022

  69. 0.80

    Effects of lauric acid on cognitive impairment in a scopolamine-induced Alzheimer's disease-like rat model

    Ayobami FG, Ogundipe OJ, Emmanuel AA et al. · Nutritional neuroscience · 2025

  70. 0.80

    Mitigating cognitive deficits with teriflunomide: unraveling PI3K-modulated behavioral outcomes in mice

    Kanika, Singh L · Molecular biology reports · 2024

  71. 0.80

    Ameliorative Role of Phosphodiesterase-5 (PDE-5) Inhibitor "Avanafil" via Modulating cAMP & cGMP Pathway Against Alzheimer's Disease

    Talib M, Siddiqui N, Tripathi PN et al. · Neurochemical research · 2025

  72. 0.80

    Dose-dependent effects of fingolimod on behavioral, molecular, and Stereological outcomes in a rat model of intracerebroventricular streptozotocin-induced Alzheimer's disease-like cognitive dysfunction

    Khani-Robati A, Banizaman M, Jahromi F et al. · 3 Biotech · 2026

  73. 0.80

    Involvement of synaptophysin and microtubule-associated protein 2 in the neuroprotective effect of berberine in an amyloid beta-induced rat model of Alzheimer's disease

    Akbarizadeh-Mashkani MH, Afshinmajd S, Iranzadeh S et al. · Avicenna journal of phytomedicine · 2025

  74. 0.80

    Scutellaria Baicalensis Georgi Stem and Leaf Flavonoids Ameliorate the Learning and Memory Impairment in Rats Induced by Okadaic Acid

    Ma S, Xu CC, Dong YC et al. · Combinatorial chemistry & high throughput screening · 2025

  75. 0.80

    Propyl Gallate Attenuates Methylglyoxal-Induced Alzheimer-like Cognitive Deficits and Neuroinflammation in Mice

    Tsai HY, Qiu J, Liao HW et al. · International journal of molecular sciences · 2026

  76. 0.80

    Neuroprotective Effects of N-methyl-(2S, 4R)-trans-4-hydroxy-L-proline (NMP) against Amyloid-beta-Induced Alzheimer's Disease Mouse Model

    Ali J, Khan A, Park JS et al. · Nutrients · 2023

  77. 0.80

    Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis

    Alharbi KM, Alshehri SA, Almarwani WA et al. · Current Alzheimer research · 2024

  78. 0.80

    Downregulation of ATF-4 Attenuates the Endoplasmic Reticulum Stress-Mediated Neuroinflammation and Cognitive Impairment in Experimentally Induced Alzheimer's Disease Model

    Goswami P, Akhter J, Mangla A et al. · Molecular neurobiology · 2024

  79. 0.79

    Neurotrophic factor neuritin ameliorates streptozotocin-induced Alzheimer's disease-like impairment of memory, neuroinflammation, apoptotic factors and compensates hippocampal neuritin expression

    Kazemi M, Esmaeili-Mahani S, Abbasnejad M et al. · Behavioural brain research · 2025

  80. 0.79

    Morin attenuates memory deficits in a rat model of Alzheimer's disease by ameliorating oxidative stress and neuroinflammation

    Mohammadi N, Asle-Rousta M, Rahnema M et al. · European journal of pharmacology · 2021

  81. 0.79

    GC/MS and LC-ESI-MS Analysis of Conocarpus erectus Leaves Extract via Regulating Amyloid-beta-Peptide, Tau Protein, Neurotransmitters, Inflammation and Oxidative Stress against AlCl(3)-Induced Alzheimer's Disease in Rats

    Nasr NN, El-Hagrassi AM, Ahmed YR et al. · Chemistry & biodiversity · 2025

  82. 0.79

    5-Methyltetrahydrofolate Alleviates Memory Impairment in a Rat Model of Alzheimer's Disease Induced by D-Galactose and Aluminum Chloride

    Zhang Z, Wu H, Qi S et al. · International journal of environmental research and public health · 2022

  83. 0.79

    Neuroprotective Effects of a 3-Amino Quinazoline Derivative via Keap1-Nrf2 Pathway Activation in an ICV-STZ-Induced Rat Model of Sporadic Alzheimer's Disease

    Maheta P, Patel C, Parmar D et al. · ACS chemical neuroscience · 2025

  84. 0.79

    Voglibose attenuates cognitive impairment, Abeta aggregation, oxidative stress, and neuroinflammation in streptozotocin-induced Alzheimer's disease rat model

    Rajkumar M, Kannan S, Thangaraj R · Inflammopharmacology · 2023

  85. 0.79

    Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer's Disease

    Samant NP, Gupta GL · Neurotoxicity research · 2022

  86. 0.79

    Dimethyl fumarate ameliorates amyloid-beta generated cognitive deficits by inhibiting RIPK1/RIPK3/MLKL necroptosis signalling in rats

    Guin S, Jangli A, Dandekar MP · International immunopharmacology · 2026

  87. 0.79

    Ambroxol confers neuroprotection against scopolamine-induced Alzheimer's-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3beta signaling pathways

    Ahmad W, Choe K, Ahmad R et al. · Frontiers in aging neuroscience · 2025

  88. 0.79

    Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats

    Badrikoohi M, Esmaeili-Bandboni A, Babaei P · Brain research bulletin · 2022

  89. 0.79

    Administration of Cilostazol Mitigates Learning and Memory Disturbance in a Rat Model of Amnesia by Modifying Cholinergic Function and Neuroinflammation

    Sani SSM, Eidi A, Rajabian A et al. · Molecular neurobiology · 2025

  90. 0.79

    Effects of co-administered melatonin and methylphenidate on cognitive impairment and histopathological alterations in an AlCl(3)-induced neurotoxicity model of alzheimer's disease in BALB/C mice

    Mohammadi F, Koohi MK, Adeli S et al. · Scientific reports · 2026

  91. 0.79

    Barbaloin's Chemical Intervention in Aluminum Chloride Induced Cognitive Deficits and Changes in Rats through Modulation of Oxidative Stress, Cytokines, and BDNF Expression

    Kazmi I, Afzal M, Imam F et al. · ACS omega · 2024

  92. 0.79

    3-(2,4-Dimethylbenzylidene)-6-chloroindolin-2-one Alleviates Memory Impairment in D-Galactose-induced Alzheimer Like Pathology in a Mouse Model

    Younas S, Badshah I, Akbar K et al. · Current neuropharmacology · 2026

  93. 0.79

    Assessment of Modified Citrus Pectin's Effects on Dementia in the Scopolamine-Induced Alzheimer's Model in Adult Male Wistar Rats

    Akgol J, Kutlay O, Keskin Aktan A et al. · Current issues in molecular biology · 2024

  94. 0.78

    EGFR-Annexin A2 signaling-mediated tauopathy in amyloid-beta and aluminum chloride-induced Alzheimer's disease and its modulation by the HDAC inhibitor butyrate

    Jayaswamy PK, Ambrish T, Sangamesh VC et al. · Ecotoxicology and environmental safety · 2026

  95. 0.78

    Protective Effect of Biobran/MGN-3 against Sporadic Alzheimer's Disease Mouse Model: Possible Role of Oxidative Stress and Apoptotic Pathways

    Ghoneum MH, El Sayed NS · Oxidative medicine and cellular longevity · 2021

  96. 0.78

    Effect of simultaneous application of adenosine A1 receptor agonist and A2A receptor antagonist on memory, inflammatory factors, and PSD-95 in lipopolysaccharide-induced memory impairment

    Ensandoust T, Khakpour-Taleghani B, Jafari A et al. · Behavioural brain research · 2025

  97. 0.78

    Vitexin Protects Against Scopolamine-Induced Cognitive Impairment by Preserving Synaptic Integrity and Modulating Nrf2/HO-1 and NF-kappaB Signaling Pathways

    Yildirim C, Cevik S, Bal R et al. · Molecular neurobiology · 2026

  98. 0.78

    Inhibition of Pro-Inflammatory Microglia with Minocycline Improves Cognitive and Sleep-Wake Dysfunction Under Respiratory Stress in a Sporadic Model for Alzheimer's Disease

    Vicente MC, Paneghini JL, Stabile AM et al. · Journal of Alzheimer's disease : JAD · 2023

  99. 0.78

    Gelatin/polyethylene glycol-loaded magnesium hydroxide nanocomposite to attenuate acetylcholinesterase, neurotoxicity, and activation of GPR55 protein in rat models of Alzheimer's disease

    Rajkumar M, Navaneethakrishnan S, Muthukumar S et al. · Journal of chemical neuroanatomy · 2023

  100. 0.78

    The synergistic effect of nanocurcumin and donepezil on Alzheimer's via PI3K/AKT/GSK-3beta pathway modulating

    Beltagy DM, Nawar NF, Mohamed TM et al. · Prostaglandins & other lipid mediators · 2024

  101. 0.78

    Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Abeta1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway

    Hasan N, Zameer S, Najmi AK et al. · Pharmacological reports : PR · 2021

  102. 0.78

    Mangostanaxanthone IV Ameliorates Streptozotocin-Induced Neuro-Inflammation, Amyloid Deposition, and Tau Hyperphosphorylation via Modulating PI3K/Akt/GSK-3beta Pathway

    Abdallah HM, El Sayed NS, Sirwi A et al. · Biology · 2021

  103. 0.78

    Neuroprotective Effects of a Benzofuran-Containing Selenium in a Mouse Alzheimer's Disease Model: Molecular, Biochemical, and Behavioral Analyses

    Hall TK, Paim MP, da Costa P et al. · ACS chemical neuroscience · 2025

  104. 0.77

    Magnolol mitigates neuroinflammation via NF-kappaB/IL-6/IL-1beta pathways in AlCl(3)-induced Alzheimer's disease: insights from in-vivo and in-silico investigations

    Lin F, Teng Y · 3 Biotech · 2026

  105. 0.77

    Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats

    Gomaa AA, Farghaly HSM, Ahmed AM et al. · International immunopharmacology · 2023

  106. 0.77

    Neuroprotective effects of ononin against the aluminium chloride-induced Alzheimer's disease in rats

    Chen X, Zhang M, Ahmed M et al. · Saudi journal of biological sciences · 2021

  107. 0.77

    Saponins and flavonoids from Bacopa floribunda plant extract exhibit antioxidant and anti-inflammatory effects on amyloid beta 1-42-induced Alzheimer's disease in BALB/c mice

    Oyeleke MB, Owoyele BV · Journal of ethnopharmacology · 2022

  108. 0.77

    Dapagliflozin ameliorates Alzheimer's disease in rats via stimulating the protective arm of renin angiotensin system and suppressing neuroinflammation

    Awwad ZM · Inflammopharmacology · 2026

  109. 0.77

    An analysis of the therapeutic efficacy and underlying mechanisms of combining lycopene with dental pulp stem cells to ameliorate alzheimer's disease in rats

    Xu Z, Zhu Y, Liu L et al. · Metabolic brain disease · 2025

  110. 0.77

    Betanin-encapsulated nanoparticles mitigate neurotoxicity against AlCl(3)-induced Alzheimer's disease via modulation of AChE/TNF-alpha/IL-1beta expression

    Razzaq R, Ahmed T, Butt AM et al. · Biochemical and biophysical research communications · 2026

  111. 0.77

    Acanthopanax Senticosus Saponins Prevent Cognitive Decline in Rats with Alzheimer's Disease

    Cui XM, Wang W, Yang L et al. · International journal of molecular sciences · 2025

  112. 0.77

    Effects of Black Garlic Extract and Nanoemulsion on the Deoxy Corticosterone Acetate-Salt Induced Hypertension and Its Associated Mild Cognitive Impairment in Rats

    Chen CY, Tsai TY, Chen BH · Antioxidants (Basel, Switzerland) · 2021

  113. 0.77

    Protective effect of andrographolide against STZ induced Alzheimer's disease in experimental rats: possible neuromodulation and Abeta((1-42)) analysis

    Patel R, Kaur K, Singh S · Inflammopharmacology · 2021

  114. 0.76

    Effect of providing purple sweet potato water extract on tumor necrosis factor-alpha levels, protein 53 expression, glial fibrillary acidic protein expression, brain-derived neurotrophic factor levels, and spatial working memory in rats with d-galactose induction

    Widyastuti K, Mahadewa TGB, Suprapta DN et al. · Dementia & neuropsychologia · 2022

  115. 0.76

    Glucagon-like peptide-1 analog improves neuronal and behavioral impairment and promotes neuroprotection in a rat model of aluminum-induced dementia

    Abd El-Rady NM, Ahmed A, Abdel-Rady MM et al. · Physiological reports · 2021

  116. 0.76

    Hippocampal Klotho expression is associated with the neuroprotective effects of metformin against ICV-STZ-induced cognitive deficits

    Shanehbandpour-Tabari F, Golchoobian R, Pourabdolhossein F · European journal of pharmacology · 2026

  117. 0.76

    Multidimensional Evaluation of the Streptozotocin-Induced Alzheimer's Model: Integrating Molecular, Histopathological, and Behavioral Correlates Over Time

    Bavafa A, Meftahi GH, Pirzad Jahromi G · Neurochemical research · 2025

  118. 0.76

    Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model

    Verma N, Gupta JK, Varshney KK et al. · Drug metabolism letters · 2021

  119. 0.76

    Combined vitamin D(3) and dimethyl fumarate treatment alleviates cognitive dysfunction, oxidative stress, and inflammation in a rat model of sporadic Alzheimer's disease

    Piekarczyk N, Berezka P, Majkutewicz I et al. · Free radical biology & medicine · 2025

  120. 0.76

    Neuroprotective effect of transient receptor potential Vanilloid 1 agonist capsaicin in Alzheimer's disease model induced with okadaic acid

    Cakir M, Yuksel F, Mustafa Ozkut M et al. · International immunopharmacology · 2023

  121. 0.76

    The role of sleep deprivation in streptozotocin-induced Alzheimer's disease-like sporadic dementia in rats with respect to the serum level of oxidative and inflammatory markers

    Arjmandi-Rad S, Zarrindast MR, Shadfar S et al. · Experimental brain research · 2022

  122. 0.76

    Astaxanthin nanoemulsion improves cognitive function and synaptic integrity in Streptozotocin-induced Alzheimer's disease model

    Chik MW, Meor Mohd Affandi MMR, Mohd Nor Hazalin NA et al. · Metabolic brain disease · 2025

  123. 0.76

    Hydrogen sulfide and mesenchymal stem cells-extracted microvesicles attenuate LPS-induced Alzheimer's disease

    Aboulhoda BE, Rashed LA, Ahmed H et al. · Journal of cellular physiology · 2021

  124. 0.75

    Water-Soluble Ginseng Oligosaccharides Prevent Scopolamine-Induced Cholinergic Dysfunction and Inflammatory Cytokine Overexpression

    Zeng T, Zhang C, Sun L et al. · Cell biochemistry and biophysics · 2025

  125. 0.75

    High-intensity interval training versus mesenchymal stem cells in amyloid-beta-induced Alzheimer's disease: comparative effects on cognitive function,hippocampal inflammation, oxidative balance, and BDNF

    Hosseini MS, Saheli M, RajiZadeh MA et al. · Biochemical and biophysical research communications · 2026

  126. 0.75

    Neuroprotective effect of alpha-pinene is mediated by suppression of the TNF-alpha/NF-kappaB pathway in Alzheimer's disease rat model

    Khan-Mohammadi-Khorrami MK, Asle-Rousta M, Rahnema M et al. · Journal of biochemical and molecular toxicology · 2022

  127. 0.75

    Repurposing of cabergoline to improve cognitive decline in D-galactose-injected ovariectomized rats: Modulation of AKT/mTOR, GLT-1/P38-MAPK, and ERK1/2 signaling pathways

    Joodi SA, Khattab MM, Ibrahim WW · Toxicology and applied pharmacology · 2025

  128. 0.75

    The effects of green tea on cognitive impairments in the rat model of Alzheimer's disease: protection against inflammatory and oxidative damage

    Amirpour M, Mirshekar MA, Sedaghat G et al. · Nutritional neuroscience · 2022

  129. 0.75

    Sesame oil mitigates memory impairment, oxidative stress, and neurodegeneration in a rat model of Alzheimer's disease. A pivotal role of NF-kappaB/p38MAPK/BDNF/PPAR-gamma pathways

    Mohamed EA, Ahmed HI, Zaky HS et al. · Journal of ethnopharmacology · 2021

  130. 0.75

    Pentoxifylline as Add-On Treatment to Donepezil in Copper Sulphate-Induced Alzheimer's Disease-Like Neurodegeneration in Rats

    Elseweidy MM, Mahrous M, Ali SI et al. · Neurotoxicity research · 2023

  131. 0.75

    Neuroprotective Profile of Triazole Grandisin Analogue against Amyloid-Beta Oligomer-Induced Cognitive Impairment

    Andrade VHBd, M Rodrigues EY, Dias NAF et al. · ACS chemical neuroscience · 2023

  132. 0.75

    Adipose tissue-derived mesenchymal stem cells ameliorate cognitive impairment in Alzheimer's disease rat model: Emerging role of SIRT1

    Nabil M, Kassem DH, Ali AA et al. · BioFactors (Oxford, England) · 2023

  133. 0.75

    Canagliflozin Mitigated Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice: Role of AMPK/SIRT-1 Signaling Pathway in Modulating Neuroinflammation

    Khamies SM, El-Yamany MF, Ibrahim SM · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024

  134. 0.75

    Repositioning of baricitinib for management of memory impairment in ovariectomized/D-galactose treated rats: A potential role of JAK2/STAT3-PI3K/AKT/mTOR signaling pathway

    Hindam MO, Ahmed LA, El Sayed NS et al. · Life sciences · 2024

  135. 0.75

    Boswellic acids ameliorate neurodegeneration induced by AlCl(3): the implication of Wnt/beta-catenin pathway

    Mohamed EA, Ahmed HI, Zaky HS et al. · Environmental science and pollution research international · 2022

  136. 0.75

    Ficus deltoidea preserves neuronal-glial ultrastructure and attenuates neuroinflammation in an Alzheimer's disease-like rat model

    Ayuba M, Che Mohd Nassir CMN, Abdul Hamid H et al. · Nutritional neuroscience · 2026

  137. 0.74

    Efficacy of curcumin-selenium nanoemulsion in alleviating oxidative damage induced by aluminum chloride in a rat model of Alzheimer's disease

    Awad SM, Attia YA, ElSayed H et al. · Journal of molecular histology · 2025

  138. 0.74

    The involvement of neuroinflammation in an animal model of dementia and depression

    Zabot GC, Medeiros EB, Macarini BMN et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2024

  139. 0.74

    Aqueous extract of Ceratonia siliqua L. leaves elicits antioxidant, anti-inflammatory, and AChE inhibiting effects in amyloid-beta42-induced cognitive deficit mice: Role of alpha7-nAChR in modulating Jak2/PI3K/Akt/GSK-3beta/beta-catenin cascade

    El Sayed NS, Abidar S, Nhiri M et al. · Phytotherapy research : PTR · 2023

  140. 0.74

    Syringaresinol from Cinnamomum cassia (L.) J.Presl ameliorates cognitive deficits and AD pathology via AMPK in a DM-AD mouse model

    Manzoor M, Iqbal MO, Dan W et al. · Journal of ethnopharmacology · 2025

  141. 0.74

    Crocin drives intestinal microbiota variation in a rat model of Alzheimer's disease by reducing DKK3 expression

    Yang X, Jiang M, Wu M et al. · Brain research · 2025

  142. 0.74

    Histological and imunohistochemical alterations of hippocampus and prefrontal cortex in a rat model of Alzheimer like-disease with a preferential role of the flavonoid "hesperidin"

    Mandour DA, Bendary MA, Alsemeh AE · Journal of molecular histology · 2021

  143. 0.74

    Protective effect of alpha-linoleic acid on Abeta-induced oxidative stress, neuroinflammation, and memory impairment by alteration of alpha7 nAChR and NMDAR gene expression in the hippocampus of rats

    Tofighi N, Asle-Rousta M, Rahnema M et al. · Neurotoxicology · 2021

  144. 0.74

    Tirzepatide attenuates neurotoxicity by suppressing inflammation, apoptosis and restoring neurotrophin expression in an Alzheimer's disease-like rat model

    Attia MSM, Ahmad SF, Nadeem A et al. · Metabolic brain disease · 2026

  145. 0.74

    Allicin ameliorates aluminium- and copper-induced cognitive dysfunction in Wistar rats: relevance to neuro-inflammation, neurotransmitters and Abeta((1-42)) analysis

    Kaur S, Raj K, Gupta YK et al. · Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2021

  146. 0.74

    Neuroprotective effects of trans-anethole on AlCl(3)-induced memory impairment: targeting AChE, oxidative stress, and NLRP3 inflammasome: a promising approach for neurodegeneration prevention

    Bagwe Parab S, Tripathi P, Barve K et al. · Metabolic brain disease · 2026

  147. 0.74

    Galantamine-Escitalopram Combination Therapy in Alzheimer's Comorbid Depression Model in Mice: Role of BDNF/KYN Pathways, Neuroinflammation, and Oxidative Stress

    Bajaj S, Mahesh R · ACS omega · 2026

  148. 0.73

    Brazilian green propolis prevent Alzheimer's disease-like cognitive impairment induced by amyloid beta in mice

    Ito T, Degawa T, Okumura N · BMC complementary medicine and therapies · 2023

  149. 0.73

    Benincasa hispida alleviates amyloid pathology by inhibition of Keap1/Nrf2-axis: Emphasis on oxidative and inflammatory stress involved in Alzheimer's disease model

    Rapaka D, Bitra VR, Ummidi R et al. · Neuropeptides · 2021

  150. 0.73

    Neuroprotective Effect of Empagliflozin/Rivastigmine in Alzheimer's Disease Rat Model: Optimization of Multifaceted Mechanism of Action

    Abdel-Lah ES, Hamad N, Taha AF et al. · Drug development research · 2025

  151. 0.73

    Lipopolysaccharide induced neuroprotective effects of bacterial protease against Alzheimer's disease in male Wistar albino rats

    Azzam SM, Abdel Rahman AAS, Ahmed-Farid OA et al. · International journal of biological macromolecules · 2023

  152. 0.73

    Moringa oleifera-supplemented diet protect against cortico-hippocampal neuronal degeneration in scopolamine-induced spatial memory deficit in mice: role of oxido-inflammatory and cholinergic neurotransmission pathway

    Onasanwo SA, Adamaigbo VO, Adebayo OG et al. · Metabolic brain disease · 2021

  153. 0.73

    Pretreatment with Liposome-Encapsulated Shrimp Shell Extract Attenuated Neuronal Damage and Death in Abeta(1-42)-Induced Memory Deficits in Rats

    Kuedo Z, Binlateh T, Benjakul S et al. · Neurochemical research · 2024

  154. 0.73

    Therapeutic Effects of Hydrogen Gas Inhalation on Trimethyltin-Induced Neurotoxicity and Cognitive Impairment in the C57BL/6 Mice Model

    Jeong ES, Bajgai J, You IS et al. · International journal of molecular sciences · 2021

  155. 0.73

    Exploring the molecular mechanisms underlying neuroprotective effect of ellagic acid in okadaic acid-induced Alzheimer's phenotype

    Baluchnejadmojarad T, Roghani M · Metabolic brain disease · 2024

  156. 0.73

    Anethole Ameliorates Scopolamine-Induced Memory Deficits and Neuronal Damage Through Antioxidant, Anti-Inflammatory, and Anticholinesterase Activities in Rats

    Khoshnam SE, Sarkaki A, Farbood Y et al. · Neurochemical research · 2025

  157. 0.73

    Metformin Prevents NDEA-Induced Memory Impairments Associated with Attenuating Beta-Amyloid, Tumor Necrosis Factor-Alpha, and Interleukin-6 Levels in the Hippocampus of Rats

    Ponce-Lopez T, Gonzalez Alvarez Tostado JA, Dias F et al. · Biomolecules · 2023

  158. 0.73

    Sinomenine Attenuates Trimethyltin-Induced Cognitive Decline via Targeting Hippocampal Oxidative Stress and Neuroinflammation

    Rostami A, Taleahmad F, Haddadzadeh-Niri N et al. · Journal of molecular neuroscience : MN · 2022

  159. 0.73

    Neurobehavioral and Molecular Rescue by Dapagliflozin in Aluminum Chloride-Induced Alzheimer's Model: Possible Relevance of NF-kappaB and Abeta((1-42))

    Singh L, Gupta GD, Singh S · Assay and drug development technologies · 2026

  160. 0.73

    Abnormal lipid metabolism and inflammatory response induced by aluminum led to the cognitive decline in mice

    Feng R, Chen Z, Chen L et al. · Neurotoxicology · 2025

  161. 0.73

    Gallic acid enhances memory, learning and reduces neuroinflammation in a rat model of scopolamine-induced cholinergic dysfunction

    Alikhanzade M, Khosravi M, Hosseini M et al. · Inflammopharmacology · 2025

  162. 0.73

    PPAR-gamma modulation restores the adiponectin-AMPK-AKT axis to attenuate metabolic stress-associated alzheimer's pathology

    Saini D, Mujeeb M, Akhtar M et al. · Molecular biology reports · 2026

  163. 0.73

    Saraswata Ghrita mitigates AlCl(3)- and D-galactose-induced cognitive deficits in a murine Alzheimer's-like model: In silico and in vivo insights

    Badal R, Kaur B, Singh H et al. · Brain research bulletin · 2026

  164. 0.73

    Evaluating the Role of N-Acetyl-L-Tryptophan in the Abeta 1-42-Induced Neuroinflammation and Cognitive Decline in Alzheimer's Disease

    Satarker S, Gurram PC, Nassar A et al. · Molecular neurobiology · 2024

  165. 0.72

    Exploration of Imatinib involved in amyloidogenesis as a common foundation for type-2 diabetes mellitus (T2DM) and Alzheimer's disease (AD)

    Mannan A, Singh S, Mohan M et al. · Metabolic brain disease · 2025

  166. 0.72

    Chitosan/PLA-loaded Magnesium oxide nanocomposite to attenuate oxidative stress, neuroinflammation and neurotoxicity in rat models of Alzheimer's disease

    Rajkumar M, Govindaraj P, Vimala K et al. · Metabolic brain disease · 2024

  167. 0.72

    Differential neuroprotective effect of curcuminoid formulations in aluminum chloride-induced Alzheimer's disease

    Shabbir A, Rehman K, Akash MSH et al. · Environmental science and pollution research international · 2022

  168. 0.72

    Celastrus paniculatus oil ameliorates NF-KB mediated neuroinflammation and synaptic plasticity in the scopolamine-induced cognitive impairment rat model

    Faldu KG, Patel SS, Shah JS · Metabolic brain disease · 2023

  169. 0.72

    Neuroprotective Effects of Isoquercetin: An In Vitro and In Vivo Study

    Yang Q, Kang ZH, Zhang J et al. · Cell journal · 2021

  170. 0.72

    Multitarget pharmacological effects of Lawsone in mitigating Alzheimer's disease

    Bashir MA, Ullah I, Batool GA et al. · European journal of pharmacology · 2026

  171. 0.72

    Acetoacetate Improves Memory in Alzheimer's Mice via Promoting Brain-Derived Neurotrophic Factor and Inhibiting Inflammation

    Wu XJ, Shu QQ, Wang B et al. · American journal of Alzheimer's disease and other dementias · 2022

  172. 0.72

    Schisandrin B combined with vitamin D inhibits NLRP3 inflammasome to improve cognitive dysfunction and Alzheimer's disease

    Wang Y, Deng L, Wang L et al. · European journal of pharmacology · 2025

  173. 0.72

    Magnoflorine-Loaded Chitosan Collagen Nanocapsules Ameliorate Cognitive Deficit in Scopolamine-Induced Alzheimer's Disease-like Conditions in a Rat Model by Downregulating IL-1beta, IL-6, TNF-alpha, and Oxidative Stress and Upregulating Brain-Derived Neurotrophic Factor and DCX Expressions

    Bashir DJ, Manzoor S, Sarfaraj M et al. · ACS omega · 2023

  174. 0.72

    HPLC-PDA-MS/MS profiling of secondary metabolites from Opuntia ficus-indica cladode, peel and fruit pulp extracts and their antioxidant, neuroprotective effect in rats with aluminum chloride induced neurotoxicity

    El-Hawary SS, Sobeh M, Badr WK et al. · Saudi journal of biological sciences · 2020

  175. 0.71

    AMBMP Hydrochloride Reverses STZ-Induced Alzheimer-Type Dementia Associated with Wnt/beta-catenin/TLR4 Signaling

    Kalra P, Chaturvedi D, Kumar A et al. · Neuromolecular medicine · 2026

  176. 0.71

    Unveiling the neuroprotective effects of pomegranate extract and/or physical activity against aluminum chloride-induced Alzheimer's disease in rats: modulation of multitude pathways

    Hamdan AME, Alahdal H, Al-Zubaidy HFS et al. · Frontiers in pharmacology · 2026

  177. 0.71

    3-(3-(diethylamino)propyl)-2-(4-(methylthio)phenyl)thiazolidin-4-one Attenuates Scopolamine-induced Cognitive Impairment in Rats: Insights Into Neuroprotective Effects

    de Souza AA, Goularte KCM, Piccoli RC et al. · Molecular neurobiology · 2025

  178. 0.71

    JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats

    Wong-Guerra M, Montano-Peguero Y, Ramirez-Sanchez J et al. · Neurotoxicology · 2021

  179. 0.71

    Therapeutic Potential of Stearylamine-Conjugated Phenylboronic Acid-Modified Nanocarriers of 4-Allyl Pyrocatechol in Modulating Sialylation and Neuroinflammation in Scopolamine-Induced Cognitive Impairment in the Rat Model

    Katti VB, Kolusu AS, Madhana RM et al. · Molecular pharmaceutics · 2026

  180. 0.71

    Thymol in Trachyspermum ammi seed extract exhibits neuroprotection, learning, and memory enhancement in scopolamine-induced Alzheimer's disease mouse model

    Timalsina B, Haque MN, Choi HJ et al. · Phytotherapy research : PTR · 2023

  181. 0.71

    Investigating the neuroprotective role of Synta-66 in type-2 diabetes mellitus-induced dementia in rats

    Mannan A, Mohan M, Singh S et al. · The Journal of pharmacy and pharmacology · 2025

  182. 0.71

    Quercetin ameliorates cognitive deficit, expression of amyloid precursor gene, and pro-inflammatory cytokines in an experimental models of Alzheimer's disease in Wistar rats

    Safarzadeh E, Ataei S, Akbari M et al. · Experimental gerontology · 2024

  183. 0.70

    Exploring the Neuroprotective Effects of Rufinamide in a Streptozotocin-Induced Dementia Model

    Kaur D, Grewal AK, Fouad D et al. · Cellular and molecular neurobiology · 2024

  184. 0.70

    Protective mechanism of apigenin in proton pump inhibitor-associated progressive cognitive impairment in adult zebrafish via targeting GSK-3beta pathway

    Bhratee A, Chatterjee D, Kaur R et al. · Metabolic brain disease · 2025

  185. 0.70

    Tangeretin offers neuroprotection against colchicine-induced memory impairment in Wistar rats by modulating the antioxidant milieu, inflammatory mediators and oxidative stress in the brain tissue

    Ogunro OB, Karigidi ME, Gyebi GA et al. · BMC complementary medicine and therapies · 2025

  186. 0.70

    Neuroprotective and Immunomodulatory effects of human hair follicle stem cells on streptozotocin-induced memory impairment in rats: insights into inflammation and neurotrophic mechanisms

    Hooshmandi E, Rafiei E, Owjfard M et al. · Molecular biology reports · 2025

  187. 0.70

    Yttrium oxide nanoparticles alleviate cognitive deficits, neuroinflammation, and mitochondrial biogenesis impairment induced by streptozotocin

    Baghaee P, Yoonesi M, Esfahani DE et al. · Neuroscience letters · 2024

  188. 0.70

    Effect of Curcumin and Coenzyme Q10 Alone and in Combination on Learning and Memory in an Animal Model of Alzheimer's Disease

    Kumar P, Singh A, Kumar A et al. · Biomedicines · 2023

  189. 0.70

    Neuroprotective Effect of Saroglitazar on Scopolamine-Induced Alzheimer's in Rats: Insights into the Underlying Mechanisms

    Sandeep Ganesh G, Konduri P, Kolusu AS et al. · ACS chemical neuroscience · 2023

  190. 0.70

    Lactobacillus paracasei HP7 with Portulaca oleracea Linn. Alleviates Scopolamine-Induced Cognitive Decline via Regulation of Neurotrophic Factor and Inflammation Signals in Mice

    Kim JH, Ra JH, Kang H et al. · Preventive nutrition and food science · 2022

  191. 0.70

    Piperine Prevents Scopolamine-Induced Cognitive Impairment via its Antioxidant and Anti-Inflammatory Roles; Suggesting Potential Modulation of Necroptosis-Related Genes Including MLKL and TNF-alpha

    Kopi TA, Shanehbandpour-Tabari F, Arani RM et al. · Journal of molecular neuroscience : MN · 2025

  192. 0.70

    Emoxypine succinate modulates behavioral and molecular responses in zebrafish model of iron Overload-Induced neuroinflammation via CDK5/GSK3- beta and NLRP3 inflammasome pathway

    Bagwe Parab S, Kaur G · Brain research · 2025

  193. 0.70

    Ferulic acid ameliorates bisphenol A (BPA)-induced Alzheimer's disease-like pathology through Akt-ERK crosstalk pathway in male rats

    Khalifa M, Fayed RH, Ahmed YH et al. · Psychopharmacology · 2025

  194. 0.70

    Amelioration of intracerebroventricular streptozotocin-induced cognitive dysfunction by Ocimum sanctum L. through the modulation of inflammation and GLP-1 levels

    Patel B, Sheth D, Vyas A et al. · Metabolic brain disease · 2022

  195. 0.70

    Poliumoside inhibits apoptosis, oxidative stress and neuro-inflammation to prevent intracerebroventricular streptozotocin-induced cognitive dysfunction in Sprague-Dawley rats: an in vivo, in vitro and in silico study

    Zuo Y, Chen B, Li X et al. · Folia morphologica · 2025

  196. 0.70

    Comparison of Yizhiqingxin formula extraction methods and their pharmacodynamic differences

    Wei W, Pei H, Ma LN et al. · Frontiers in neuroscience · 2023

  197. 0.69

    Pharmacological mechanism of xanthoangelol underlying Nrf-2/TRPV1 and anti-apoptotic pathway against scopolamine-induced amnesia in mice

    Syed Z, Shal B, Azhar A et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022

  198. 0.69

    H3 relaxin mediated neuroprotection in Alzheimer's disease pathology induced by streptozotocin in mouse models: Impact on memory improvement, autophagy and PI3K/Akt-mTOR signalling pathway

    Zhao H, Sun Y, Hussain SA et al. · Acta pharmaceutica (Zagreb, Croatia) · 2026

  199. 0.69

    Simultaneous inhibition of cholinesterase and antagonism of histamine H3 receptors alleviates cognitive deficits and mitigates apoptosis in scopolamine-induced amnesia in mice

    Ebdah W, Thomas SD, Eissa N et al. · Frontiers in behavioral neuroscience · 2026

  200. 0.69

    Umuhengerin Neuroprotective Effects in Streptozotocin-Induced Alzheimer's Disease Mouse Model via Targeting Nrf2 and NF-Kbeta Signaling Cascades

    Sirwi A, El Sayed NS, Abdallah HM et al. · Antioxidants (Basel, Switzerland) · 2021

  201. 0.69

    Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer's Disease Rat Model

    Duan L, Qian X, Wang Q et al. · Journal of Alzheimer's disease : JAD · 2022

  202. 0.69

    Impact of levetiracetam on cognitive impairment, neuroinflammation, oxidative stress, and neuronal apoptosis caused by lipopolysaccharides in rats

    Mani V, Rashed Almutairi S · Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023

  203. 0.69

    Protective effects of curcumin and resveratrol on neurodegeneration and cognitive dysfunction in a streptozotocin-induced alzheimer rat model

    Soylemez DO, Unur E, Sagir D · Scientific reports · 2026

  204. 0.69

    Effects of Rosemary Oil (Rosmarinus officinalis) supplementation on the fate of the transplanted human olfactory bulb neural stem cells against ibotenic acid-induced neurotoxicity (Alzheimer model) in rat

    Rezk S, Lashen S, El-Adl M et al. · Metabolic brain disease · 2022

  205. 0.69

    Ziziphus jujuba (Rhamnaceae) Alleviates Working Memory Impairment and Restores Neurochemical Alterations in the Prefrontal Cortex of D-Galactose-Treated Rats

    Kandeda AK, Nguedia D, Ayissi ER et al. · Evidence-based complementary and alternative medicine : eCAM · 2021

  206. 0.69

    Dimethyl Fumarate as the Peripheral Blood Inflammatory Mediators Inhibitor in Prevention of Streptozotocin-Induced Neuroinflammation in Aged Rats

    Wrona D, Majkutewicz I, Swiatek G et al. · Journal of inflammation research · 2022

  207. 0.69

    Syringic acid mitigates scopolamine-induced cognitive impairment by regulating PSD-95 and GSK-3beta and by preventing neurodegeneration in an Alzheimer-like rat model

    Altindag F, Bayir MH, Alhalboosi JKI et al. · Experimental neurology · 2026

  208. 0.69

    Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation

    Leone P, Mincheva G, Balzano T et al. · Biomedicines · 2022

  209. 0.69

    Magnolol attenuates the locomotor impairment, cognitive deficit, and neuroinflammation in Alzheimer's disease mice with brain insulin resistance via up-regulating miR-200c

    Chen T, Shou L, Guo X et al. · Bioengineered · 2022

  210. 0.68

    Nervonic acid reduces the cognitive and neurological disturbances induced by combined doses of D-galactose/AlCl(3) in mice

    Aihaiti M, Shi H, Liu Y et al. · Food science & nutrition · 2023

  211. 0.68

    Treadmill running and Levisticum Officinale extract protect against LPS-induced memory deficits by modulating neurogenesis, neuroinflammation and oxidative stress

    Amraie E, Pouraboli I, Salehi H et al. · Metabolic brain disease · 2023

  212. 0.68

    Protective effect of pterostilbene in a streptozotocin-induced mouse model of Alzheimer's disease by targeting monoamine oxidase B

    Li Q, Li X, Tian B et al. · Journal of applied toxicology : JAT · 2022

  213. 0.68

    Memantine versus Ginkgo biloba Extract: A Comparative Study on Cognitive Dysfunction Treatment in a Novel Rat Model

    Allam EAH, Assi AA, Badary DM et al. · Planta medica · 2024

  214. 0.68

    Wheatgrass extract imparts neuroprotective actions against scopolamine-induced amnesia in mice

    Katiyar P, Singh Rathore A, Banerjee S et al. · Food & function · 2022

  215. 0.68

    Therapeutic Role of l-Theanine in Mitigating Cognitive Dysfunction and Neuropathology in Scopolamine-Treated Mice

    Elbaz EM, Ibrahim SM, Rashad E et al. · ACS chemical neuroscience · 2025

  216. 0.68

    Neuroprotective Effect of Famotidine in Mouse Models of Alzheimer's Disease

    Sadiq MH, Al-Zubaidy AA · Clinical laboratory · 2024

  217. 0.68

    Anticholinergic effect of resveratrol with vitamin E on scopolamine-induced Alzheimer's disease in rats: Mechanistic approach to prevent inflammation

    Foudah AI, Devi S, Alam A et al. · Frontiers in pharmacology · 2023

  218. 0.68

    Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway

    Khalifa M, Abdelsalam RM, Safar MM et al. · Inflammopharmacology · 2022

  219. 0.68

    Propranolol reinstates mitochondrial dynamics and synaptic memory pathways through CaMKII/CREB-BDNF/ PKMzeta cascades in an AD-like rat model

    Pinky, Neha, Kaushik M et al. · Frontiers in aging neuroscience · 2026

  220. 0.68

    Effects of Minocycline on Cognitive Impairment, Hippocampal Inflammatory Response, and Hippocampal Alzheimer's Related Proteins in Aged Rats after Propofol Anesthesia

    Liang X, Zhang R · Disease markers · 2022

  221. 0.68

    Synergistic Effect of Donepezil and Neurotropic B Vitamins on Dysregulated Antioxidant, Inflammation and Neurotransmitter Status in Aluminium Chloride-Induced Neurotoxicity in Rats

    Ekundayo BE, Adewale OB, Obafemi BA et al. · Cell biochemistry and function · 2024

  222. 0.68

    Isoimperatorin therapeutic effect against aluminum induced neurotoxicity in albino mice

    Rajendran P, Althumairy D, Bani-Ismail M et al. · Frontiers in pharmacology · 2023

  223. 0.67

    Majoon-e-Boolis as a neurotherapeutic agent: cognitive and neuronal restoration in alzheimer's disease model

    Wani OH, Dhaka P, Pinky et al. · Metabolic brain disease · 2026

  224. 0.67

    Combination of docosahexaenoic acid and Ginko biloba extract improves cognitive function and hippocampal tissue damages in a mouse model of Alzheimer's disease

    Abdelmeguid NE, Khalil MIM, Elhabet R et al. · Journal of chemical neuroanatomy · 2021

  225. 0.67

    Sabinene Inhibits Lipopolysaccharide-Induced Memory Decline by Enhancing Cholinergic Function, Decreasing Molybdenum Enzymes, and Suppressing Oxidative Stress and Neuroinflammation

    Amenotie AJ, Ben-Azu B, Esuku DT et al. · Neurotoxicity research · 2025

  226. 0.67

    Effects of diverse Types of Toxoplasma gondii on the outcome of Alzheimer's disease in the rat model

    Galeh TM, Ghazvini H, Mohammadi M et al. · Microbial pathogenesis · 2023

  227. 0.67

    Myricetin alleviates learning and memory deficits in trimethyltin Alzheimer's phenotype via attenuating hippocampal endoplasmic reticulum stress and regulating inflammation and oxidative stress

    Asgari Z, Iranzadeh S, Roghani M · Brain research bulletin · 2025

  228. 0.67

    Ambroxol Improves Amyloidogenic, NF-kappaB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease

    Faldu KG, Shah JS · Drug development research · 2024

  229. 0.67

    Selenium supplementation enhanced the expression of selenoproteins in hippocampus and played a neuroprotective role in LPS-induced neuroinflammation

    Liang X, Xue Z, Zheng Y et al. · International journal of biological macromolecules · 2023

  230. 0.67

    Natural antioxidants enhance the power of physical and mental activities versus risk factors inducing progression of Alzheimer's disease in rats

    Ali AA, Abd El-Fattah AI, Abu-Elfotuh K et al. · International immunopharmacology · 2021

  231. 0.66

    Study on multi-target effects of the novel HDAC6 inhibitor W5 on Abeta/Cu(2+)-induced Alzheimer's disease model of rats

    Liu R, Guo L, Zhao Y et al. · Brain research · 2024

  232. 0.66

    The modulatory role of prime identified compounds in Geophila repens in mitigating scopolamine-induced neurotoxicity in experimental rats of Alzheimer's disease via attenuation of cholinesterase, beta-secretase, MAPt levels and inhibition of oxidative stress imparts inflammation

    Dash UC, Swain SK, Kanhar S et al. · Journal of ethnopharmacology · 2022

  233. 0.66

    Portulaca oleracea L. Methanolic Extract Protects the Brain of Male Rats Against Alzheimer's Disease

    El Rabey HA, Rezk SM, Mahmoud SA et al. · Scientifica · 2025

  234. 0.66

    Neuroprotective activity of Ulmus pumila L. in Alzheimer's disease in rats; role of neurotrophic factors

    Hussein RA, Afifi AH, Soliman AAF et al. · Heliyon · 2020

  235. 0.66

    Inhibition of mitochondrial pyruvate carrier 1 by lapatinib ditosylate mitigates Alzheimer's-like disease in D-galactose/ovariectomized rats

    Mansour HM, Fawzy HM, El-Khatib AS et al. · Neurochemistry international · 2021

  236. 0.66

    Propofol protects rats against intra-cerebroventricular streptozotocin-induced cognitive dysfunction and neuronal damage

    Sun L, Dou X, Yang W · Folia morphologica · 2023

  237. 0.66

    Neuroprotective and nootropic effects of a standardised Siddha polyherbal formulation, Bhiramiyadhi bhavanai choornam, against beta-amyloid-Induced neurodegeneration

    Bhosale S, Chakor R, Lohidasan S et al. · Journal of ethnopharmacology · 2026

  238. 0.66

    Ameliorating the Role of Aripiprazole in Memory Deficits Induced by Intracerebroventricular Streptozotocin-Induced Dementia of Alzheimer's Type

    Gupta T, Singh V, Hefnawy M et al. · ACS omega · 2023

  239. 0.66

    Amelioration of oxidative stress and neuroinflammation in lipopolysaccharide-induced memory impairment using Rosmarinic acid in mice

    Thingore C, Kshirsagar V, Juvekar A · Metabolic brain disease · 2021

  240. 0.66

    Physical Exercise Enhances Melatonin Effect in D-Galactose/Aluminum Chloride-Induced Alzheimer's Disease of Ovariectomized Rats: Irisin Induction Associated with Upregulation of PPAR-gamma/IGF-1/BDNF and Decreasing TNF-alpha/p38-MAPK/NLRP3/GFAP Pathway

    Badawi GA, Shaaban RS, Almutairi JA et al. · Pharmaceuticals (Basel, Switzerland) · 2026

  241. 0.66

    Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia

    Erdogan MA, Kirazlar M, Yigitturk G et al. · Neurochemical research · 2022

  242. 0.66

    Nanoformulated fisetin ameliorates Alzheimer's disease via reducing proinflammatory cytokines and activating the NRF2/HO-1 pathway

    Rakshit D, Goyal R, Yadav V et al. · Nanomedicine (London, England) · 2024

  243. 0.66

    Possible Prophylactic Effects of Sulforaphane on LPS-Induced Recognition Memory Impairment Mediated by Regulating Oxidative Stress and Neuroinflammatory Proteins in the Prefrontal Cortex Region of the Brain

    Alzahrani NA, Bahaidrah KA, Mansouri RA et al. · Biomedicines · 2024

  244. 0.66

    Crocin Improves Cognitive Impairment in LPS-treated Rats through Anti-Apoptotic, Anti-Inflammatory, and Antioxidant Activities

    Dastan M, Rajaei Z, Sharifi M et al. · Molecular neurobiology · 2025

  245. 0.65

    Therapeutic potential of chrysin in regulation of interleukin-17 signaling in a repeated intranasal amyloid-beta-induced Alzheimer's disease model

    Singh Gautam A, Panda ES, Balki S et al. · Food & function · 2025

  246. 0.65

    Comparison of the chemical constituents and anti-Alzheimer's disease effects of Uncaria rhynchophylla and Uncaria tomentosa

    Xu QQ, Shaw PC, Hu Z et al. · Chinese medicine · 2021

  247. 0.65

    Polysaccharides from sea buckthorn (Hippophae rhamnoides L.) berries ameliorate cognitive dysfunction in AD mice induced by a combination of d-gal and AlCl(3) by suppressing oxidative stress and inflammation reaction

    Zhao H, Liu J, Wang Y et al. · Journal of the science of food and agriculture · 2023

  248. 0.65

    Neuroprotective effects of vildagliptin on drug induced Alzheimer's disease in rats with metabolic syndrome: Role of hippocampal klotho and AKT signaling pathways

    Yossef RR, Al-Yamany MF, Saad MA et al. · European journal of pharmacology · 2020

  249. 0.65

    Saffron (Crocus sativus L.) extract attenuates chronic scopolamine-induced cognitive impairment, amyloid beta, and neurofibrillary tangles accumulation in rats

    Patel KS, Dharamsi A, Priya M et al. · Journal of ethnopharmacology · 2024

  250. 0.65

    A supercritical fluid co-extract of turmeric powder and dried coconut shreds shows neuroprotection against AlCl(3)-induced Alzheimer's disease in rats through nose to brain delivery

    Sharma A, Ray A, Sathaye S et al. · Bioorganic chemistry · 2024

  251. 0.65

    The citrus flavonoid "Nobiletin" impedes STZ-induced Alzheimer's disease in a mouse model through regulating autophagy mastered by SIRT1/FoxO3a mechanism

    El-Maraghy SA, Reda A, Essam RM et al. · Inflammopharmacology · 2023

  252. 0.65

    Polyphenols from Conyza dioscoridis (L.) ameliorate Alzheimer's disease- like alterations through multi-targeting activities in two animal models

    Gomaa AA, Farghaly HSM, Makboul RM et al. · BMC complementary medicine and therapies · 2022

  253. 0.65

    Neuroprotective Effects of Cilomilast and Chlorogenic Acid Against Scopolamine-Induced Memory Deficits via Modulation of the cAMP/PKA-CREB-BDNF Pathway

    Mosalam EM, Atya SM, Mesbah NM et al. · International journal of molecular sciences · 2025

  254. 0.65

    Ameliorative effect of carveol on scopolamine-induced memory impairment in rats

    Latif K, Saneela S, Khan AU · Iranian journal of basic medical sciences · 2022

  255. 0.65

    Neuromodulation with low-intensity pulsed ultrasound (Lipus) combined with curcumin-gold nanoparticles (Cur-AuNPs) in an Alzheimer's disease model

    Casagrande LdR, Medeiros EB, Venturini LM et al. · Drug delivery · 2025

  256. 0.65

    An aqueous macerate of Ziziphus jujuba reduces long-term spatial memory impairment in D-galactose treated rats: role of anti-inflammatory pathways

    Kandeda AK, Nguedia D, Djeuzong E et al. · Metabolic brain disease · 2022

  257. 0.65

    Hesperidin attenuates aluminum chloride-induced cognitive impairment by modulating ERK/MAPK Signaling, tau protein immunoexpression, neuroinflammation, and microglial activation in mice

    Oria RS, Akpang KE, Ben RB et al. · Metabolic brain disease · 2026

  258. 0.65

    Supplementation of Carvacrol Attenuates Hippocampal Tumor Necrosis Factor-Alpha Level, Oxidative Stress, and Learning and Memory Dysfunction in Lipopolysaccharide-Exposed Rats

    Amooheydari Z, Rajaei Z, Alaei H et al. · Advanced biomedical research · 2022

  259. 0.65

    Ecballium elaterium attenuates neuroinflammation in an animal model of Alzheimer's disease through modulation of nuclear factor kappaB pathway

    Heysieattalab S, Sadeghi L · Avicenna journal of phytomedicine · 2022

  260. 0.65

    Rosmarinic acid attenuates lipopolysaccharide-induced neuroinflammation and cognitive impairment in rats

    Hassanzadeh-Taheri M, Ahmadi-Zohan A, Mohammadifard M et al. · Journal of chemical neuroanatomy · 2021

  261. 0.65

    Limettin and PD98059 Mitigated Alzheimer's Disease Like Pathology Induced by Streptozotocin in Mouse Model: Role of p-ERK1/2/p-GSK-3beta/p-CREB/BDNF Pathway

    Hassan RM, Elsayed NS, Assaf N et al. · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025

  262. 0.65

    Vitamin D exerts neuroprotection via SIRT1/nrf-2/ NF-kB signaling pathways against D-galactose-induced memory impairment in adult mice

    Ali A, Shah SA, Zaman N et al. · Neurochemistry international · 2021

  263. 0.64

    FTY720 Prevents Spatial Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via a SIRT3-Independent Pathway

    Zhang M, Hu Y, Zhang J et al. · Frontiers in aging neuroscience · 2020

  264. 0.64

    Triptolide injection reduces Alzheimer's disease-like pathology in mice

    Mao R, Xu S, Sun G et al. · Synapse (New York, N.Y.) · 2023

  265. 0.64

    Neuroprotective effects of carbenoxolone against amyloid-beta 1-42 oligomer-induced neuroinflammation and cognitive decline in rats

    Sharma S, Saini A, Nehru B · Neurotoxicology · 2021

  266. 0.64

    Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology

    Orciani C, Do Carmo S, Foret MK et al. · Neurobiology of aging · 2023

  267. 0.64

    Exploring the Therapeutic Potential of N-(3,4-dimethoxy phenyl)-6,7-dimethoxyquinazoline-4-amine (TKM01) in Aluminium-Induced Alzheimer's Disease-Like Model of Zebrafish

    Kashif M, Chandrabose K, Pandurangan AK · Neurochemical research · 2026

  268. 0.64

    Biochemical profiling of berberine-enriched extract in aluminum chloride induced oxidative damage and neuroinflammation

    Akash MSH, Akbar M, Rehman K et al. · Environmental science and pollution research international · 2023

  269. 0.64

    Cucurbitacin B exerts neuroprotection in a murine Alzheimer's disease model by modulating oxidative stress, inflammation, and neurotransmitter levels

    Liu Z, Kumar M, Kabra A · Frontiers in bioscience (Landmark edition) · 2022

  270. 0.64

    Pioglitazone improves learning and memory in a rat model of cholinergic dysfunction induced by scopolamine, the roles of oxidative stress and neuroinflammation

    Rajabian A, Kioumarsi Darbandi Z, Aliyari M et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2025

  271. 0.64

    Neuroprotective effect of Betalain against AlCl(3)-induced Alzheimer's disease in Sprague Dawley Rats via putative modulation of oxidative stress and nuclear factor kappa B (NF-kappaB) signaling pathway

    Shunan D, Yu M, Guan H et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021

  272. 0.63

    D-ribose-L-cysteine reduces oxidative stress and inflammatory cytokines to mitigate liver damage, and memory decline induced by copper sulfate in mice

    Isibor H, Ajayi AM, Ben-Azu B et al. · Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2022

  273. 0.63

    Neonatal maternal separation causes depressive-like behavior and potentiates memory impairment induced by amyloid-beta oligomers in adult mice

    Suman PR, Kincheski GC, Frozza RL et al. · Behavioral and brain functions : BBF · 2025

  274. 0.63

    Behavioral and Molecular Effects of Thapsigargin-Induced Brain ER- Stress: Encompassing Inflammation, MAPK, and Insulin Signaling Pathway

    Askari S, Javadpour P, Rashidi FS et al. · Life (Basel, Switzerland) · 2022

  275. 0.63

    Suppression of ER stress underlies Montelukast's neuroprotective actions in D-gal/AlCl(3)-induced Alzheimer's disease in rats

    Mahmoud AH, Ibrahim SM, El-Yamany MF et al. · Neuropharmacology · 2026

  276. 0.63

    Neuroprotective Roles of Metformin in a Streptozotocin-Induced Dementia Model in Rats

    Vizuete AFK, Moreira AP, Zin LEF et al. · Neurotoxicity research · 2025

  277. 0.63

    Neuroprotective potential of Erigeron bonariensis ethanolic extract against ovariectomized/D-galactose-induced memory impairments in female rats in relation to its metabolite fingerprint as revealed using UPLC/MS

    Ibrahim WW, Sayed RH, Abdelhameed MF et al. · Inflammopharmacology · 2024

  278. 0.63

    Nanotherapeutic potential of Baicalein-encapsulated hUC-MSC exosomes in Alzheimer's disease: Modulating oxidative stress and neuroinflammation

    Xu J, He Z, Pan Y et al. · Biomaterials advances · 2026

  279. 0.63

    Lapatinib ditosylate rescues memory impairment in D-galactose/ovariectomized rats: Potential repositioning of an anti-cancer drug for the treatment of Alzheimer's disease

    Mansour HM, Fawzy HM, El-Khatib AS et al. · Experimental neurology · 2021

  280. 0.62

    Promising neuroprotective potential of naringenin against trimethyltin-induced cognitive deficits and hippocampal neurodegeneration in rats

    Faryadras K, Golchoobian R, Iranzadeh S et al. · Frontiers in neuroscience · 2025

  281. 0.62

    Protective effects of camellia and olive oils against cognitive impairment via gut microbiota-brain communication in rats

    Chen SY, Weng MH, Li ZY et al. · Food & function · 2022

  282. 0.62

    Dihydroquercetin ameliorates LPS-induced neuroinflammation and memory deficit

    Alam Q, Krishnamurthy S · Current research in pharmacology and drug discovery · 2022

  283. 0.62

    Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer's disease in rats: role of AMPK/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress

    Abdel-Lah ES, Sherkawy HS, Mohamed WH et al. · Inflammopharmacology · 2025

  284. 0.62

    Antioxidative and Anti-inflammatory Effects of Kojic Acid in Abeta-Induced Mouse Model of Alzheimer's Disease

    Khan A, Park TJ, Ikram M et al. · Molecular neurobiology · 2021

  285. 0.62

    In Silico Prediction, Characterization, and Pre-clinical Appraisal of the Neuroprotective Effect of the Methanolic Extract of Cassytha filiformis

    R N, Dubey S, Kumar D et al. · Current neurovascular research · 2026

  286. 0.61

    Rosiridin Protects Against Aluminum Chloride-Induced Memory Impairment via Modulation of BDNF/NFkappaB/PI3K/Akt Pathway in Rats

    Alqarni SS, Afzal M, Alharbi KS et al. · Medicina (Kaunas, Lithuania) · 2024

  287. 0.61

    Effect of curcumin nanoparticles on streptozotocin-induced male Wistar rat model of Alzheimer's disease

    Noor NA, Hosny EN, Khadrawy YA et al. · Metabolic brain disease · 2022

  288. 0.61

    Pharmacological Characterization of Ruellia tuberosa Ethanolic Extract in a Rodent Model of Cognitive Impairment

    Kumar R, Tyagi N · Recent advances in inflammation & allergy drug discovery · 2026

  289. 0.61

    Investigating the Effect of Inosine on Brain Purinergic Receptors and Neurotrophic and Neuroinflammatory Parameters in an Experimental Model of Alzheimer's Disease

    Teixeira FC, Soares MSP, Blodorn EB et al. · Molecular neurobiology · 2022

  290. 0.61

    Neuroprotective effect of Tozasertib in Streptozotocin-induced alzheimer's mice model

    Kaur D, Grewal AK, Almasoudi SH et al. · Scientific reports · 2025

  291. 0.60

    Oxidative stress, inflammation, and apoptosis in Alzheimer's disease associated with HSV-1 and CMV coinfection

    Khodamoradi S, Khodaei F, Mohammadian T et al. · Virology journal · 2025

  292. 0.60

    Neuroprotective effect of nose-to-brain delivery of Asiatic acid in solid lipid nanoparticles and its mechanisms against memory dysfunction induced by Amyloid Beta(1-42) in mice

    Islamie R, Myint SLL, Rojanaratha T et al. · BMC complementary medicine and therapies · 2023

  293. 0.60

    Exploring the combined neuroprotective effects of resveratrol and hesperidin in a scopolamine-induced rat model of cognitive impairment

    Bhattacharjee B, Shakya A, Shivavedi N et al. · Neuroscience · 2025

  294. 0.60

    Neuropharmacological insights into artesunate alone and rivastigmine Co-therapy: Synergistic modulation of cognitive impairment in Alzheimer's disease

    Siraganahalli Eshwaraiah PK, Bairy KL, Kiran A et al. · European journal of pharmacology · 2026

  295. 0.60

    Neuroprotective effect of ranolazine improves behavioral discrepancies in a rat model of scopolamine-induced dementia

    Samir SM, Hassan HM, Elmowafy R et al. · Frontiers in neuroscience · 2023

  296. 0.59

    Sildenafil ameliorates Alzheimer disease via the modulation of vascular endothelial growth factor and vascular cell adhesion molecule-1 in rats

    Ibrahim MA, Haleem M, AbdelWahab SA et al. · Human & experimental toxicology · 2021

  297. 0.59

    Activation of GPR55 attenuates cognitive impairment, oxidative stress, neuroinflammation, and synaptic dysfunction in a streptozotocin-induced Alzheimer's mouse model

    Xiang X, Wang X, Wu Y et al. · Pharmacology, biochemistry, and behavior · 2022

  298. 0.59

    Methylphenidate and Rosmarinus officinalis improves cognition and regulates inflammation and synaptic gene expression in AlCl(3)-induced neurotoxicity mouse model

    Khalid A, Abbasi UA, Amber S et al. · Molecular biology reports · 2020

  299. 0.58

    Mechanisms of the Procognitive Effects of Xanthotoxin and Umbelliferone on LPS-Induced Amnesia in Mice

    Kurach L, Kulczycka-Mamona S, Kowalczyk J et al. · International journal of molecular sciences · 2021

  300. 0.58

    Zeaxanthin and Lutein Ameliorate Alzheimer's Disease-like Pathology: Modulation of Insulin Resistance, Neuroinflammation, and Acetylcholinesterase Activity in an Amyloid-beta Rat Model

    Kim DS, Kang S, Moon NR et al. · International journal of molecular sciences · 2024

  301. 0.58

    miRNA-124 alleviated memory impairment induced by d-galactose rapidly in male rats via microglia polarization

    Huang J, Chen D, Lin X et al. · Hippocampus · 2023

  302. 0.58

    Lycopene alleviates cognitive dysfunctions in an Alzheimer's disease rat model via suppressing the oxidative and neuroinflammatory signaling

    El-Kazaz SES, Hafez MH, Noreldin AE et al. · Tissue & cell · 2025

  303. 0.58

    Gallic acid ameliorates LPS-induced memory decline by modulating NF-kappaB, TNF-alpha, and Caspase 3 gene expression and attenuating oxidative stress and neuronal loss in the rat hippocampus

    Dastan M, Rajaei Z, Sharifi M et al. · Metabolic brain disease · 2024

  304. 0.58

    A novel multi-target strategy for Alzheimer's disease treatment via sublingual route: Donepezil/memantine/curcumin-loaded nanofibers

    Topal F, Ertas B, Guler E et al. · Biomaterials advances · 2022

  305. 0.58

    Silymarin attenuates senescence-exacerbated amyloidogenesis, neuroinflammation, and oxidative stress in lipopolysaccharide-induced memory impairment in aging mice

    Chijioke BS, Ben-Azu B, Esuku DT et al. · Biogerontology · 2026

  306. 0.57

    Lantana camara leaf extract ameliorates memory deficit and the neuroinflammation associated with scopolamine-induced Alzheimer's-like cognitive impairment in zebrafish and mice

    Amoah V, Atawuchugi P, Jibira Y et al. · Pharmaceutical biology · 2023

  307. 0.57

    Dysregulation of Drp1 and Mfn2 is associated with reduced PSD-95, synaptophysin, and BDNF expression in a rat model of Alzheimer's disease

    Alfateh M, Vasconcelos C, Choker AH et al. · International journal of biological macromolecules · 2026

  308. 0.57

    The Protective Effects of Zeaxanthin on Amyloid-beta Peptide 1-42-Induced Impairment of Learning and Memory Ability in Rats

    Li X, Zhang P, Li H et al. · Frontiers in behavioral neuroscience · 2022

  309. 0.57

    Effect of imipramine on memory, adult neurogenesis, neuroinflammation, and mitochondrial biogenesis in a rat model of alzheimer's disease

    Hasanabadi AJ, Beirami E, Kamaei M et al. · Experimental gerontology · 2024

  310. 0.57

    Neuroprotective effects of dexpanthenol on streptozotocin-induced neuronal damage in rats

    Erdogan MA, Yigitturk G, Erbas O et al. · Drug and chemical toxicology · 2022

  311. 0.57

    Dual protective role of curcumin- encapsulated chitosan nanoparticles against gastric and neural injury in a rat model of gut-brain axis dysfunction: a histological and biochemical study

    Fikry H, Sadek DR, Saleh LA et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2026

  312. 0.55

    Minocycline attenuates cholinergic dysfunction and neuro-inflammation-mediated cognitive impairment in scopolamine-induced Alzheimer's rat model

    Amirahmadi S, Farimani FD, Akbarian M et al. · Inflammopharmacology · 2022

  313. 0.55

    Erucic acid arbitrates neuroprotection in streptozotocin-induced memory deficit via improving oxidative stress/neuroinflammatory indicators/cholinergic activity in rodents

    Sayyed N, Afzal M, Rafeeq M et al. · Nutritional neuroscience · 2026

  314. 0.55

    Resveratrol as a potential natural compound to ameliorate cognitive impairment in aluminum-exposed mice: impacts on behavior, purinergic system, and brain inflammation

    Visentini AE, Reichert KP, Schetinger MRC et al. · Metabolic brain disease · 2026

  315. 0.55

    Ranuncoside's attenuation of scopolamine-induced memory impairment in mice via Nrf2 and NF-kB signaling

    Sara Salahuddin H, Attaullah S, Ali Shah S et al. · Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023

  316. 0.55

    Moderate-intensity intermittent exercise prevents memory deficit, hippocampal neuron loss, and elevated level of Alzheimer's dementia markers in the hippocampus of trimethyltin-induced rats

    Nurmasitoh T, Sari DCR, Susilowati R · Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft · 2023

  317. 0.55

    Advancing Cell Therapy to Enhance Passive Avoidance Memory: Integrative Approaches Combining Neural-Like Cells and Rosmarinic Acid Through Behavioral, Molecular, and Histological Analyses

    Hoveizi E, Bijavi G, Parsa H · Neurochemical research · 2025

  318. 0.54

    Curcumin-enhanced stem cell exosomes: A novel approach to modulating neuroinflammation and improving cognitive function in a rat model of Alzheimer's disease

    Bashirrohelleh MA, Bavarsad K, Khodadadi A et al. · European journal of pharmacology · 2025

  319. 0.54

    Arbutin attenuates monosodium L-glutamate induced neurotoxicity and cognitive dysfunction in rats

    Kumar M, Kumar A, Sindhu RK et al. · Neurochemistry international · 2021

  320. 0.54

    Persistent diazinon induced neurotoxicity: The effect on inhibitory avoidance memory performance, amyloid precursor proteins, and TNF-alpha levels in the prefrontal cortex of rats

    Afshari S, Sarailoo M, Asghariazar V et al. · Human & experimental toxicology · 2024

  321. 0.54

    Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Abeta ((1-42)) and NF-kB expression in experimental model of rats

    Singh L, Singh S · Neuroscience letters · 2023

  322. 0.53

    A novel Zebrafish model of Alzheimer's disease by Aluminium chloride; involving nitro-oxidative stress, neuroinflammation and cholinergic pathway

    Nadiga APR, Suman, Krishna KL · European journal of pharmacology · 2024

  323. 0.53

    Neuropharmacological Study on Capsaicin in Scopolamine-injected Mice

    Tyagi S, Thakur AK · Current Alzheimer research · 2023

  324. 0.53

    Neuroprotective Effects of Metformin and Berberine in Lipopolysaccharide-Induced Sickness-Like Behaviour in Mice

    Kodi T, Praveen S, Paka SK et al. · Advances in pharmacological and pharmaceutical sciences · 2024

  325. 0.52

    A Leaf Extract of Harrisonia abyssinica Ameliorates Neurobehavioral, Histological and Biochemical Changes in the Hippocampus of Rats with Aluminum Chloride-Induced Alzheimer's Disease

    Anwar HM, Georgy GS, Hamad SR et al. · Antioxidants (Basel, Switzerland) · 2021

  326. 0.52

    Vitamin D alleviates cognitive dysfunction and brain damage induced by copper sulfate intake in experimental rats: focus on its combination with donepezil

    Elseweidy MM, Mahrous M, Ali SI et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2023

  327. 0.51

    Ameliorative and Neuroprotective Effect of Core-Shell Type Se@Au Conjugated Hesperidin Nanoparticles in Diabetes-Induced Cognitive Impairment

    Behera A, Pradhan SP, Tejaswani P et al. · Molecular neurobiology · 2023

  328. 0.51

    Chronic oral exposure of aluminum chloride in rat modulates molecular and functional neurotoxic markers relevant to Alzheimer's disease

    Dey M, Singh RK · Toxicology mechanisms and methods · 2022

  329. 0.50

    RETRACTED: Repurposing Diltiazem for Its Neuroprotective Anti-Dementia Role against Intra-Cerebroventricular Streptozotocin-Induced Sporadic Alzheimer's Disease-Type Rat Model

    Alluri R, Kilari EK, Pasala PK et al. · Life (Basel, Switzerland) · 2023

  330. 0.50

    In Vitro and In Vivo Neuroprotective Effects of Sarcosine

    Tanas A, Tozlu OO, Gezmis T et al. · BioMed research international · 2022

  331. 0.50

    Improved Spatial Memory And Neuroinflammatory Profile Changes in Aged Rats Submitted to Photobiomodulation Therapy

    Cardoso FDS, de Souza Oliveira Tavares C, Araujo BHS et al. · Cellular and molecular neurobiology · 2022

  332. 0.50

    Neuroprotective Potential of Broccoli Sprout Extract in Scopolamine-Induced Memory-Impaired Mice

    Jeong H, Choi H, Park YS · Foods (Basel, Switzerland) · 2025

02mice · activation318편

  1. 0.89

    The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Abeta clearance in 5XFAD mice

    Zhu Z, Zhang L, Elsherbini A et al. · EBioMedicine · 2023

  2. 0.89

    Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer's disease mice

    Liu M, Pan J, Li X et al. · Journal of neuroinflammation · 2024

  3. 0.88

    3,6'-Disinapoylsucrose alleviates the amyloid precursor protein and lipopolysaccharide induced cognitive dysfunction through upregulation of the TrkB/BDNF pathway

    Wang YT, Wang H, Ren WJ et al. · Journal of Asian natural products research · 2023

  4. 0.88

    Effects of TYROBP Deficiency on Neuroinflammation of a Alzheimer's Disease Mouse Model Carrying a PSEN1 p.G378E Mutation

    Li R, Lv ZY, Li YX et al. · Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih · 2022

  5. 0.88

    Mechanistic and functional study of lncRNA SNHG3/miR-128-3p/UBR5 axis in neuroinflammation in Alzheimer's disease

    Zhu XA, Lu H, Liu Y et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026

  6. 0.88

    LiuweiDihuang improved cognitive functions in SAMP8 mice by inhibiting COX-2 expression and subsequent neuroinflammation

    Song J, Jia Y, Li J et al. · Journal of ethnopharmacology · 2022

  7. 0.88

    Crocin ameliorates neuroinflammation and cognitive impairment in mice with Alzheimer's disease by activating PI3K/AKT pathway

    Su W, Wang Y, Shao S et al. · Brain and behavior · 2024

  8. 0.87

    Regulatory Effects of the PDE8B Inhibitor PF-04957325 on Cognitive Impairment and Neuroinflammation in Abeta-Induced Alzheimer's Disease Mouse Models

    Liu Y, Li M, Yu H et al. · Neurochemical research · 2026

  9. 0.87

    Oridonin Ameliorates Alzheimer's Disease-Like Pathology in Male Mice Through Inhibition of Receptor-Interacting Protein Kinase 1

    Li Y, Cheng Q, Tian S et al. · Phytotherapy research : PTR · 2026

  10. 0.87

    Unraveling the therapeutic potential of ginsenoside compound Mc1 in Alzheimer's disease: Exploring the role of AMPK/SIRT1/NF-kappaB signaling pathway and mitochondrial function

    Yuan Q, Yang Z · Advances in clinical and experimental medicine : official organ Wroclaw Medical University · 2024

  11. 0.87

    Scopoletin alleviates cognitive deficits in 5xFAD mice via suppressing microglial inflammatory response

    Ouyang X, Zhao Z, Hou Y et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026

  12. 0.87

    Jiaohong pills attenuate neuroinflammation and amyloid-beta protein-induced cognitive deficits by modulating the mitogen-activated protein kinase/nuclear factor kappa-B pathway

    Zhang H, Cai W, Dong L et al. · Animal models and experimental medicine · 2024

  13. 0.87

    Effects of electroacupuncture on microglia phenotype and epigenetic modulation of C/EBPbeta in SAMP8 mice

    Wang L, Li W, Wu W et al. · Brain research · 2025

  14. 0.87

    Cognitive improvement effects of PF-04957325, a phosphodiesterase-8 inhibitor, in mouse models of Alzheimer's disease via modulating neuroinflammation

    Guo TY, Zhang M, Lv YL et al. · The international journal of neuropsychopharmacology · 2025

  15. 0.87

    Regulation of the NF-kappaB/NLRP3 signalling pathway by Shenghui Yizhi decoction reduces neuroinflammation in mice with Alzheimer's disease

    Wang P, Sun ZY, Zhang GY et al. · Annals of medicine · 2024

  16. 0.87

    Cornuside ameliorates cognitive impairments via RAGE/TXNIP/NF-kappaB signaling in Abeta(1-42) induced Alzheimer's disease mice

    Lian W, Wang Z, Zhou F et al. · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024

  17. 0.87

    Multi-Component Xinjiang Basil Essential Oil Mitigates Alzheimer's Disease-like Pathology Through Amyloid and Neuroinflammatory Modulation

    Hailati S, Yasheng Y, Yin Y et al. · Nutrients · 2026

  18. 0.86

    STC1 ameliorates cognitive impairment and neuroinflammation of Alzheimer's disease mice via inhibition of ERK1/2 pathway

    Wang P, Li XL, Cao ZH · Immunobiology · 2021

  19. 0.86

    Double-negative T cells mediate M1 polarization of microglial cells via TNF-alpha-NLRP3 to aggravate neuroinflammation and cognitive impairment in Alzheimer's disease mice

    Han C, Sheng Y, Wang J et al. · Journal of cellular physiology · 2022

  20. 0.86

    Suan-Zao-Ren Decoction ameliorates synaptic plasticity through inhibition of the Abeta deposition and JAK2/STAT3 signaling pathway in AD model of APP/PS1 transgenic mice

    Long QH, Wu YG, He LL et al. · Chinese medicine · 2021

  21. 0.86

    JWX-A0108, a positive allosteric modulator of alpha7 nAChR, attenuates cognitive deficits in APP/PS1 mice by suppressing NF-kappaB-mediated inflammation

    Li H, Gao J, Chang Y et al. · International immunopharmacology · 2021

  22. 0.86

    Cognitive improving actions of tofacitinib in a mouse model of Alzheimer disease involving TNF-alpha, IL-6, PI3K-Akt and GSK-3beta signalling pathway

    Sui S, Lv H · The International journal of neuroscience · 2024

  23. 0.86

    MANF improves cognitive function and attenuates neuroinflammation in APP/PS1 transgenic mice through the TLR4/MYD88/NF-kappaB signaling pathway

    Tang Y, Zhuo E, Li P et al. · Journal of anesthesia and translational medicine · 2025

  24. 0.86

    Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3beta Pathway in Experimental Models of Alzheimer's Disease

    Yang W, Liu Y, Xu QQ et al. · Oxidative medicine and cellular longevity · 2020

  25. 0.86

    Berberine Ameliorates Cognitive Disorder via GSK3beta/PGC-1alpha Signaling in APP/PS1 Mice

    Yang M, Wang J · Journal of nutritional science and vitaminology · 2022

  26. 0.86

    Baicalein ameliorates Alzheimer's disease via orchestration of CX3CR1/NF-kappaB pathway in a triple transgenic mouse model

    Xie XM, Hao JJ, Shi JZ et al. · International immunopharmacology · 2023

  27. 0.86

    Picroside II Alleviates the Progression of Alzheimer's Disease via the NLRP3/Caspase-1/GSDMD Pathway

    Li S, Gao Y, Zhang Y et al. · Neuromolecular medicine · 2025

  28. 0.86

    DMTHB ameliorates memory impairment in Alzheimer's disease mice through regulation of neuroinflammation

    Zhang Y, Liu D, Yao X et al. · Neuroscience letters · 2022

  29. 0.86

    Tieguanyin Oolong Tea Extracts Alleviate Behavioral Abnormalities by Modulating Neuroinflammation in APP/PS1 Mouse Model of Alzheimer's Disease

    Kang H, Zhou H, Ye Y et al. · Foods (Basel, Switzerland) · 2021

  30. 0.86

    miR-107-5p ameliorates neurological damage, oxidative stress, and immune responses in mice with Alzheimer's disease by suppressing the Toll-like receptor 4 (TLR4)/nuclear factor-kappaB(NF-kappaB) pathway

    Hu GJ, Jiang XY, Du SY et al. · The Kaohsiung journal of medical sciences · 2024

  31. 0.86

    Diminazene Ameliorates Neuroinflammation by Suppression of Astrocytic miRNA-224-5p/NLRP3 Axis in Alzheimer's Disease Model

    Sun X, Deng Y, Ge P et al. · Journal of inflammation research · 2023

  32. 0.85

    Quercetin Regulates the Polarization of Microglia through the NRF2/HO1 Pathway and Mitigates Alzheimer's Disease

    Feng Y, Yu X, Han J · Actas espanolas de psiquiatria · 2024

  33. 0.85

    ZuoGui Pill Ameliorates Alzheimer's Disease-Like Pathology in 3xTg-AD Mice by Targeting Abeta Production, Tau Phosphorylation, Synaptic Loss, and Neuroinflammation

    Li S, Wang D, Li A et al. · Molecular neurobiology · 2025

  34. 0.85

    Kai-Xin-San ameliorates mild cognitive impairment in SAMP8 mice by inhibiting neuroinflammation and pyroptosis via NLRP3/Caspase-1 pathway modulation

    Liu S, Song X, Sun Y et al. · Frontiers in pharmacology · 2025

  35. 0.85

    Quercetin mitigates memory deficits in scopolamine mice model via protection against neuroinflammation and neurodegeneration

    Olayinka J, Eduviere A, Adeoluwa O et al. · Life sciences · 2022

  36. 0.85

    Rubiadin Alleviates Alzheimer's Disease Pathology via NF-kappaB Pathway Regulation

    Zhang Y, Fan J, Nan S et al. · Journal of integrative neuroscience · 2025

  37. 0.85

    Up-regulation of miR-548 m Leading to Neuroinflammation to Promote the Progression of Alzheimer's Disease

    Zhan M, Liu G, Liu YM et al. · Molecular neurobiology · 2026

  38. 0.85

    Sotagliflozin improves cognitive deficits and attenuates neuroinflammation of Alzheimer's disease

    Ning Y, Chen M, Yang H et al. · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026

  39. 0.85

    Apelin-13-Mediated Upregulation of METTL3 Ameliorates Alzheimer's Disease via Inhibiting Neuroinflammation Through m6A-Dependent Regulation of lncRNA BDNF-AS

    Han L, Wei S, Wang R et al. · Biomolecules · 2025

  40. 0.85

    Tetrahydroxy stilbene glycoside ameliorates neuroinflammation for Alzheimer's disease via cGAS-STING

    Gao D, Hao JP, Li BY et al. · European journal of pharmacology · 2023

  41. 0.85

    ShengHui Decoction mitigates oxidative stress and neuroinflammation in AlCl(3)-induced AD zebrafish via activating Nrf2/HO-1 and inhibiting NF-kappaB signaling pathway

    Kong M, Xu Z, Lu H et al. · Journal of ethnopharmacology · 2026

  42. 0.85

    Neuroprotective effects of SRS11-92 against oxidative stress-induced senescence via Nrf2/HO-1/NF-kappaB in Alzheimer's disease models

    Guo Y, Cao H, Zuo C et al. · Inflammopharmacology · 2026

  43. 0.84

    The Involvement of lncRNA HOTAIR/miR-130a-3p Axis in the Regulation of Voluntary Exercise on Cognition and Inflammation of Alzheimer's Disease

    Lu J, Liu L, Chen J et al. · American journal of Alzheimer's disease and other dementias · 2022

  44. 0.84

    Cognition-enhancing effect of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in the 5 x FAD transgenic mouse model of Alzheimer's pathology

    Dai W, Yao RM, Mi TY et al. · Journal of psychopharmacology (Oxford, England) · 2022

  45. 0.84

    DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways

    Yuan L, Zhang J, Guo JH et al. · Journal of Alzheimer's disease : JAD · 2021

  46. 0.84

    Etanercept Reduces Neuron Injury and Neuroinflammation via Inactivating c-Jun N-terminal Kinase and Nuclear Factor-kappaB Pathways in Alzheimer's Disease: An In Vitro and In Vivo Investigation

    Li Y, Fan H, Ni M et al. · Neuroscience · 2022

  47. 0.84

    Diosmin ameliorates inflammation, apoptosis and activates PI3K/AKT pathway in Alzheimer's disease rats

    Wang Y, Ye X, Su W et al. · Metabolic brain disease · 2024

  48. 0.84

    Palmatine Protects PC12 Cells and Mice from Abeta25-35-Induced Oxidative Stress and Neuroinflammation via the Nrf2/HO-1 Pathway

    Wang Y, Pei H, Chen W et al. · Molecules (Basel, Switzerland) · 2023

  49. 0.84

    PKCdelta serves as a potential biomarker and therapeutic target for microglia-mediated neuroinflammation in Alzheimer's disease

    Du Y, Guo T, Hao Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  50. 0.84

    DL0410 Alleviates Memory Impairment in D-Galactose-Induced Aging Rats by Suppressing Neuroinflammation via the TLR4/MyD88/NF-kappaB Pathway

    Zhang B, Lian W, Zhao J et al. · Oxidative medicine and cellular longevity · 2021

  51. 0.84

    Quercetin Ameliorates Learning and Memory in OVX/D-gal-Induced Alzheimer's Disease in Rats by Inhibiting Neuroinflammation via cGAS-STING Signal Pathway

    Zhang X, Ma MF, Zong R et al. · The American journal of Chinese medicine · 2025

  52. 0.84

    Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-kappaB signaling pathway in vivo and in vitro

    Ding B, Lin C, Liu Q et al. · Journal of neuroinflammation · 2020

  53. 0.84

    Rolipram Ameliorates Memory Deficits and Depression-Like Behavior in APP/PS1/tau Triple Transgenic Mice: Involvement of Neuroinflammation and Apoptosis via cAMP Signaling

    Cong YF, Liu FW, Xu L et al. · The international journal of neuropsychopharmacology · 2023

  54. 0.84

    Mechanism of Autonomic Exercise Improving Cognitive Function of Alzheimer's Disease by Regulating lncRNA SNHG14

    He Y, Qiang Y · American journal of Alzheimer's disease and other dementias · 2021

  55. 0.84

    Bilobalide alleviates neuroinflammation and promotes autophagy in Alzheimer's disease by upregulating lincRNA-p21

    Qin YR, Ma CQ, Wang DP et al. · American journal of translational research · 2021

  56. 0.84

    Shenghui Decoction ameliorates cognitive impairment and neuroinflammation in APP/PS1 mice via modulation of the HMGB1/TLR4/NLRP3 pathway

    Liu X, Song X, Zhang J et al. · Journal of ethnopharmacology · 2026

  57. 0.83

    Kai-Xin-San Improves Cognitive Impairment via Wnt/beta-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice

    Xu YM, Lu FM, Xu HC et al. · Rejuvenation research · 2023

  58. 0.83

    Fucosylated chondroitin sulfate modulates microglia-associated responses and reduces Abeta burden with ERK1/2-related signaling changes

    Xiao X, Gao F, Xie J et al. · Neurochemistry international · 2026

  59. 0.83

    GPR34 Knockdown Relieves Cognitive Deficits and Suppresses Neuroinflammation in Alzheimer's Disease via the ERK/NF-kappaB Signal

    Lin LL, Song GJ, Zhang H et al. · Neuroscience · 2023

  60. 0.83

    IL-24 ameliorates cognitive dysfunction via the inhibition PERK-eIF2alpha Signaling pathway in Alzheimer's disease

    Du Y, Zheng X, Yue X et al. · International immunopharmacology · 2026

  61. 0.83

    Schizandrin A ameliorates cognitive functions via modulating microglial polarisation in Alzheimer's disease mice

    Wang Q, Liu L, Guan H et al. · Pharmaceutical biology · 2021

  62. 0.83

    Chitotriosidase attenuates brain inflammation via HDAC3/NF-kappaB pathway in D-galactose and aluminum-induced rat model with cognitive impairments

    Yu X, Yu W, Wu L et al. · Neuroscience research · 2021

  63. 0.83

    Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer's disease

    Fu XX, Duan R, Wang SY et al. · Neural regeneration research · 2023

  64. 0.83

    USP53 promotes NOTCH2-induced neuroinflammation in Alzheimer's disease

    He D, Zhao H, Zhu Y et al. · Neurochemistry international · 2026

  65. 0.83

    Based on the Dual Pathway of Interaction-Mediated NF-kappaB in Cell Apoptosis and Immune Inflammation to Study the Effect of Danzhi Xiaoyao Powder on the Learning and Cognitive Ability of AD Model Rats

    Wang HP, Li MC, Yang J et al. · Degenerative neurological and neuromuscular disease · 2025

  66. 0.83

    Degradation of NLRP3 by p62-dependent-autophagy improves cognitive function in Alzheimer's disease by maintaining the phagocytic function of microglia

    Zhang D, Zhang Y, Pan J et al. · CNS neuroscience & therapeutics · 2023

  67. 0.82

    Deer Antler Uridine Regulates Glycolysis in Microglia via HSP90/HIF-1alpha to Improve Cognitive Impairment in Alzheimer's Disease Mice

    Liu Y, Han C, Guo L et al. · CNS neuroscience & therapeutics · 2025

  68. 0.82

    Korean black ginseng extract alleviates Alzheimer's disease-related cognitive impairment by activating the Nrf2/HO-1 pathway and suppressing the p38 MAPK/NF-kappaB/STAT3 pathways and NLRP3 inflammasome via TLR2 and TLR4 modulation

    Ha Y, Jo HS, Kwon TW et al. · Journal of ginseng research · 2025

  69. 0.82

    Anti-neuroinflammatory and Neuroprotective Effects of T-006 on Alzheimer's Disease Models by Modulating TLR4-Mediated MyD88/ NF-kappaB Signaling

    Chen H, Chang X, Zhou J et al. · CNS & neurological disorders drug targets · 2025

  70. 0.82

    BV2 Membrane-Coated PEGylated-Liposomes Delivered hFGF21 to Cortical and Hippocampal Microglia for Alzheimer's Disease Therapy

    Wang HC, Yang W, Xu L et al. · Advanced healthcare materials · 2024

  71. 0.82

    Steroidal alkaloid H89712 ameliorates neuroinflammation and memory deficits: Enhancing cerebral oxidative phosphorylation in APP/PS1 mice

    Jiang L, Zhang Z, Luo X et al. · Life sciences · 2026

  72. 0.82

    Multi-omics analysis identifies the miR-28a-5p/SerpinA3N/PI3K/AKT axis as a regulator of microglial neuroinflammation and cognitive decline in Alzheimer's disease

    Liu Y, Fu R, Ge C et al. · Brain research bulletin · 2026

  73. 0.82

    Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-kappaB Signaling Pathways in beta-Amyloid-Induced Alzheimer's Disease Models

    An F, Xuan X, Liu Z et al. · Molecules (Basel, Switzerland) · 2022

  74. 0.82

    Aurantio-Obtusin Attenuates Abeta-Induced Cognitive Impairment and Synaptic Dysfunction by Suppressing Neuroinflammation in Mice

    Feng X, Yu W, Guo S et al. · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026

  75. 0.81

    Nobiletin Ameliorates Alzheimer's Disease Pathology by Reducing Oxidative Stress and Neuroinflammation Through the AMPK/SIRT1/PGC-1alpha and PI3K/Akt-CREB-BDNF Pathways in 5XFAD Mice

    Baek H, Park M, Lee HJ · Biomedicines · 2026

  76. 0.81

    The potential effects of festidinol treatment against the NLRP3 inflammasome and pyroptosis in D-galactose and aluminum chloride-induced Alzheimer's-like pathology in mouse brain

    Wongpun J, Chanmanee T, Tocharus J et al. · International immunopharmacology · 2023

  77. 0.81

    Knockdown of TREML2 Alleviates Neuropathological Hallmarks and Cognitive Deficiency in a Model of Sporadic Alzheimer's Disease

    Fu XX, Huang ZH, Wang SY et al. · Journal of inflammation research · 2024

  78. 0.81

    Porphyromonas gingivalis-induced periodontitis could contribute to cognitive impairment in Sprague-Dawley rats via the P38 MAPK signaling pathway

    Jin R, Ning X, Liu X et al. · Frontiers in cellular neuroscience · 2023

  79. 0.81

    CircLPAR1 Promotes Neuroinflammation and Oxidative Stress in APP/PS1 Mice by Inhibiting SIRT1/Nrf-2/HO-1 Axis Through Destabilizing GDF-15 mRNA

    Xiong W, Li D, Feng Y et al. · Molecular neurobiology · 2023

  80. 0.81

    The total withanolides from the leaves of Datura stramonium L. Improves Alzheimer's disease pathology by restraining neuroinflammation through NLRP3/IL-1beta/IL1R1/TOM 1 pathway

    Li X, Pan J, Liu X et al. · International immunopharmacology · 2025

  81. 0.81

    Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease

    Sun XY, Li LJ, Dong QX et al. · Journal of neuroinflammation · 2021

  82. 0.81

    GSK3beta is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein(NL-F/NL-F) knock-in mice

    Jiang M, Zhang X, Yan X et al. · Brain, behavior, and immunity · 2021

  83. 0.81

    Potential of nobiletin against Alzheimer's disease through inhibiting neuroinflammation

    Chai W, Zhang J, Xiang Z et al. · Metabolic brain disease · 2022

  84. 0.81

    Crry silencing alleviates Alzheimer's disease injury by regulating neuroinflammatory cytokines and the complement system

    Zhu XC, Liu L, Dai WZ et al. · Neural regeneration research · 2022

  85. 0.81

    Levistilide A ameliorates neuroinflammation via inhibiting JAK2/STAT3 signaling for neuroprotection and cognitive improvement in scopolamine-induced Alzheimer's disease mouse model

    Ni H, Liao Y, Zhang Y et al. · International immunopharmacology · 2023

  86. 0.81

    AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway

    Sun X, Deng Y, Fu X et al. · Brain sciences · 2021

  87. 0.81

    Co-Aggregation of Syndecan-3 with beta-Amyloid Aggravates Neuroinflammation and Cognitive Impairment in 5xFAD Mice

    Ye F, Li M, Liu M et al. · International journal of molecular sciences · 2025

  88. 0.81

    Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis

    Wang J, Liu B, Xu Y et al. · Experimental neurology · 2022

  89. 0.81

    Eicosapentaenoic acid attenuates Abeta-induced neurotoxicity by decreasing neuroinflammation through regulation of microglial polarization

    Dong Y, Long S, Gu Y et al. · Neuro endocrinology letters · 2021

  90. 0.80

    Sodium propionate improves cognitive and memory function in mouse models of Alzheimer's disease

    Lang W, Li X, Wang Y et al. · Neuroscience letters · 2022

  91. 0.80

    Korean Red Ginseng Marc-Derived Gintonin Improves Alzheimer's Cognitive Dysfunction by Upregulating LPAR1

    Ha Y, Lee R, Jeon SH et al. · The American journal of Chinese medicine · 2025

  92. 0.80

    The protective role of miR-132 targeting HMGA2 through the PI3K/AKT pathway in mice with Alzheimer's disease

    Liu X, Wang H, Bei J et al. · American journal of translational research · 2021

  93. 0.80

    HMGB1/RAGE/TLR4 axis and glutamate as novel targets for PCSK9 inhibitor in high fat cholesterol diet induced cognitive impairment and amyloidosis

    Abuelezz SA, Hendawy N · Life sciences · 2021

  94. 0.80

    Electroacupuncture Improves M2 Microglia Polarization and Glia Anti-inflammation of Hippocampus in Alzheimer's Disease

    Xie L, Liu Y, Zhang N et al. · Frontiers in neuroscience · 2021

  95. 0.80

    Structural characterization of polysaccharide purified from Amanita caesarea and its pharmacological basis for application in Alzheimer's disease: endoplasmic reticulum stress

    Hu W, Li Z, Wang W et al. · Food & function · 2021

  96. 0.80

    Photobiomodulation of immune crosstalk rescues neuroinflammation in Alzheimer's disease models

    Shen Q, Chang H, Li J et al. · Brain : a journal of neurology · 2026

  97. 0.80

    Glycyrrhizin Ameliorates Learning and Memory Impairment via Inhibition of Neuroinflammation in an Alzheimer's Disease Mouse Model SAMP8

    Wang G, Hiramoto K, Ma N et al. · International journal of molecular sciences · 2026

  98. 0.80

    Luteolin alleviates cognitive impairment in Alzheimer's disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation

    Kou JJ, Shi JZ, He YY et al. · Acta pharmacologica Sinica · 2022

  99. 0.80

    TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K/AKT/FoxO3a signaling pathway in Alzheimer's disease mice

    Wang Y, Lin Y, Wang L et al. · Aging · 2020

  100. 0.80

    Gastrodin ameliorates neuroinflammation in Alzheimer's disease mice by inhibiting NF-kappaB signaling activation via PPARgamma stimulation

    Yin H, Liu R, Bie L · Aging · 2024

  101. 0.80

    A novel biomimetic nanovesicle containing caffeic acid-coupled carbon quantum dots for the the treatment of Alzheimer's disease via nasal administration

    Hu Y, Cui J, Sun J et al. · Journal of nanobiotechnology · 2024

  102. 0.80

    CCA, a cassane diterpene from Caesalpinia bonduc ameliorates cognition impairment in Alzheimer's disease mice by regulating neuroinflammation and autophagy

    Zhou J, Zhang W, Yang Y et al. · Chinese journal of natural medicines · 2026

  103. 0.80

    Ginsenoside Ro ameliorates cognitive impairment and neuroinflammation in APP/PS1 mice via the IBA1/GFAP-MAPK signaling pathway

    Li T, Chen J, Xie Z et al. · Frontiers in pharmacology · 2025

  104. 0.79

    Tetrandrine ameliorated Alzheimer's disease through suppressing microglial inflammatory activation and neurotoxicity in the 5XFAD mouse

    Ren D, Fu Y, Wang L et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021

  105. 0.79

    Abeta promotes CD38 expression in senescent microglia in Alzheimer's disease

    Hu Y, Huang Y, Xing S et al. · Biological research · 2022

  106. 0.79

    Pinoresinol diglucoside attenuates neuroinflammation, apoptosis and oxidative stress in a mice model with Alzheimer's disease

    Lei S, Wu S, Wang G et al. · Neuroreport · 2021

  107. 0.79

    Exercise training-induced benefits for Alzheimer's disease are associated with modulation of the BDNF-TrkB signaling complex

    Kim T, Cho J, Kang H · Scientific reports · 2025

  108. 0.79

    Alpinae Oxyphyllae Fructus alleviated LPS-induced cognitive impairments via PI3K/AKT/NF-kappaB signaling pathway

    Yan T, Zhang X, Mao Q et al. · Environmental toxicology · 2022

  109. 0.79

    Cornuside Is a Potential Agent against Alzheimer's Disease via Orchestration of Reactive Astrocytes

    Shi JZ, Zheng XM, Zhou YF et al. · Nutrients · 2022

  110. 0.79

    Ginsenoside Rg2 alleviates neurovascular damage in 3xTg-AD mice with Alzheimer's disease through the MAPK-ERK pathway

    Ye X, Shao S, Wang Y et al. · Journal of chemical neuroanatomy · 2023

  111. 0.79

    TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-beta-Induced Neuroinflammation in Alzheimer's Disease

    Zhu M, Liu Y, Chen C et al. · Journal of Alzheimer's disease : JAD · 2024

  112. 0.79

    A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse model

    Orti-Casan N, Zuhorn IS, Naude PJW et al. · Proceedings of the National Academy of Sciences of the United States of America · 2022

  113. 0.79

    Porphyromonas gingivalis and Its Outer Membrane Vesicles Induce Neuroinflammation in Mice Through Distinct Mechanisms

    Qiu Y, Zhao Y, He G et al. · Immunity, inflammation and disease · 2025

  114. 0.79

    Zunyimycin C enhances immunity and improves cognitive impairment and its mechanism

    Wang X, Li Z, Sun R et al. · Frontiers in cellular and infection microbiology · 2022

  115. 0.79

    Combined royal jelly 10-hydroxydecanoic acid and aspirin has a synergistic effect against memory deficit and neuroinflammation

    You M, Wang K, Pan Y et al. · Food & function · 2022

  116. 0.78

    Epimedii Folium and Curculiginis Rhizoma ameliorate lipopolysaccharides-induced cognitive impairment by regulating the TREM2 signaling pathway

    Shi K, Chen L, Chen L et al. · Journal of ethnopharmacology · 2022

  117. 0.78

    Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3beta-dependent synaptic defects and cause cognitive decline in a low-amyloid-beta-concentration environment in Alzheimer's disease

    Gui S, Zeng F, Wu Z et al. · Journal of Alzheimer's disease : JAD · 2025

  118. 0.78

    Apelin-13 Improves Cognitive Impairment and Repairs Hippocampal Neuronal Damage by Activating PGC-1alpha/PPARgamma Signaling

    Chen B, Wu J, Hu S et al. · Neurochemical research · 2023

  119. 0.78

    Hesperetin attenuates cognitive dysfunction via SIRT6/NLRP3 pathway in scopolamine-induced mice

    Jing S, Wang X, Zhang Z et al. · Metabolic brain disease · 2023

  120. 0.78

    SARM1 Promotes Neurodegeneration and Memory Impairment in Mouse Models of Alzheimer's Disease

    Miao X, Wu Q, Du S et al. · Aging and disease · 2024

  121. 0.78

    The anesthetic sevoflurane induces tau trafficking from neurons to microglia

    Dong Y, Liang F, Huang L et al. · Communications biology · 2021

  122. 0.78

    Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer's Disease in an APP/PS1 Mouse Model

    Chen Q, Yin Y, Li L et al. · Neuropsychiatric disease and treatment · 2021

  123. 0.78

    Ponicidin ameliorates Alzheimer's disease through dual inhibition of RIPK1-mediated neuroinflammation and necroptosis

    Hu H, Cheng Q, Li D et al. · International immunopharmacology · 2026

  124. 0.78

    Low-dose radiotherapy ameliorates Alzheimer's-like pathology in 5xFAD mice and is associated with HIF-1alpha-related inflammatory signaling downregulation

    Jiao H, Huang H, Chen S et al. · Pathology, research and practice · 2026

  125. 0.78

    MST1 promotes microglial pyroptosis and neuroinflammation in alzheimer's disease by regulating the novel DPP8/NLRP1/Caspase-1/GSDMD-N axis

    Cui D, Liu S, Liu Y et al. · Journal of neuroinflammation · 2026

  126. 0.77

    Butyrate antagonizes Annexin A2-mediated tauopathy via Annexin A1 reciprocity in Alzheimer's disease

    Jayaswamy PK, Ambrish T, Sangamesh VC et al. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2026

  127. 0.77

    Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NFkappaBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats

    Abd El-Rahman SS, Fayed HM · PloS one · 2022

  128. 0.77

    Standardized extract of Glehnia Littoralis abrogates memory impairment and neuroinflammation by regulation of CREB/BDNF and NF-kappaB/MAPK signaling in scopolamine-induced amnesic mice model

    Balakrishnan R, Kim YS, Kim GW et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023

  129. 0.77

    Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-beta Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2

    Orti-Casan N, Wajant H, Kuiperij HB et al. · Journal of Alzheimer's disease : JAD · 2023

  130. 0.77

    Lupeol protect against LPS-induced neuroinflammation and amyloid beta in adult mouse hippocampus

    Choe K, Park JS, Park HY et al. · Frontiers in nutrition · 2024

  131. 0.77

    Ginkgo biloba extract 50 alleviates memory and synaptic plasticity deficits by inhibiting neuroinflammation via the blockage of ATP-P2X7R axis in presenilin 1/2 conditional double knockout mice

    Hu K, Gao W, Pan J et al. · Journal of ethnopharmacology · 2027

  132. 0.77

    Lycium barbarum Extract Enhanced Neuroplasticity and Functional Recovery in 5xFAD Mice via Modulating Microglial Status of the Central Nervous System

    Sun Z, Liu J, Chen Z et al. · CNS neuroscience & therapeutics · 2024

  133. 0.77

    Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Abeta Induced Alzheimer's Disease Mouse Model via Inhibition of Microglial Activation and NADPH Oxidase Expression

    Chen F, Yang D, Cheng XY et al. · Biological & pharmaceutical bulletin · 2021

  134. 0.77

    Chuanxiong Renshen Decoction Inhibits Alzheimer's Disease Neuroinflammation by Regulating PPARgamma/NF-kappaB Pathway

    Hou J, Wang X, Zhang J et al. · Drug design, development and therapy · 2024

  135. 0.77

    3,6'-Disinapoyl sucrose alleviates cognitive deficits in APP/PS1 transgenic mice

    Yuan J, He M, Dai X et al. · Journal of neurophysiology · 2023

  136. 0.77

    Investigation of Novel Aronia Bioactive Fraction-Alginic Acid Nanocomplex on the Enhanced Modulation of Neuroinflammation and Inhibition of Abeta Aggregation

    Jang BK, Shin SJ, Park HH et al. · Pharmaceutics · 2024

  137. 0.77

    Neuroprotective Effect of Isorhapontigenin (ISO) Against LPS-Induced Neurodegenerative Condition via TLR4/RAGE-Mediated p-NF-kB Activation

    Atiq A, Choe K, Kang MH et al. · Molecular neurobiology · 2026

  138. 0.77

    Microglial exosome TREM2 ameliorates ferroptosis and neuroinflammation in alzheimer's disease by activating the Wnt/beta-catenin signaling

    Zhu L, Zhou T, Wu L et al. · Scientific reports · 2025

  139. 0.77

    Artesunate restores mitochondrial fusion-fission dynamics and alleviates neuronal injury in Alzheimer's disease models

    Qin YR, Ma CQ, Jiang JH et al. · Journal of neurochemistry · 2022

  140. 0.77

    Tooth Loss Induces Memory Impairment and Gliosis in App Knock-In Mouse Models of Alzheimer's Disease

    Taslima F, Jung CG, Zhou C et al. · Journal of Alzheimer's disease : JAD · 2021

  141. 0.77

    Electroacupuncture ameliorates tau-driven cognitive decline by modulating NF-kappaB/NLRP3 inflammasome signaling in P301S mice

    Zheng R, Liu X, Liao Z et al. · Experimental neurology · 2026

  142. 0.77

    Edaravone Dexborneol ameliorates the cognitive deficits of APP/PS1 mice by inhibiting TLR4/MAPK signaling pathway via upregulating TREM2

    Wang J, Du L, Zhang T et al. · Neuropharmacology · 2024

  143. 0.77

    Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse Model

    Ding J, Huang J, Yin D et al. · Oxidative medicine and cellular longevity · 2021

  144. 0.77

    Cilostazol and SB203580 combination: Targeting ER stress and p38MAPK signaling in Alzheimer's disease mouse model

    Ali MM, Sayed RH, Wadie W et al. · European journal of pharmacology · 2025

  145. 0.77

    Treadmill Running Improves Spatial Learning Memory Through Inactivation of Nuclear Factor Kappa B/Mitogen-Activated Protein Kinase Signaling Pathway in Amyloid-beta-Induced Alzheimer Disease Rats

    Kim SH, Ko YJ, Kim JY et al. · International neurourology journal · 2021

  146. 0.77

    Ficus erecta Thunb. Leaves Ameliorate Cognitive Deficit and Neuronal Damage in a Mouse Model of Amyloid-beta-Induced Alzheimer's Disease

    Sohn E, Kim YJ, Kim JH et al. · Frontiers in pharmacology · 2021

  147. 0.77

    2'-Fucosyllactose Ameliorates Cognitive Impairment and Neuroinflammation in AD Mice

    Ma Y, Zhang M, Jin Y et al. · Journal of agricultural and food chemistry · 2025

  148. 0.76

    Microglial histone H3K18 crotonylation promotes STAT1 expression and induces cognitive deficit in Alzheimer disease

    Weng Y, He T, Li M et al. · Frontiers in immunology · 2026

  149. 0.76

    Vorinostat Rescues Cognitive Deficits in a Neuroinflammatory Mouse Model: A Study of Sex Differences and the Underlying TLR4/NF-kappaB Mechanism

    Wu H, Xia J, Shi Z et al. · Neurochemical research · 2026

  150. 0.76

    Combined administration of catalpol, puerarin, gastrodin, and borneol modulates the Tlr4/Myd88/NF-kappaB signaling pathway and alleviates microglia inflammation in Alzheimer's disease

    Ren H, Tang L, Yuan Z et al. · Frontiers in pharmacology · 2024

  151. 0.76

    Neuroprotective effect of tanshinone IIA-modified mesenchymal stem cells in a lipopolysaccharide-induced neuroinflammation model

    Wu J, Chen J, Ge Y et al. · Heliyon · 2024

  152. 0.76

    Porphyromonas gingivalis-Induced NETs Mediate Neuroinflammation via TLR4 Activation

    Xu L, Zhou Y, Chen H et al. · Journal of dental research · 2026

  153. 0.76

    Geniposidic Acid Confers Neuroprotective Effects in a Mouse Model of Alzheimer's Disease through Activation of a PI3K/AKT/GAP43 Regulatory Axis

    Chen QY, Yin Y, Li L et al. · The journal of prevention of Alzheimer's disease · 2022

  154. 0.76

    Dendrobium huoshanense stem polysaccharide protects against Alzheimer's disease by modulating SCFAs/GLP-1 axis-mediated neuroinflammation suppression

    Li QM, Zhang-Yang QQ, Tan YY et al. · International journal of biological macromolecules · 2026

  155. 0.76

    Arsenic exposure activates microglia, inducing neuroinflammation and promoting the occurrence and development of Alzheimer's disease-like neurodegeneration in mice

    Zhang B, Wang J, Chen J et al. · Ecotoxicology and environmental safety · 2025

  156. 0.76

    Early intervention attenuates synaptic plasticity impairment and neuroinflammation in 5xFAD mice

    Li K, Wang X, Jiang Y et al. · Journal of psychiatric research · 2021

  157. 0.75

    Treadmill Exercise Reduces Neuroinflammation, Glial Cell Activation and Improves Synaptic Transmission in the Prefrontal Cortex in 3 x Tg-AD Mice

    Mu L, Xia D, Cai J et al. · International journal of molecular sciences · 2022

  158. 0.75

    MiR-216a-5p ameliorates learning-memory deficits and neuroinflammatory response of Alzheimer's disease mice via regulation of HMGB1/NF-kappaB signaling

    Shao P · Brain research · 2021

  159. 0.75

    Fisetin targets multiple signaling pathways to suppress microglia-mediated neuroinflammation and cognitive decline in Alzheimer's disease

    Dai YT, Chen Q, Ma YD et al. · Neuropharmacology · 2026

  160. 0.75

    Compensatory enhancement of orexinergic system functionality induced by amyloid-beta protein: a neuroprotective response in Alzheimer's disease

    Zhuang C, Yan H, Lu J et al. · Frontiers in physiology · 2025

  161. 0.75

    Acacetin improves cognitive function of APP/PS1 Alzheimer's disease model mice via the NLRP3 inflammasome signaling pathway

    Bu J, Zhang Y, Mahan Y et al. · Translational neuroscience · 2022

  162. 0.75

    TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway

    Ruganzu JB, Zheng Q, Wu X et al. · Experimental neurology · 2021

  163. 0.75

    Pterosin B improves cognitive dysfunction by promoting microglia M1/M2 polarization through inhibiting Klf5/Parp14 pathway

    Zhang Y, Chen JC, Zheng JH et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024

  164. 0.75

    ZDWX-25, a dual DYRK1A/GSK3beta inhibitor, attenuates tau hyperphosphorylation and neuroinflammation in acute mouse models

    Wang W, Xing Y, Xu Z et al. · Frontiers in pharmacology · 2026

  165. 0.75

    Tianma-Gouteng pair ameliorates the cognitive deficits on two transgenic mouse models of Alzheimer's disease

    Zhong M, Xu QQ, Hu Z et al. · Journal of ethnopharmacology · 2024

  166. 0.75

    Benzene, 1,2,4-Trimethoxy-5-(2-Methyl-1-Propen-1-yl) Attenuates D-galactose/AlCl(3)-induced Cognitive Impairment by Inhibiting Inflammation, Apoptosis, and improving Expression of Memory-Related Proteins

    Yang P, Liao C, Hu Q et al. · Neuroscience · 2023

  167. 0.75

    Irisin ameliorates cognitive impairment in a lipopolysaccharide-induced neuroinflammation mouse model by inhibiting the NLRP3 inflammasome pathway in microglia

    Zhang DQ, Li G, Fu ZD et al. · Neuropharmacology · 2025

  168. 0.75

    Targeting lncRNA NEAT1 Hampers Alzheimer's Disease Progression

    Li Y, Fan H, Ni M et al. · Neuroscience · 2023

  169. 0.75

    Catalpol rescues cognitive deficits by attenuating amyloid beta plaques and neuroinflammation

    Li S, Tian Z, Xian X et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023

  170. 0.75

    CD22 modulation alleviates amyloid beta-induced neuroinflammation

    Mai YD, Zhang Q, Fung CL et al. · Journal of neuroinflammation · 2025

  171. 0.75

    Exploring the therapeutic efficacy of Chlorella pyrenoidosa peptides in ameliorating Alzheimer's disease

    Wang SM, Chuu JJ, Lee CK et al. · Heliyon · 2023

  172. 0.74

    Electroacupuncture with Bushen Jiannao improves cognitive deficits in senescence-accelerated mouse prone 8 mice by inhibiting neuroinflammation

    Wang X, Li Z, Li C et al. · Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2020

  173. 0.74

    The novel sphingolipids cP1P and P1P attenuate neuroinflammation and enhance S1PR1/Akt/mTOR signaling to mitigate cognitive decline in an Alzheimer's disease mouse model

    Choe K, Ahmad R, Kang MH et al. · Cell communication and signaling : CCS · 2025

  174. 0.74

    Legumain Knockout Protects Against Abeta(1-42)-Induced AD-like Cognitive Deficits and Synaptic Plasticity Dysfunction Via Inhibiting Neuroinflammation Without Cleaving APP

    Chen R, Zhang Q, Yan Y et al. · Molecular neurobiology · 2021

  175. 0.74

    Melatonin Ameliorates the Progression of Alzheimer's Disease by Inducing TFEB Nuclear Translocation, Promoting Mitophagy, and Regulating NLRP3 Inflammasome Activity

    Fan L, Zhaohong X, Xiangxue W et al. · BioMed research international · 2022

  176. 0.74

    A Chloroform Fraction Derived from Vitis vinifera Root Ethanol Extract Attenuates Lipopolysaccharide-Induced Inflammatory Responses and Cognitive Dysfunction in BV-2 Microglia Cells and C57BL/6J Mouse Model

    Kim YS, Lee SB, Kang SI et al. · International journal of molecular sciences · 2025

  177. 0.74

    Fruit-Derived Citri Reticulatae Semen Extract Attenuates Alzheimer's Disease Neuroinflammation and Cognitive Impairment via Modulation of the PI3K/Akt/FoxO1 Pathway

    Li S, Zhang X, Zhang P et al. · Molecular nutrition & food research · 2026

  178. 0.74

    Sanweidoukou decoction, a Chinese herbal formula, ameliorates beta-amyloid protein-induced neuronal insult via modulating MAPK/NF-kappaB signaling pathways: Studies in vivo and in vitro

    An FM, Liu Z, Xuan XR et al. · Journal of ethnopharmacology · 2021

  179. 0.74

    Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation

    Li W, Huang W, Zhou P et al. · Frontiers in pharmacology · 2025

  180. 0.74

    Ganaxolone Reverses the Effect of Amyloid beta-Induced Neurotoxicity by Regulating the Liver X Receptor Expression in APP Transfected SH-SY5Y Cells and Murine Model of Alzheimer's Disease

    Divya, Faruq M, Nazir SS et al. · Journal of neurochemistry · 2025

  181. 0.74

    Long-term fucoxanthin treatment prevents cognitive impairments and neuroinflammation via the inhibition of Nogo-A in APP/PS1 transgenic mice

    Jiang Y, Chen H, Xu J et al. · Food & function · 2025

  182. 0.74

    Astragaloside IV attenuates neuroinflammation and ameliorates cognitive impairment in Alzheimer's disease via inhibiting NF-kappaB signaling pathway

    He L, Sun J, Miao Z et al. · Heliyon · 2023

  183. 0.74

    Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

    Chen M, Ning Y, Yang H et al. · Molecular neurobiology · 2025

  184. 0.74

    Pharmacological Inhibition of Spleen Tyrosine Kinase Suppressed Neuroinflammation and Cognitive Dysfunction in LPS-Induced Neurodegeneration Model

    Kim MW, Choe K, Park JS et al. · Cells · 2022

  185. 0.74

    Tripterygium glycoside ameliorates neuroinflammation in a mouse model of Abeta25-35-induced Alzheimer's disease by inhibiting the phosphorylation of IkappaBalpha and p38

    Tang L, Xiang Q, Xiang J et al. · Bioengineered · 2021

  186. 0.74

    Classic Famous Prescription Kai-Xin-San Ameliorates Alzheimer's Disease via the Wnt/beta-Catenin Signaling Pathway

    Shan X, Lv S, Huang P et al. · Molecular neurobiology · 2024

  187. 0.73

    Ceftriaxone ameliorates hippocampal synapse loss by inhibiting microglial/macrophages activation in glial glutamate transporter-1 dependent manner in the APP/PS1 mouse model of Alzheimer's disease

    Liu LZ, Fan SJ, Gao JX et al. · Brain research bulletin · 2023

  188. 0.73

    Platycodin D and voluntary running synergistically ameliorate memory deficits in 5 x FAD mice via mediating neuromodulation and neuroinflammation

    Liu J, Jiang J, He C et al. · Frontiers in aging neuroscience · 2024

  189. 0.73

    The Protective Effects of Small-Molecule Compound 0242 Against LPS-Induced Neuroinflammation and in P301S Tau Transgenic Mice

    Suo X, Wan P, Yu J et al. · Neurochemical research · 2026

  190. 0.73

    Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology

    Liu S, Fan M, Xu JX et al. · Journal of neuroinflammation · 2022

  191. 0.73

    Relaxin-2 protects synaptic integrity via hippocampal NLRP3-mTOR-autophagy pathways in an age-dependent Alzheimer-like model

    Wang D, Zhao Z, Ding Y · Acta pharmaceutica (Zagreb, Croatia) · 2026

  192. 0.73

    Cognitive enhancement and neuroprotective effects of OABL, a sesquiterpene lactone in 5xFAD Alzheimer's disease mice model

    Tang JJ, Huang LF, Deng JL et al. · Redox biology · 2022

  193. 0.73

    A combination of lycopene and human amniotic epithelial cells can ameliorate cognitive deficits and suppress neuroinflammatory signaling by choroid plexus in Alzheimer's disease rat

    Xu Z, Liu C, Wang R et al. · The Journal of nutritional biochemistry · 2021

  194. 0.73

    NaoXinTong Capsule ameliorates memory deficit in APP/PS1 mice by regulating inflammatory cytokines

    Wang X, Yin Z, Cao P et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021

  195. 0.73

    The Neuroprotective Effect of Byu d Mar 25 in LPS-Induced Alzheimer's Disease Mice Model

    Liu L, Zhang Y, Tang L et al. · Evidence-based complementary and alternative medicine : eCAM · 2021

  196. 0.73

    Gardenia jasminoides J.Ellis extract GJ-4 alleviated cognitive deficits of APP/PS1 transgenic mice

    Zang C, Liu H, Shang J et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021

  197. 0.73

    Mir-199a-3p aggravates neuroinflammation in an Alzheimer's disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1

    Wang C, Bu X, Cao M et al. · BMC neuroscience · 2025

  198. 0.73

    Leptin ameliorates Abeta1-42-induced Alzheimer's disease by suppressing inflammation via activating p-Akt signaling pathway

    Lu L, Fu Z, Wu B et al. · Translational neuroscience · 2023

  199. 0.73

    A Novel Missense Variant in SORBS2 Is Causative With Familial Alzheimer's Disease

    Wang Q, Wang S, Cao S et al. · CNS neuroscience & therapeutics · 2025

  200. 0.73

    The soluble epoxide hydrolase inhibitor TPPU alleviates Abeta-mediated neuroinflammatory responses in Drosophila melanogaster and cellular models of alzheimer's disease

    Sun X, Liu H, Li W et al. · Journal of inflammation (London, England) · 2025

  201. 0.73

    Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer's disease

    Ruganzu JB, Peng X, He Y et al. · Molecular immunology · 2022

  202. 0.73

    Gastrodin Ameliorates Tau Pathology and BBB Dysfunction in 3xTg-AD Transgenic Mice by Regulating the ADRA1/NF-kappaB/NLRP3 Pathway to Reduce Neuroinflammation

    Li B, Wang L, Xiao Y et al. · Phytotherapy research : PTR · 2025

  203. 0.73

    Natural Small-Molecule Bergapten Ameliorates Amyloid-beta Pathology and Neuroinflammation in Alzheimer's Disease

    Zhang J, Zhang J · Nutrients · 2025

  204. 0.73

    Curcumin alleviates Alzheimer's disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway

    Shao S, Ye X, Su W et al. · Journal of chemical neuroanatomy · 2023

  205. 0.72

    Polygonatum sibiricum polysaccharide ameliorates neurotoxicity in Alzheimer disease mice by inhibiting endoplasmic reticulum stress and lipid raft formation through AMPK/GSK3beta/Nrf2 pathway

    Wu S, Liu W, Zhang C · Neurological research · 2026

  206. 0.72

    Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: Involved with the fundamental role of neuroinflammation

    Fan M, Liu S, Sun HM et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022

  207. 0.72

    Tannic acid inhibits lipopolysaccharide-induced cognitive impairment in adult mice by targeting multiple pathological features

    Ullah R, Ali G, Baseer A et al. · International immunopharmacology · 2022

  208. 0.72

    Far infrared light irradiation enhances Abeta clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice

    Li Q, Peng J, Luo Y et al. · Journal of neuroinflammation · 2022

  209. 0.72

    Ameliorating Alzheimer's-like Pathology by Minocycline via Inhibiting Cdk5/p25 Signaling

    Zhao Y, Wang C, He W et al. · Current neuropharmacology · 2022

  210. 0.72

    Thymosin beta4-derived peptides alleviate neuroinflammation and neurite atrophy in both in vitro models and in vivo 5 x FAD mice: A potential therapy for memory improvement in Alzheimer's disease

    Ou H, Chen R, Zhou L et al. · International immunopharmacology · 2026

  211. 0.72

    Ginsenoside Rg1 alleviates learning and memory impairments and Abeta disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice

    Li X, Huang L, Kong L et al. · Molecular medicine reports · 2023

  212. 0.72

    Porphyromonas gingivalis Promotes Neuroinflammation by Microglial Ferroptosis via NOX4/PPAR-alpha/PGC-1alpha Pathway

    Li X, Wu Z, Yao C et al. · Research (Washington, D.C.) · 2026

  213. 0.72

    Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer's Disease

    Li WY, Lee CY, Lee KM et al. · Diabetes, metabolic syndrome and obesity : targets and therapy · 2022

  214. 0.72

    Haploinsufficiency of microglial MyD88 ameliorates Alzheimer's pathology and vascular disorders in APP/PS1-transgenic mice

    Quan W, Luo Q, Hao W et al. · Glia · 2021

  215. 0.72

    Electroacupuncture alleviates cognitive impairments in APP/PS1 mice via gastric vagal afferent-mediated activation of the nucleus tractus solitarius‒locus coeruleus noradrenergic circuit

    Yu C, Li M, Shen F et al. · Chinese medicine · 2025

  216. 0.71

    Alkaloids in Uncaria rhynchophylla improves AD pathology by restraining CD4(+) T cell-mediated neuroinflammation via inhibition of glycolysis in APP/PS1 mice

    Kuang Y, Zhu M, Gu H et al. · Journal of ethnopharmacology · 2024

  217. 0.71

    Berbamine targets the FKBP12-rapamycin-binding (FRB) domain of the mTOR complex to promote microglial autophagy and ameliorate neuroinflammation in Alzheimer's disease

    Ge P, Guo S, Wang P et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025

  218. 0.71

    Fluvoxamine maleate alleviates amyloid-beta load and neuroinflammation in 5XFAD mice to ameliorate Alzheimer disease pathology

    Kaur S, Sharma K, Sharma A et al. · Frontiers in immunology · 2024

  219. 0.71

    Acori tatarinowii Rhizoma-Curcumae Radix herbal pair ameliorates cognitive impairment and suppresses neuro-inflammation via Ca(2+)/CaMKKbeta/AMPK/mTOR pathway in Alzheimer's disease

    Wang C, Xu X, Zhu H et al. · Journal of ethnopharmacology · 2026

  220. 0.71

    Peony seed oil ameliorates neuroinflammation-mediated cognitive deficits by suppressing microglial activation through inhibition of NF-kappaB pathway in presenilin 1/2 conditional double knockout mice

    Gao J, Wang L, Zhao C et al. · Journal of leukocyte biology · 2021

  221. 0.71

    Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer's disease

    Shao L, Dong C, Geng D et al. · Metabolic brain disease · 2022

  222. 0.71

    INO10, a Chaga Mushroom Extract, Alleviates Alzheimer's Disease-Related Pathology and Cognitive Deficits in 3xTg-AD Mice

    Ban S, Do TT, Pyo JW et al. · International journal of molecular sciences · 2025

  223. 0.71

    Polypeptide-PNP2 in Corn Cervi Pantotrichum Ameliorates Cognitive Impairment in Alzheimer's Disease Mice by Inhibiting Microglial Cell Activation

    Pei H, He Z, Du R et al. · Molecular neurobiology · 2025

  224. 0.71

    Erinacine C Attenuates Alzheimer's-like Pathology: A Study in APP/PS1 Mice and PC12 Cells

    Wang LY, Yeh SL, Hsu ST et al. · Molecules (Basel, Switzerland) · 2026

  225. 0.71

    IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease

    Wang SY, Huang ZH, Duan R et al. · Journal of Alzheimer's disease : JAD · 2025

  226. 0.71

    Schisandrin B ameliorates Alzheimer's disease by suppressing neuronal ferroptosis and ensuing microglia M1 polarization

    Ding T, Song M, Wu Y et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025

  227. 0.71

    Echinacoside Improves Cognitive Impairment by Inhibiting Abeta Deposition Through the PI3K/AKT/Nrf2/PPARgamma Signaling Pathways in APP/PS1 Mice

    Qiu H, Liu X · Molecular neurobiology · 2022

  228. 0.71

    Hyperactivation of TRPV4 causes the hippocampal pyroptosis pathway and results in cognitive impairment in LPS-treated mice

    Guo D, Xu Y, Wang Y et al. · Behavioural brain research · 2023

  229. 0.71

    Effects of Luffa cylindrica (L.) Roem Extract on Microglial Activation-Mediated Mild Cognitive Impairment via Regulation of CREB Signaling Pathway

    Park J, Kim Y, Lee JE et al. · Journal of microbiology and biotechnology · 2025

  230. 0.70

    Kojic acid reverses LPS-induced neuroinflammation and cognitive impairment by regulating the TLR4/NF-kappaB signaling pathway

    Ali W, Choe K, Park JS et al. · Frontiers in pharmacology · 2024

  231. 0.70

    Xixin Decoction's novel mechanism for alleviating Alzheimer's disease cognitive dysfunction by modulating amyloid-beta transport across the blood-brain barrier to reduce neuroinflammation

    Yang C, Zhao E, Zhang H et al. · Frontiers in pharmacology · 2024

  232. 0.70

    Inhibiting mtDNA-STING-NLRP3/IL-1beta axis-mediated neutrophil infiltration protects neurons in Alzheimer's disease

    Xia X, He X, Zhao T et al. · Cell proliferation · 2024

  233. 0.70

    Isoliensinine ameliorates cognitive dysfunction in AlCl(3)/D-gal-induced Alzheimer's disease-like mice by inhibiting the calcium signaling pathway

    Li JQ, Ma XH, Dai H et al. · Journal of ethnopharmacology · 2025

  234. 0.70

    Human-Derived Induced GABAergic Progenitor Cells Improve Cognitive Function in Mice and Inhibit Astrocyte Activation with Anti-Inflammatory Exosomes

    Chen C, Lan Z, Tang X et al. · Annals of neurology · 2024

  235. 0.69

    Knockdown and inhibition of hippocampal GPR17 attenuates lipopolysaccharide-induced cognitive impairment in mice

    Liang Y, Kang X, Zhang H et al. · Journal of neuroinflammation · 2023

  236. 0.69

    Bone Marrow-Derived Mesenchymal Stem Cells and gamma-Secretase Inhibitor Treatments Suppress Amyloid-beta25-35-Induced Cognitive Impairment in Rat Dams and Cortical Degeneration in Offspring

    Gaber A, Elbakry AM, Aljarari RM et al. · Stem cells international · 2023

  237. 0.69

    Ellagic acid(EA) ameliorates Alzheimer's disease by reducing Abeta levels, oxidative stress and attenuating inflammation

    Li Y, Zhang J, Zhang L et al. · European journal of pharmacology · 2025

  238. 0.69

    FoxG1 as a Potential Therapeutic Target for Alzheimer's Disease: Modulating NLRP3 Inflammasome via AMPK/mTOR Autophagy Pathway

    Yun Q, Ma SF, Zhang WN et al. · Cellular and molecular neurobiology · 2024

  239. 0.69

    Neurotropin alleviates Alzheimer's disease pathology by inhibiting FUS-mediated Calhm2 transcription, blocking the Calhm2/EFhd2 interaction, to improve mitochondrial dysfunction-associated microglia polarization

    Huang Y, Wei F, Cheng X et al. · Bioscience trends · 2025

  240. 0.69

    Micheliolide attenuates neuroinflammation to improve cognitive impairment of Alzheimer's disease by inhibiting NF-kappaB and PI3K/Akt signaling pathways

    Yang G, Hu Y, Qin X et al. · Heliyon · 2023

  241. 0.69

    Study on the Pharmacological Efficacy and Mechanism of Dual-Target Liposome Complex AD808 Against Alzheimer's Disease

    Liu C, Wang X, Xu W et al. · Pharmaceuticals (Basel, Switzerland) · 2025

  242. 0.69

    Polydopamine Modified with Brain Targeting Peptide Rabies Virus Glycoprotein for Treatment of Alzheimer's Disease by Inhibiting Oxidative Stress and Inflammatory Response

    Chu H, Sun Y, Huang C et al. · International journal of nanomedicine · 2026

  243. 0.68

    Treatment with Histone Deacetylase Inhibitor Attenuates Peripheral Inflammation-Induced Cognitive Dysfunction and Microglial Activation: The Effect of SAHA as a Peripheral HDAC Inhibitor

    Takada N, Nakamura Y, Ikeda K et al. · Neurochemical research · 2021

  244. 0.68

    Meloxicam Inhibits Apoptosis in Neurons by Deactivating Tumor Necrosis Factor Receptor Superfamily Member 25, Leading to the Decreased Cleavage of DNA Fragmentation Factor Subunit alpha in Alzheimer's Disease

    Guan P, Zhu D, Wang P · Molecular neurobiology · 2023

  245. 0.68

    miR-34a/TAN1/CREB Axis Engages in Alleviating Oligodendrocyte Trophic Factor-Induced Myelin Repair Function and Astrocyte-Dependent Neuroinflammation in the Early Stages of Alzheimer's Disease: The Anti-Neurodegenerative Effect of Treadmill Exercise

    Liu Y, Meng XK, Shao WZ et al. · Neurochemical research · 2024

  246. 0.68

    Silk fibroin@polydopamine for acupoint catgut-embedding therapy in Alzheimer's disease

    Wang C, Liu X, Fan Y et al. · Journal of integrative medicine · 2026

  247. 0.68

    TMEM16F may be a new therapeutic target for Alzheimer's disease

    Cui ZQ, Hu XY, Yang T et al. · Neural regeneration research · 2023

  248. 0.67

    The Role of Sirt1 in Regulating Inflammatory Cytokines and Oxidative Stress in the Transition Mechanism from Depressive Disorder to Alzheimer's Disease

    Zou J, Liu L, Chai F et al. · Molecular neurobiology · 2025

  249. 0.67

    MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease

    Liang C, Zou T, Zhang M et al. · Theranostics · 2021

  250. 0.67

    TLR4/NF-kappaB-Mediated Anti-Inflammatory and Cognitive Protective Actions of Curcuma longa and Ar-turmerone in Alzheimer's Disease Models

    Oh KN, Bae D, Oh DR et al. · Journal of microbiology and biotechnology · 2025

  251. 0.67

    Longan Aril polysaccharides ameliorate cognitive impairment in AD mice via restoration of the immune phagocytosis of microglia

    Zhang H, Bi F, Zhao P et al. · Journal of ethnopharmacology · 2025

  252. 0.67

    SCFAs promote intestinal double-negative T cells to regulate the inflammatory response mediated by NLRP3 inflammasome

    Ruan S, Zhai L, Wu S et al. · Aging · 2021

  253. 0.67

    Far-Infrared Radiation Ameliorates the Cognitive Dysfunction in an Alzheimer's Disease Transgenic Mouse via Modulating Jak-2/Stat3 and Nrf-2/HO-1 Pathways

    Yang W, Yu Q, Wang N et al. · Neuromolecular medicine · 2025

  254. 0.67

    CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease

    Puntambekar SS, Moutinho M, Lin PBC et al. · Molecular neurodegeneration · 2022

  255. 0.67

    Platycodon grandiflorum root extract inhibits Abeta deposition by breaking the vicious circle linking oxidative stress and neuroinflammation in Alzheimer's disease

    Nam Y, Ji YJ, Shin SJ et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024

  256. 0.67

    Harnessing the power of ginger leaf polysaccharide: A potential strategy to combat Abeta-induced toxicity through the Wnt/beta-catenin pathway

    Zhang ZH, Pei YH, Duan ZH et al. · International journal of biological macromolecules · 2025

  257. 0.66

    PFOS sub-chronic exposure selectively activates Abeta clearance pathway to improve the cognitive ability of AD mice

    Zhang H, Zhang C, Wang Q et al. · Environmental pollution (Barking, Essex : 1987) · 2024

  258. 0.66

    Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer's disease by regulating microglia homeostasis and inhibiting HMGB1 pathway

    Xu Y, Shao N, Zhi F et al. · Alzheimer's research & therapy · 2025

  259. 0.66

    ADAM17 Inhibition Protects Cognition in Intermittent Hypoxia: The Role of TREM2

    Xu J, Jin H, Li X et al. · Nature and science of sleep · 2025

  260. 0.66

    An Exosome-Based Therapeutic Strategy Targeting Neuroinflammation in Alzheimer's Disease with Berberine and Palmatine

    Zhao X, Ge P, Lei S et al. · Drug design, development and therapy · 2023

  261. 0.65

    Nuclear receptor TLX may be through regulating the SIRT1/NF-kappaB pathway to ameliorate cognitive impairment in chronic cerebral hypoperfusion

    Qu C, Qu C, Xu L et al. · Brain research bulletin · 2021

  262. 0.65

    Targeting IGF2BP2 alleviates high fat diet aggravated Alzheimer's disease by inhibiting ferroptosis

    Zhang D, Shao L, He M et al. · Brain research bulletin · 2026

  263. 0.65

    Pomegranate polyphenol punicalagin improves learning memory deficits, redox homeostasis, and neuroinflammation in aging mice

    Chen P, Chen F, Lei J et al. · Phytotherapy research : PTR · 2023

  264. 0.64

    MCU knockdown in hippocampal neurons improves memory performance of an Alzheimer's disease mouse model

    Cai H, Qiao J, Chen S et al. · Acta biochimica et biophysica Sinica · 2022

  265. 0.64

    Naringenin ameliorates amyloid-beta pathology and neuroinflammation in Alzheimer's disease

    Zhu Y, Guo X, Li S et al. · Communications biology · 2024

  266. 0.64

    Pongamol Alleviates Neuroinflammation and Promotes Autophagy in Alzheimer's Disease by Regulating the Akt/mTOR Signaling Pathway

    Hu K, Wu S, Xu J et al. · Journal of agricultural and food chemistry · 2024

  267. 0.64

    Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer's disease cell and mouse models for neuroprotection and cognitive improvement

    Chiu YJ, Lin CH, Lee MC et al. · Aging · 2021

  268. 0.64

    Quercitrin improved cognitive impairment through inhibiting inflammation induced by microglia in Alzheimer's disease mice

    Wang L, Sun J, Miao Z et al. · Neuroreport · 2022

  269. 0.63

    Acidic oligosaccharide sugar chain combined with hyperbaric oxygen delays D-galactose-induced brain senescence in mice via attenuating oxidative stress and neuroinflammation

    Wang G, Wang X, Zheng X et al. · Neuroscience research · 2022

  270. 0.63

    Isovitexin modulates autophagy in Alzheimer's disease via miR-107 signalling

    Cheng J, Wang G, Zhang N et al. · Translational neuroscience · 2020

  271. 0.63

    Huanshaodan regulates microglial glucose metabolism reprogramming to alleviate neuroinflammation in AD mice through mTOR/HIF-1alpha signaling pathway

    Shang C, Su Y, Ma J et al. · Frontiers in pharmacology · 2024

  272. 0.63

    Probucol attenuates bone loss in APP/PS1 mice and ameliorates Abeta42-induced osteoblast dysfunction by regulating AKT/FOXO3a signaling pathway

    Liu D, Yang H, Feng X et al. · Experimental gerontology · 2026

  273. 0.63

    Bushen Huoxue acupuncture ameliorates Alzheimer's disease by upregulating MARCHF3 to induce NLRP3 ubiquitination and inhibit caspase-1-dependent pyroptosis

    Zhu H, Zhang T, Li R et al. · Metabolic brain disease · 2024

  274. 0.62

    Chitooligosaccharide ameliorates cognitive deficits and neuroinflammation in APP/PS1 mice associated with the regulation of Nrf2/NF-kappaB axis

    Cai M, Zhang X, Gao X et al. · International journal of biological macromolecules · 2025

  275. 0.62

    Microglial cathepsin E plays a role in neuroinflammation and amyloid beta production in Alzheimer's disease

    Xie Z, Meng J, Kong W et al. · Aging cell · 2022

  276. 0.62

    A mixture of extracts from natural ingredients reduces the neurotoxic polarization of microglia via modulating NF-kappaB/NF-E2-related factor 2 activation

    Gui S, Ni J, Mizutani S et al. · Food science & nutrition · 2024

  277. 0.62

    Interleukin-10 deficiency exacerbates inflammation-induced tau pathology

    Weston LL, Jiang S, Chisholm D et al. · Journal of neuroinflammation · 2021

  278. 0.62

    IL-17A promotes the progression of Alzheimer's disease in APP/PS1 mice

    Cao M, Liu J, Zhang X et al. · Immunity & ageing : I & A · 2023

  279. 0.62

    HPLC/UV analysis of mulberry vinegar and its protective role in LPS-induced cognitive impairment via regulating NF-kappaB signaling pathway and amyloidogenesis in mice

    Bang SI, Seo WT, Lee S et al. · Food science and biotechnology · 2025

  280. 0.61

    Ginsenoside Rh2 Alleviates Alzheimer Disease Models via Effects on Ferroptosis-Related Neuroinflammation

    Meng Q, Li J, Xu G et al. · Journal of biochemical and molecular toxicology · 2026

  281. 0.61

    Pharmacological Activation of GPR55 Improved Cognitive Impairment Induced by Lipopolysaccharide in Mice

    Wang X, Xiang X, Hu J et al. · Journal of molecular neuroscience : MN · 2022

  282. 0.60

    Increment of CSF fractalkine-positive microvesicles preceded the spatial memory impairment in amyloid beta neurotoxicity

    Karimi-Zandi L, Zahmatkesh M, Hassanzadeh G et al. · Cytokine · 2022

  283. 0.59

    Histamine H3R antagonist counteracts the impaired hippocampal neurogenesis in Lipopolysaccharide-induced neuroinflammation

    Wang J, Liu B, Sun F et al. · International immunopharmacology · 2022

  284. 0.59

    Pharmacological Inhibition of the Asparaginyl Endopeptidase (AEP) in an Alzheimer's Disease Model Improves the Survival and Efficacy of Transplanted Neural Stem Cells

    Cheng Q, Ma X, Liu J et al. · International journal of molecular sciences · 2023

  285. 0.59

    Noninvasive Terahertz Wave Binocular Stimulation Improves Cognition in Amyloid-beta-Related Dementia

    Wu H, Zhang T, Ma J et al. · Research (Washington, D.C.) · 2026

  286. 0.59

    The piperine derivative HJ105 inhibits Abeta(1-42)-induced neuroinflammation and oxidative damage via the Keap1-Nrf2-TXNIP axis

    Yang X, Zhi J, Leng H et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021

  287. 0.59

    Melatonin modulates TLR4/MyD88/NF-kappaB signaling pathway to ameliorate cognitive impairment in sleep-deprived rats

    Yin C, Zhang M, Cheng L et al. · Frontiers in pharmacology · 2024

  288. 0.59

    An enriched environment prevents cognitive impairment in an Alzheimer's disease model by enhancing the secretion of exosomal microRNA-146a from the choroid plexus

    Nakano M, Kubota K, Hashizume S et al. · Brain, behavior, & immunity - health · 2020

  289. 0.58

    The effects of Saccharomyces boulardii on TLR4/NF-kappaB neuroinflammatory pathway in the hippocampus of LPS-induced rats

    Akhbari M, Babaei F, Navidi-Moghaddam A et al. · IBRO neuroscience reports · 2026

  290. 0.58

    Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis

    Cai Y, Chai Y, Fu Y et al. · Frontiers in aging neuroscience · 2021

  291. 0.58

    The mechanism of Yizhi Qingxin formula to improve neuroinflammation in Alzheimer's disease by regulating the TLR4/NF‑kappaB/NLRP3 pathway

    Chen WX, Huang QY, Sun JH et al. · Journal of Asian natural products research · 2026

  292. 0.58

    Ambroxol attenuates detrimental effect of LPS-induced glia-mediated neuroinflammation, oxidative stress, and cognitive dysfunction in mice brain

    Ullah S, Park TJ, Park JS et al. · Frontiers in immunology · 2025

  293. 0.58

    Inhibition of miR-25-3p Alleviates Neuroinflammation in Alzheimer's Disease By Targeting ADAM10

    Chen P, Qiang X, Zhao Z et al. · Molecular neurobiology · 2026

  294. 0.58

    FSTL1-knockdown improves neural oscillation via decreasing neuronal-inflammation regulating apoptosis in Abeta(1-42) induced AD model mice

    Kumari E, Xu A, Chen R et al. · Experimental neurology · 2023

  295. 0.57

    7,8-Dihydroxyflavone ameliorates bone loss by regulating TRKB/AKT/FOXO3a pathway in a mouse model of alzheimer's disease

    Liu D, Li X, Shi P et al. · Psychopharmacology · 2026

  296. 0.57

    Grape skin extract modulates neuronal stem cell proliferation and improves spatial learning in senescence-accelerated prone 8 mice

    Sasaki K, Geribaldi-Doldan N, Szele FG et al. · Aging · 2021

  297. 0.57

    Macelignan mitigates oxidative and inflammatory damage in hypoxic neurons through PPARgamma-dependent pathways: implications for Alzheimer's disease

    Chu X, Qi Z, Li S et al. · European journal of pharmacology · 2026

  298. 0.57

    SSEA3 and CD105 positivity are associated with the treatment potency of human neural crest-derived nasal turbinate stem cells for Alzheimer's disease

    Lim JY, Lee JE, Lee M et al. · Translational neurodegeneration · 2026

  299. 0.57

    Hippocampal Galectin-3 knockdown alleviates lipopolysaccharide-induced neurotoxicity and cognitive deficits by inhibiting TLR4/NF-small ka, CyrillicB signaling in aged mice

    Chen F, Wu X, Yang J et al. · European journal of pharmacology · 2022

  300. 0.57

    Hypoxic pretreatment of adipose-derived stem cell exosomes improved cognition by delivery of circ-Epc1 and shifting microglial M1/M2 polarization in an Alzheimer's disease mice model

    Liu H, Jin M, Ji M et al. · Aging · 2022

  301. 0.56

    Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/beta-catenin pathway

    Sha S, Shen X, Cao Y et al. · Aging · 2021

  302. 0.56

    Valsartan Mitigates LPS-Induced Neuroinflammation and Cognitive Deficits via Modulation of RAS-ECS Crosstalk in Mice

    Salama A, Elgohary R, Elesawy WH · Molecular neurobiology · 2026

  303. 0.56

    Pomegranate polyphenol punicalin ameliorates lipopolysaccharide-induced memory impairment, behavioral disorders, oxidative stress, and neuroinflammation via inhibition of TLR4-NF-small ka, CyrillicB pathway

    Chen P, Guo Z, Lei J et al. · Phytotherapy research : PTR · 2024

  304. 0.55

    Identification of cytochrome P450 2E1 as a novel target in neuroinflammation and development of its inhibitor Q11 as a treatment strategy

    Yang R, Deng MY, Yang LK et al. · Free radical biology & medicine · 2025

  305. 0.55

    Stigmasterol attenuates inflammatory response of microglia via NF-kappaB and NLRP3 signaling by AMPK activation

    Jie F, Yang X, Yang B et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022

  306. 0.54

    Tetrahydrocurcumin ameliorates Alzheimer's pathological phenotypes by inhibition of microglial cell cycle arrest and apoptosis via Ras/ERK signaling

    Xiao Y, Dai Y, Li L et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021

  307. 0.54

    Microglia regulate adult neurogenesis via interleukin-6 trans-signaling triggered by apoptotic progenitors

    Tanzi R, Castro R, Gavrilles E et al. · Research square · 2026

  308. 0.53

    Activation of GPR55 attenuates cognitive impairment and neurotoxicity in a mouse model of Alzheimer's disease induced by Abeta(1-42) through inhibiting RhoA/ROCK2 pathway

    Xiang X, Wang X, Jin S et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2022

  309. 0.53

    Isorhamnetin Attenuated the Release of Interleukin-6 from beta-Amyloid-Activated Microglia and Mitigated Interleukin-6-Mediated Neurotoxicity

    Wei PC, Lee-Chen GJ, Chen CM et al. · Oxidative medicine and cellular longevity · 2022

  310. 0.52

    Intrahippocampal Inoculation of Abeta(1-42) Peptide in Rat as a Model of Alzheimer's Disease Identified MicroRNA-146a-5p as Blood Marker with Anti-Inflammatory Function in Astrocyte Cells

    Aquino R, de Concini V, Dhenain M et al. · Cells · 2023

  311. 0.52

    Neurotropin alleviates cognitive impairment by inhibiting TLR4/MyD88/NF-kappaB inflammation signaling pathway in mice with vascular dementia

    Zou H, Chen X, Lu J et al. · Neurochemistry international · 2023

  312. 0.51

    Petasites japonicus leaf extract inhibits Alzheimer's-like pathology through suppression of neuroinflammation

    Eo H, Lee S, Kim SH et al. · Food & function · 2022

  313. 0.51

    Aortic aneurysm and dissection and its multidimensional impact on cognitive function: The pivotal role of PRDX6 in pathophysiological mechanisms

    Xie R, Lin X, Chen S et al. · Atherosclerosis · 2026

  314. 0.51

    Tincr protects against cognitive decline by upregulating MYPT1 mediated phosphorylation of structural protein NM IIA in microglia

    Wang Q, Sun L, Ma J et al. · Journal of neuroinflammation · 2025

  315. 0.51

    Parthenolide alleviates microglia-mediated neuroinflammation via MAPK/TRIM31/NLRP3 signaling to ameliorate cognitive disorder

    Fan M, Wang C, Zhao X et al. · International immunopharmacology · 2023

  316. 0.51

    Neuroprotective effect of Geijigadaehwang-tang against trimethyltin-induced hippocampal neurodegeneration: An in vitro and in vivo study

    Lee S, Ryu SM, Kim DH et al. · Journal of ethnopharmacology · 2022

  317. 0.51

    beta-hydroxybutyrate improves cognitive impairment caused by chronic cerebral hypoperfusion via amelioration of neuroinflammation and blood-brain barrier damage

    Wang Z, Li T, Du M et al. · Brain research bulletin · 2023

  318. 0.50

    P2-engineered exosomes encapsulating curcumin alleviate cognitive decline in AD-like mice by improving microglia-related neuropathology

    Huang X, Xu G, Zhou Y et al. · Materials today. Bio · 2026

03mice · gut microbiota266편

  1. 0.91

    Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease

    Lyra E Silva NM, Goncalves RA, Pascoal TA et al. · Translational psychiatry · 2021

  2. 0.90

    Qisheng Wan formula ameliorates cognitive impairment of Alzheimer's disease rat via inflammation inhibition and intestinal microbiota regulation

    Xiong W, Zhao X, Xu Q et al. · Journal of ethnopharmacology · 2022

  3. 0.89

    Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota

    Qu C, Li QP, Su ZR et al. · Journal of advanced research · 2022

  4. 0.88

    Cerebralcare Granule(R) enhances memantine hydrochloride efficacy in APP/PS1 mice by ameliorating amyloid pathology and cognitive functions

    Qiao O, Zhang X, Zhang Y et al. · Chinese medicine · 2021

  5. 0.88

    Qingke beta-glucan and Lactobacillus mitigate neuroinflammation and enhance cognitive function in an Alzheimer's disease mouse model

    Wu Y, Shao Y, Shao X et al. · International journal of biological macromolecules · 2025

  6. 0.87

    Oral administration of evening primrose leaf extract improves cognitive impairment in 5xFAD transgenic mice

    Kim Y, Cho M, Woo Y et al. · Food science and biotechnology · 2026

  7. 0.87

    Secoisolariciresinol diglucoside attenuates neuroinflammation and cognitive impairment in female Alzheimer's disease mice via modulating gut microbiota metabolism and GPER/CREB/BDNF pathway

    Jia M, Ning F, Wen J et al. · Journal of neuroinflammation · 2024

  8. 0.86

    Prevotella intermedia oral infection induces cognitive impairment in C57BL/6 mice via neuroinflammation and barrier damage

    Cai Y, Han S, Zhao M et al. · Journal of oral microbiology · 2026

  9. 0.86

    Intranasal delivery of rapamycin via brain-targeting polymeric micelles for Alzheimer's disease treatment

    Sugandhi VV, Gattu K, Mundrathi V et al. · International journal of pharmaceutics · 2025

  10. 0.86

    Thymoquinone-Loaded Hexosomal Nanoparticles Attenuate Neuroinflammation and Improve Cognitive Function in an Alzheimer's Disease Mouse Model

    Eissa N, Alwattar JK, Jayaprakash P et al. · International journal of nanomedicine · 2026

  11. 0.86

    Clostridium butyricum enhances cognitive function in APP/PS1 mice by modulating neuropathology and regulating acetic acid levels in the gut microbiota

    Shiqing Y, Xinjie L, Xiaotong Z et al. · Microbiology spectrum · 2025

  12. 0.85

    Anti-Abeta3-10 monoclonal antibody 7B8 improves cognitive function and protects the blood-brain barrier in APP/PS1 mice by regulating the HMGB-1/RAGE/NF-kappaB pathway

    You J, Liu Q, Li X · Frontiers in immunology · 2026

  13. 0.85

    Integrated multi-omics profiling identifies a convergent gut-metabolic-immune signature in Alzheimer's disease

    Ling Z, Xu X, Cheng Y et al. · Free radical biology & medicine · 2026

  14. 0.85

    Chuanxiong-Renshen medicine pair ameliorates neuroinflammation in Alzheimer's disease through modulation of the PKC-alpha/NF-kappaB signaling pathway

    Wang XY, Wang YY, Zhang J et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025

  15. 0.84

    Gut dysbiosis and systemic inflammation in elderly hypertensive patients with amnestic mild cognitive impairment

    Ling Z, Cheng Y, Xu X et al. · Frontiers in immunology · 2026

  16. 0.84

    SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer's Disease

    Sola-Sevilla N, Mesa-Lombardo A, Aleixo M et al. · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023

  17. 0.84

    Simvastatin improves learning and memory impairment via gut-brain axis regulation in an ovariectomized/D-galactose Alzheimer's rat model

    Zahedi E, Sanaeierad A, Nikbakhtzadeh M et al. · Behavioural brain research · 2023

  18. 0.84

    Neuroprotective Effects of Molecular Hydrogen via Oxidative Stress and Neuroinflammation Regulation in a 5xFAD Mouse Model

    Mo C, Bajgai J, Rahman MH et al. · Antioxidants (Basel, Switzerland) · 2026

  19. 0.83

    Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain

    Yue X, Zhou Y, Qiao M et al. · Alzheimer's research & therapy · 2021

  20. 0.83

    Electroacupuncture could balance the gut microbiota and improve the learning and memory abilities of Alzheimer's disease animal model

    Jiang J, Liu H, Wang Z et al. · PloS one · 2021

  21. 0.83

    Impairment of brain function in a mouse model of Alzheimer's disease during the pre-depositing phase: The role of alpha7 nicotinic acetylcholine receptors

    Lykhmus O, Tzeng WY, Koval L et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024

  22. 0.83

    Zhinao Capsule improves learning and memory impairment in APP/PS1 mice through gut-brain axis-mediated inhibition of neuroinflammation

    Fang S, Xi H, Zhang K et al. · Frontiers in microbiology · 2026

  23. 0.83

    From gut to brain: donepezil and nimodipine combination therapy improves cognitive deficits in Alzheimer's disease via gut microbiota and metabolites

    Liu J, Liu K, Cui X et al. · Biochemical and biophysical research communications · 2025

  24. 0.83

    Alleviation of Cognitive Impairment-like Behaviors, Neuroinflammation, Colitis, and Gut Dysbiosis in 5xFAD Transgenic and Aged Mice by Lactobacillus mucosae and Bifidobacterium longum

    Ma X, Kim JK, Shin YJ et al. · Nutrients · 2023

  25. 0.83

    Ginger Extract Improves Cognitive Dysfunction via Modulation of Gut Microbiota-Derived Short-Chain Fatty Acids in D-Galactose/Ovariectomy-Induced Alzheimer-Like Disease

    Zahedi E, Naseri FM, Zamani E et al. · Molecular neurobiology · 2025

  26. 0.83

    Salidroside Attenuates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice and Modulates Inflammation of the Gut-Brain Axis

    Xie Z, Lu H, Yang S et al. · Frontiers in pharmacology · 2020

  27. 0.83

    Pseudostellaria heterophylla polysaccharide mitigates Alzheimer's-like pathology via regulating the microbiota-gut-brain axis in 5 x FAD mice

    He C, Jiang J, Liu J et al. · International journal of biological macromolecules · 2024

  28. 0.83

    Ameliorative effects of probiotics in AlCl(3)-induced mouse model of Alzheimer's disease

    Hamid M, Zahid S · Applied microbiology and biotechnology · 2023

  29. 0.83

    A peripheral signature of Alzheimer's disease featuring microbiota-gut-brain axis markers

    Marizzoni M, Mirabelli P, Mombelli E et al. · Alzheimer's research & therapy · 2023

  30. 0.83

    TNFR2 contributes to synaptic potentiation failure in hippocampal synapses and memory loss in a familial Alzheimer's disease mouse model

    Almazan JL, Cortes-Flores E, Ramirez-Olvera A et al. · Brain, behavior, and immunity · 2025

  31. 0.83

    A High-Tryptophan Diet Alleviated Cognitive Impairment and Neuroinflammation in APP/PS1 Mice through Activating Aryl Hydrocarbon Receptor via the Regulation of Gut Microbiota

    Pan S, Zhang Y, Ye T et al. · Molecular nutrition & food research · 2024

  32. 0.83

    Gut Microbiota Dysbiosis Drives Early Alzheimer's Pathogenesis via Microglial TREM2/SYK/NF-kappaB Signaling Axis

    Tian M, Wang D, Zhang C et al. · ACS chemical neuroscience · 2026

  33. 0.82

    Losartan Improves Memory, Neurogenesis and Cell Motility in Transgenic Alzheimer's Mice

    Drews HJ, Klein R, Lourhmati A et al. · Pharmaceuticals (Basel, Switzerland) · 2021

  34. 0.82

    Lactobacillaceae improve cognitive dysfunction via regulating gut microbiota and suppressing Abeta deposits and neuroinflammation in APP/PS1 mice

    Wu Y, Niu X, Li P et al. · Archives of microbiology · 2023

  35. 0.82

    Investigating the Impact of IL-6 and CXCL8 on Neurodegeneration and Cognitive Decline in Alzheimer Disease

    Jin D, Zhang M, Shi L et al. · The international journal of neuropsychopharmacology · 2024

  36. 0.82

    Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer's disease through multi-omics analysis

    Song Z, He J, Yu W et al. · Frontiers in microbiology · 2024

  37. 0.82

    An Abeta3‑10‑KLH vaccine decreases Abeta plaques and astrocytes and microglia activation in the brain of APP/PS1 transgenic mice

    Wang Y, Xu B, Zhou J et al. · Acta neurobiologiae experimentalis · 2021

  38. 0.82

    Danggui Shaoyao San: comprehensive modulation of the microbiota-gut-brain axis for attenuating Alzheimer's disease-related pathology

    He J, Jin Y, He C et al. · Frontiers in pharmacology · 2023

  39. 0.81

    Structure characterisation of polysaccharides purified from Boletus aereus Bull. and its improvement on AD-like behaviours via reliving neuroinflammation in APP/PS1 mice

    Zhu Y, Li L, Jin X et al. · International journal of biological macromolecules · 2024

  40. 0.81

    Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP/PS1 mice

    Sun J, Zhang Y, Kong Y et al. · Brain, behavior, and immunity · 2022

  41. 0.81

    Exercise-Induced Reduction of IGF1R Sumoylation Attenuates Neuroinflammation in APP/PS1 Transgenic Mice

    Chen Y, Chen X, Luo Z et al. · Journal of advanced research · 2025

  42. 0.81

    Effects of alpha5 GABA(A) receptor modulation on social interaction, memory, and neuroinflammation in a mouse model of Alzheimer's disease

    Arandelovic J, Santrac A, Batinic B et al. · CNS neuroscience & therapeutics · 2022

  43. 0.81

    Investigating the Protective Mechanisms of Ginseng-Natto Composite Fermentation Products in Alzheimer's Disease: A Gut Microbiota and Metabolomic Approach

    Li Z, Wang H, Yuan H et al. · Pharmaceuticals (Basel, Switzerland) · 2026

  44. 0.81

    hucMSC-derived exosomes rescue cognitive impairment and Alzheimer-like pathology in APP/PS1 mice via metabolic remodeling

    Zhou S, Yue C, Wang P et al. · Experimental neurology · 2026

  45. 0.81

    Maraviroc attenuates inflammation-exacerbated cognitive and amyloid pathology in an early-stage Alzheimer's disease mouse model

    Liu C, Zhang T, E ED et al. · Translational psychiatry · 2026

  46. 0.80

    Treadmill Exercise Modulates the Leptin/LepR/GSK-3beta Signalling Pathway to Improve Leptin Sensitivity and Alleviate Neuroinflammation in High-Fat Diet-Fed APP/PS1 Mice

    Wang J, Liao M, Tong Z et al. · Molecular neurobiology · 2025

  47. 0.80

    RGD-functionalized cannabidiol lipid nanoparticles improve brain delivery and alleviate cognitive and metabolic dysfunction via gut-brain axis modulation in an Alzheimer's disease model

    Lapmanee S, Thonapan N, Sriwong S et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026

  48. 0.80

    A Gut Microbial Metabolite Alleviates Stress-Induced Neurobehavioral Dysfunction in an Alzheimer's Disease Model

    Hochuli N, Kadyan S, Park G et al. · Molecular neurobiology · 2025

  49. 0.80

    Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer's disease

    Li Z, Gan L, Yan S et al. · Translational neuroscience · 2020

  50. 0.80

    Lipopolysaccharide-producing Veillonella infantium and Escherichia fergusonii cause vagus nerve-mediated cognitive impairment in mice

    Ma X, Kim JK, Shin YJ et al. · Brain, behavior, and immunity · 2024

  51. 0.80

    Poria cocos Polysaccharide Reshapes Gut Microbiota to Regulate Short-Chain Fatty Acids and Alleviate Neuroinflammation-Related Cognitive Impairment in Alzheimer's Disease

    Song M, Zhang S, Gan Y et al. · Journal of agricultural and food chemistry · 2025

  52. 0.80

    ABT263 Ameliorates Cellular Senescence, Abeta-Dependent Pathology and Cognitive Decline in Aged APP/PS1 Mice via Regulating PI3K/AKT/GSK-3beta Pathways

    Tang Z, Wang XL, Deng YX et al. · Cell biochemistry and biophysics · 2025

  53. 0.80

    Prenatal stress aggravates age-dependent cognitive decline, insulin signaling dysfunction, and the pro-inflammatory response in the APP(NL-F/NL-F) mouse model of Alzheimer's disease

    Trojan E, Curzytek K, Cieslik P et al. · Neurobiology of disease · 2023

  54. 0.80

    Kilovoltage Energy Significantly Enhances the Therapeutic Efficacy of Low-Dose Radiation in a 3xTg-AD Mouse Model of Alzheimer's Disease

    Lee S, Yoo YJ, Kim G et al. · International journal of molecular sciences · 2026

  55. 0.80

    Bidirectional modulation of Alzheimer's disease via gut microbiota: rescue by fecal transplantation from healthy donors and aggravation by colitis-associated dysbiosis

    Zhou C, Feng X, Liu H et al. · Frontiers in neuroscience · 2025

  56. 0.79

    Daphnetin ameliorates Abeta pathogenesis via STAT3/GFAP signaling in an APP/PS1 double-transgenic mouse model of Alzheimer's disease

    Gao P, Wang Z, Lei M et al. · Pharmacological research · 2022

  57. 0.79

    Effects of Qi-fu-yin on Improving Cognitive Impairment and Reducing Cellular Senescence in the Brains of 5xFAD Mice

    Li Y, Ye T, Lu H et al. · Journal of visualized experiments : JoVE · 2026

  58. 0.79

    Oxytocin Nanogels Inhibit Innate Inflammatory Response for Early Intervention in Alzheimer's Disease

    Ye C, Cheng M, Ma L et al. · ACS applied materials & interfaces · 2022

  59. 0.79

    Combined supplementation of short-chain fatty acids reduces hyperphosphorylation of Tau at T181,T231 and S396 sites and improves cognitive impairment in a chemically induced AD mouse model via regulation of HDAC and Keap1

    Pu D, Jin Y, Wang L et al. · Neurochemistry international · 2025

  60. 0.79

    Alleviation of cognitive impairment by gut microbiota lipopolysaccharide production-suppressing Lactobacillus plantarum and Bifidobacterium longum in mice

    Lee DY, Shin YJ, Kim JK et al. · Food & function · 2021

  61. 0.79

    A Novel Probiotic Limosilactobacillus fermentum IOB802 and Its Postbiotic Alleviate Cognitive Impairment Induced by Scopolamine in Mice

    Song Y, Pan W, Meng L et al. · Foods (Basel, Switzerland) · 2025

  62. 0.79

    Gut microbiota dysbiosis is associated with hippocampal neuronal damage and behavioral alterations in APP/PS1 mice with high-salt diet

    Zhang H, Kou J, Ge P et al. · Frontiers in microbiology · 2026

  63. 0.79

    Intranasal Delivery of Lithium Salt Suppresses Inflammatory Pyroptosis in the brain and Ameliorates Memory Loss and Depression-like Behavior in 5XFAD mice

    Bhuiyan P, Zhang W, Liang G et al. · bioRxiv : the preprint server for biology · 2024

  64. 0.79

    Akkermansia muciniphila reduces neuroinflammation and Abeta deposition via tryptophan metabolism in the APP/PS1 mouse model of Alzheimer's disease

    Wang B, Pan M, Yang L et al. · Alzheimer's research & therapy · 2026

  65. 0.79

    Glyphosate exposure exacerbates neuroinflammation and Alzheimer's disease-like pathology despite a 6-month recovery period in mice

    Bartholomew SK, Winslow W, Sharma R et al. · Journal of neuroinflammation · 2024

  66. 0.79

    Neuro-Cells Mitigate Amyloid Plaque Formation and Behavioral Deficits in the APPswe/PS1dE9 Model of Alzheimer Disease While Also Reducing IL-6 Production in Human Monocytes

    de Munter J, Chaprov K, Lang E et al. · Cells · 2025

  67. 0.79

    Gut Microbiota-Driven Metabolic Alterations Reveal the Gut-Brain Communication of Ergothioneine in Ameliorating Cognitive Impairment in APP/PS1 Mice

    Li N, Wang S, Li H et al. · Journal of agricultural and food chemistry · 2025

  68. 0.79

    Combined Gamma-Rays and Carbon-12 Nuclei Irradiation Modulates Brain Chemokine and Cytokine Production and Improves Spatial Learning in Tau P301S, but not 5xFAD Mouse Line

    Kokhan VS, Nesterov MS, Levashova AI · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2023

  69. 0.78

    Attenuation of Alzheimer's brain pathology in 5XFAD mice by PTH(1-34), a peptide of parathyroid hormone

    Chen L, Xiong L, Yao L et al. · Alzheimer's research & therapy · 2023

  70. 0.78

    N-acetylcysteine (NAC) ameliorates ethanol-induced oxidative stress, neuroinflammation, and cognitive dysfunction in APP/PS1 mouse model

    Pan X, Su Z, Huang Z et al. · Translational psychiatry · 2025

  71. 0.78

    P2Y1R silencing in Astrocytes Protected Neuroinflammation and Cognitive Decline in a Mouse Model of Alzheimer's Disease

    Luo S, Tamada A, Saikawa Y et al. · Aging and disease · 2024

  72. 0.78

    Ergothioneine-rich water extracts of Hericium erinaceus HE-17 alleviate Alzheimer's disease in mice by regulating oxidative stress, inflammation, and the gut microenvironment

    Gao PP, Zhou FL, Zheng GB et al. · Frontiers in nutrition · 2026

  73. 0.78

    Transplantation of gut microbiota derived from Alzheimer's disease mouse model impairs memory function and neurogenesis in C57BL/6 mice

    Kim N, Jeon SH, Ju IG et al. · Brain, behavior, and immunity · 2021

  74. 0.78

    Prebiotics modulate the microbiota-gut-brain axis and ameliorate cognitive impairment in APP/PS1 mice

    Zhang S, Lv S, Li Y et al. · European journal of nutrition · 2023

  75. 0.78

    Endothelial NAD(+) depletion drives vascular senescence and neuroinflammation via mtDNA-cGAS/STING-CD38 signaling in Alzheimer's disease

    Luo QH, Li F, Yang L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  76. 0.78

    Antroquinonol administration in animal preclinical studies for Alzheimer's disease (AD): A new avenue for modifying progression of AD pathophysiology

    Francesca F, Caitlin A, Sarah L et al. · Brain, behavior, & immunity - health · 2022

  77. 0.78

    The impact of the Lab4 probiotic on neurodegenerative processes in a murine Alzheimer's disease model

    Hughes TR, Webberley TS, John D et al. · Frontiers in neuroscience · 2026

  78. 0.77

    Jiawei Qifuyin Enhances Immunity and Improves Cognitive Impairment in APP/PS1 Mice Through Modulation of Neuroinflammatory Pathways

    Cheng J, Li W, Wang L et al. · Journal of inflammation research · 2024

  79. 0.77

    Caffeic acid protects against atherosclerotic lesions and cognitive decline in ApoE(-/-) mice

    Sun R, Wu T, Xing S et al. · Journal of pharmacological sciences · 2023

  80. 0.77

    Exogenous monocyte myeloid-derived suppressor cells ameliorate immune imbalance, neuroinflammation and cognitive impairment in 5xFAD mice infected with Porphyromonas gingivalis

    Cheng X, Chi L, Lin T et al. · Journal of neuroinflammation · 2023

  81. 0.77

    Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Abeta(42,) P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus

    Zeng L, Zhang D, Liu Q et al. · Neuroscience · 2021

  82. 0.77

    Plasma and feces multiomics unveil cognition-associated perturbations of chronic inflammatory pathways of the gut-microbiota-brain axis

    Hosseinkhani F, Chevalier C, Marizzoni M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  83. 0.77

    Oral Administration of Euonymus alatus Leaf Extract Ameliorates Alzheimer's Disease Phenotypes in 5xFAD Transgenic Mice

    Kim Y, Cho M, Jang CH et al. · Foods (Basel, Switzerland) · 2024

  84. 0.77

    Effects of the ApoE genotype on cognitive function in aging mice fed with a high-fat diet and the protective potential of n-3 polyunsaturated fatty acids

    Zhang X, Xie T, Zhou S et al. · Food & function · 2024

  85. 0.77

    Chia seeds as a potential cognitive booster in the APP23 Alzheimer's disease model

    Schreyer S, Klein C, Pfeffer A et al. · Scientific reports · 2020

  86. 0.77

    Qi-fu-yin attenuated cognitive disorders in 5xFAD mice of Alzheimer's disease animal model by regulating immunity

    Yang X, Ye T, He Y et al. · Frontiers in neurology · 2023

  87. 0.77

    Molecular hydrogen inhibits neuroinflammation and ameliorates depressive-like behaviors and short-term cognitive impairment in senescence-accelerated mouse prone 8 mice

    Nakagawa K, Kodama K, Nagata W et al. · Behavioural brain research · 2025

  88. 0.77

    Sex-Dependent Effects of Intestinal Microbiome Manipulation in a Mouse Model of Alzheimer's Disease

    Kaur H, Nookala S, Singh S et al. · Cells · 2021

  89. 0.77

    Probiotics attenuate AlCl(3)-induced Alzheimer's disease via gut-brain axis modulation and suppression of NF-kappaB/NLRP3 neuroinflammation

    Elfiky AM, Shahy EM, Mahmoud AA · Physiology & behavior · 2026

  90. 0.77

    Intranasal triptolide in mice: a strategy to reduce neuroinflammation and boost cognitive function

    Yan M, Zhang L, Zhao J et al. · Immunopharmacology and immunotoxicology · 2026

  91. 0.77

    Cobrotoxin mitigates neuroinflammation and cognitive impairment by suppressing CD8(+) T cell-microglia interactions in male 5 x FAD mice

    Li Z, Tan B, Dong K et al. · Biochemical pharmacology · 2026

  92. 0.77

    Chronic sleep deprivation induces depression- and Alzheimer's disease-like changes in adult and ageing wild-type and Fat-1 transgenic mice

    Niazi NUK, Yang Z, Zhang Y et al. · Prostaglandins, leukotrienes, and essential fatty acids · 2025

  93. 0.76

    Antibiotic-induced gut microbiota depletion from early adolescence exacerbates spatial but not recognition memory impairment in adult male C57BL/6 mice with Alzheimer-like disease

    Mosaferi B, Jand Y, Salari AA · Brain research bulletin · 2021

  94. 0.76

    Cistanche deserticola Polysaccharides Mitigate Alzheimer's Disease Progression by Dynamic Regulation of Gut Microbiota Composition and Metabolites

    Gao Y, Zhang CS, Liang Y et al. · The American journal of Chinese medicine · 2025

  95. 0.76

    Caspase-1 inhibition improves cognition without significantly altering amyloid and inflammation in aged Alzheimer disease mice

    Flores J, Fillion ML, LeBlanc AC · Cell death & disease · 2022

  96. 0.76

    Caloric restriction leading to attenuation of experimental Alzheimer's disease results from alterations in gut microbiome

    Chen J, Zou C, Guan H et al. · CNS neuroscience & therapeutics · 2024

  97. 0.76

    Moderate ethanol exposure reduces astrocyte-induced neuroinflammatorysignaling and cognitive decline in presymptomatic APP/PS1 mice

    Kang S, Lee J, Choi S et al. · Research square · 2023

  98. 0.76

    Antibiotic-Induced Gut Dysbiosis Modulates Alzheimer's Disease-Associated Gene Expression and Protein Aggregation in 3xTg-AD Mice via the Gut-Brain Axis

    Tettevi EJ, Simpong DL, Maina M et al. · Brain and behavior · 2025

  99. 0.76

    Astragalus Polysaccharides Can Effectively Alleviate Cognitive Impairment in Mice With Alzheimer's Disease by Regulating the Gut Microbiota

    Wang X, Ge X, Di X et al. · Food science & nutrition · 2026

  100. 0.76

    Multiomics analysis reveals early administration of the Medhya rasayana formulation of Bacopa monnieri (L.) Wettst. and Centella asiatica (L.) Urb. prevents neuroinflammation and cognitive deficits in an AbetaO-injected AD mouse model

    Maruthiyodan S, Munegowda G, Thomas M et al. · Journal of ethnopharmacology · 2026

  101. 0.75

    Alzheimer's disease-like pathology induced by Porphyromonas gingivalis in middle-aged mice is mediated by NLRP3 inflammasome via the microbiota-gut-brain axis

    Zhang P, Liu Y, Jin X et al. · Journal of Alzheimer's disease : JAD · 2025

  102. 0.75

    Poly(lactic-co-glycolic acid) immunomodulatory nanoparticles attenuate neuroinflammation and Alzheimer's disease-related pathology in 5xFAD mice

    Sanders B, Korthauer M, Parihar KS et al. · bioRxiv : the preprint server for biology · 2026

  103. 0.75

    Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment

    Flores J, Noel A, Fillion ML et al. · Cell death and differentiation · 2022

  104. 0.75

    Mulberroside A Alleviates Scopolamine-Induced Cognitive Deficits by Suppressing Neuroinflammation and Oxidative Stress via the Dubosiella-Associated Microbiota-Gut-Brain Axis

    Li J, Cheng S, Zhang W et al. · Biology · 2026

  105. 0.75

    Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice

    Matsuzaki Tada A, Hamezah HS, Pahrudin Arrozi A et al. · Journal of Alzheimer's disease : JAD · 2022

  106. 0.75

    Long-Term Treatment of Cuban Policosanol Attenuates Abnormal Oxidative Stress and Inflammatory Response via Amyloid Plaques Reduction in 5xFAD Mice

    Kim JH, Lim DK, Suh YH et al. · Antioxidants (Basel, Switzerland) · 2021

  107. 0.75

    Cannabidiol and pBDNF Cotreatment Attenuates Pathological Symptoms and Improves Cognition in 3 month-Old 5XFAD Mice

    Chaulagain B, Gothwal A, Mahanta AK et al. · ACS chemical neuroscience · 2026

  108. 0.75

    The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer's Disease

    Maskery M, Goulding EM, Gengler S et al. · American journal of Alzheimer's disease and other dementias · 2020

  109. 0.75

    Probiotics Lactobacillus acidophilus LA4 and Lacticaseibacillus paracasei F5 Alleviate Cognitive Dysfunction in Alzheimer's Disease Models: A Dual-Screening Study in Drosophila and Mice

    Liu J, Ren G, Niu S et al. · Foods (Basel, Switzerland) · 2026

  110. 0.74

    Bulbocodin D ameliorate cognitive impairment in APP/PS1 transgenic mice by modulating amyloid-beta burden, oxidative status and neuroinflammation

    Hao F, Feng Y · Psychopharmacology · 2021

  111. 0.74

    Sciadonic acid ameliorates cognitive impairment in APP/PS1 mice with concomitant modulation of gut microbiota and brain metabolism

    Xie S, Zheng B, Li M et al. · Food & function · 2026

  112. 0.74

    Astragalus polysaccharide alleviates neuropathology and cognitive deficits by modulating gut microbiota and neuroinflammation in an Alzheimer's disease model

    Cui X, Wei Z, Wang Q et al. · Frontiers in pharmacology · 2026

  113. 0.74

    Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer's disease mice via suppressing TLR4 signaling pathway through the gut-brain axis

    Su Y, Wang D, Liu N et al. · PloS one · 2023

  114. 0.74

    Treatment with glatiramer acetate in APPswe/PS1dE9 mice at an early stage of Alzheimer's disease prior to amyloid-beta deposition delays the disease's pathological development and ameliorates cognitive decline

    Huang Z, Gong Z, Lin Y et al. · Frontiers in aging neuroscience · 2024

  115. 0.74

    Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice

    Zhang S, Wei D, Lv S et al. · Journal of Alzheimer's disease : JAD · 2022

  116. 0.74

    Extracellular vesicles derived from Porphyromonas gingivalis induce trigeminal nerve-mediated cognitive impairment

    Ma X, Shin YJ, Yoo JW et al. · Journal of advanced research · 2023

  117. 0.74

    KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer's disease

    Arcos-Encarnacion B, Cortes-Flores E, Baron-Mendoza I et al. · Journal of neuroinflammation · 2025

  118. 0.74

    Abnormal amyloid precursor protein processing in periodontal tissue in a murine model of periodontitis induced by Porphyromonas gingivalis

    Shen H, Jiang Y, Qiu C et al. · Journal of periodontal research · 2024

  119. 0.74

    Multi-omics reveal the neuroprotective mechanisms of Xinshubao tablet against scopolamine-induced cognitive dysfunction in mice

    Yang Z, Zhang FR, Ren L et al. · Frontiers in pharmacology · 2025

  120. 0.74

    The 4-(Phenylsulfanyl) butan-2-one Improves Impaired Fear Memory Retrieval and Reduces Excessive Inflammatory Response in Triple Transgenic Alzheimer's Disease Mice

    Varinthra P, Ganesan K, Huang SP et al. · Frontiers in aging neuroscience · 2021

  121. 0.73

    Ginseng and Polygonum multiflorum formula protects brain function in Alzheimer's disease

    Liu JJ, Wei F, Wang YD et al. · Frontiers in pharmacology · 2025

  122. 0.73

    2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid beta-induced Alzheimer-like mice model: Bring the alpha2 adrenergic receptor back into play

    Infantino R, Boccella S, Scuteri D et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022

  123. 0.73

    Low-intensity pulsed ultrasound enhances microglial-mediated Abeta clearance and synaptic preservation in an APP transgenic mouse model of Alzheimer's disease

    Su WS, Wu MT, Cheng IHJ et al. · Experimental neurology · 2025

  124. 0.73

    Neuroprotective effects of polysaccharide from Sparassis crispa on Alzheimer's disease-like mice: Involvement of microbiota-gut-brain axis

    Zhang W, Guo Y, Cheng Y et al. · International journal of biological macromolecules · 2023

  125. 0.73

    Dietary vitamin A modifies the gut microbiota and intestinal tissue transcriptome, impacting intestinal permeability and the release of inflammatory factors, thereby influencing Abeta pathology

    Wang ZL, Pang SJ, Zhang KW et al. · Frontiers in nutrition · 2024

  126. 0.73

    Neuroinflammatory suppression with protocatechuic acid attenuates Alzheimer's disease phenotypes in 5 xFAD transgenic mice

    Kim Y, Cho M, Jeon CJ et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025

  127. 0.73

    Low to moderate ethanol exposure reduces astrocyte-induced neuroinflammatory signaling and cognitive decline in presymptomatic APP/PS1 mice

    Kang S, Lee J, Ali DN et al. · Scientific reports · 2024

  128. 0.73

    Fluoxetine Repurposing Mitigates Alzheimer's Disease Pathology via the GSK3beta-CREB-ADAM10 Axis

    Lee SH, Son Y, Jang H et al. · International journal of molecular sciences · 2026

  129. 0.73

    Effect of Probiotic Fungi against Cognitive Impairment in Mice via Regulation of the Fungal Microbiota-Gut-Brain Axis

    Ye T, Yuan S, Kong Y et al. · Journal of agricultural and food chemistry · 2022

  130. 0.72

    HDAC11 displays neuropathological alterations and offers as a novel drug target for Alzheimer's disease

    Bai P, Mondal P, Liu Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  131. 0.72

    Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer's disease

    Sola-Sevilla N, Garmendia-Berges M, Aleixo M et al. · Brain, behavior, and immunity · 2025

  132. 0.72

    Effects of early tooth loss on chronic stress and progression of neuropathogenesis of Alzheimer's disease in adult Alzheimer's model App(NL-G-F) mice

    Ochi S, Yamada K, Saito T et al. · Frontiers in aging neuroscience · 2024

  133. 0.72

    Effects of Chronic 100 mg/kg Cannabidiol Treatment in Male Double Transgenic APP(Swe)/PS1∆E9 Mice

    Watt G, Olaya J, Muench G et al. · Pharmaceuticals (Basel, Switzerland) · 2026

  134. 0.72

    Neuroplastin 65 deficiency reduces amyloid plaque formation and cognitive deficits in an Alzheimer's disease mouse model

    Wu DD, Cheng J, Zheng YN et al. · Frontiers in cellular neuroscience · 2023

  135. 0.72

    The Neuroprotective Effects of Spray-Dried Porcine Plasma Supplementation Involve the Microbiota-Gut-Brain Axis

    Rosell-Cardona C, Amat C, Grinan-Ferre C et al. · Nutrients · 2022

  136. 0.72

    Neuroavailable peptides from hempseed protein hydrolysates reduce hippocampal inflammation and glial activation in a scopolamine-induced Alzheimer's disease

    Torrecillas-Lopez M, Claro-Cala CM, Gonzalez-de la Rosa T et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025

  137. 0.72

    Transcranial Ultrasound Stimulation Pulsed at 40 Hz Improves Cognition and Neuroinflammation in Female Mice with Alzheimer's Disease

    Yi S, Zou J, He X et al. · Research (Washington, D.C.) · 2026

  138. 0.72

    Alzheimer's Disease-Derived Outer Membrane Vesicles Exacerbate Cognitive Dysfunction, Modulate the Gut Microbiome, and Increase Neuroinflammation and Amyloid-beta Production

    Wei S, Ma X, Chen Y et al. · Molecular neurobiology · 2025

  139. 0.72

    Blueberry-Mulberry Extract Alleviates Cognitive Impairment, Regulates Gut Metabolites, and Inhibits Inflammation in Aged Mice

    Li H, Xiao C, Wang F et al. · Foods (Basel, Switzerland) · 2023

  140. 0.72

    The role of wheat embryo globulin nutrients in improving cognitive dysfunction in AD rats

    Zheng S, Pan L, Hou J et al. · Food & function · 2022

  141. 0.71

    Long-term systemic androgen deprivation partially modulates neuroinflammation in male App(NL-G-F/NL-G-F) mice

    Maekawa K, Sobue A, Komine O et al. · Scientific reports · 2025

  142. 0.71

    Ameliorative effects of Akkermansia muciniphila on anxiety-like behavior and cognitive deficits in a rat model of Alzheimer's disease

    Maftoon H, Davar Siadat S, Tarashi S et al. · Brain research · 2024

  143. 0.71

    A Mediterranean-style diet protects against cognitive and behavioral deficits, adiposity, and Alzheimer's disease-related markers, compared to a macronutrient-matched typical American diet in C57BL/6J mice

    Braden-Kuhle PN, Lacy VA, Brice KN et al. · Journal of Alzheimer's disease : JAD · 2025

  144. 0.71

    Sesamol Attenuates Amyloid Peptide Accumulation and Cognitive Deficits in APP/PS1 Mice: The Mediating Role of the Gut-Brain Axis

    Liu Q, Xie T, Xi Y et al. · Journal of agricultural and food chemistry · 2021

  145. 0.71

    Astrocyte-Specific Upregulation of Tumor Necrosis Factor Receptor II Ameliorates Pathological Phenotypes in APP(NL-F/NL-F) Mice

    Li D, Li Y, Wen L et al. · Neuroscience bulletin · 2026

  146. 0.71

    Aflatoxin B(1)-induced lipid disturbance and neuroinflammation contribute to Alzheimer's disease-like neuropathology in C57BL/6J mice

    Lin J, Li J, Liang Z et al. · Ecotoxicology and environmental safety · 2025

  147. 0.71

    Reducing brain Abeta burden ameliorates high-fat diet-induced fatty liver disease in APP/PS1 mice

    Tsay HJ, Gan YL, Su YH et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024

  148. 0.71

    Intranasal Delivery of Lithium Salt Suppresses Inflammatory Pyroptosis in the Brain and Ameliorates Memory Loss and Depression-like Behavior in 5XFAD Mice

    Bhuiyan P, Zhang W, Liang G et al. · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025

  149. 0.71

    Reproductive history differentially shapes the neural response of middle-aged hAPOEvarepsilon4 female rats to estradiol therapy after a metabolic challenge

    Richard JE, Mohammad A, Lieblich SE et al. · Biology of sex differences · 2026

  150. 0.71

    Spatial Memory and Microglia Activation in a Mouse Model of Chronic Neuroinflammation and the Anti-inflammatory Effects of Apigenin

    Chesworth R, Gamage R, Ullah F et al. · Frontiers in neuroscience · 2021

  151. 0.71

    Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease

    Marizzoni M, Cattaneo A, Mirabelli P et al. · Journal of Alzheimer's disease : JAD · 2020

  152. 0.71

    Manual acupuncture benignly regulates blood-brain barrier disruption and reduces lipopolysaccharide loading and systemic inflammation, possibly by adjusting the gut microbiota

    Zhang Y, Ding N, Hao X et al. · Frontiers in aging neuroscience · 2022

  153. 0.70

    Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease

    Mirzaei N, Mota BC, Birch AM et al. · British journal of pharmacology · 2021

  154. 0.70

    Integrating transcriptome, metabolome and 16S rRNA sequencing to reveal the effect of celastrol on Alzheimer's disease in rats

    Wang Y, Liu L, Zhang Y et al. · Scientific reports · 2026

  155. 0.70

    Cognitive impairment in Alzheimer's disease FAD(4T) mouse model: Synaptic loss facilitated by activated microglia via C1qA

    Zhang C, Qi H, Jia D et al. · Life sciences · 2024

  156. 0.70

    APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of Alzheimer's Disease in Mice via the Blood-Brain Barrier, Amyloid-beta, and Inflammation

    Liu J, Xie Y, Lu Y et al. · Journal of Alzheimer's disease : JAD · 2023

  157. 0.70

    Plasmon-activated water as a therapeutic strategy in Alzheimer's disease by altering gut microbiota

    Cheng CH, Liu YC, Yang YCSH et al. · Aging · 2023

  158. 0.70

    Live and Heat-Inactivated Streptococcus thermophilus MN-ZLW-002 Mediate the Gut-Brain Axis, Alleviating Cognitive Dysfunction in APP/PS1 Mice

    Zhang Y, Wang Y, Zhou Z et al. · Nutrients · 2024

  159. 0.70

    Effects of Intravenously Administered Plasma from Exercise-Trained Donors on Microglia and Cytokines in a Transgenic Rat Model of Alzheimer's Disease

    Huuha AM, Norevik CS, Coombes JS et al. · Brain plasticity (Amsterdam, Netherlands) · 2024

  160. 0.70

    Disturbance of REM sleep exacerbates microglial activation in APP/PS1 mice

    Liu S, Meng Y, Wang N et al. · Neurobiology of learning and memory · 2023

  161. 0.70

    Shenqi Xingnao Granules ameliorates cognitive impairments and Alzheimer's disease-like pathologies in APP/PS1 mouse model

    Yang CC, Jia XY, Zhang L et al. · Chinese herbal medicines · 2020

  162. 0.70

    The anti-inflammatory drug Montelukast ameliorates cognitive deficits by rescuing the inflammatory levels in young AD animal models

    Wu M, Chen YF, Yao W et al. · Scientific reports · 2025

  163. 0.70

    Inhibition of the CEBPbeta-NFkappaB interaction by nanocarrier-packaged Carnosic acid ameliorates glia-mediated neuroinflammation and improves cognitive function in an Alzheimer's disease model

    Yi-Bin W, Xiang L, Bing Y et al. · Cell death & disease · 2022

  164. 0.70

    Oleracone F Alleviates Cognitive Impairment and Neuropathology in APPswe/PSEN1dE9 Mice by Reducing the Expression of Vascular Cell Adhesion Molecule and Leukocyte Adhesion to Brain Vascular Endothelial Cells

    Kwon YS, Ko JS, Oh SY et al. · International journal of molecular sciences · 2023

  165. 0.70

    Bone marrow B lymphopoiesis accelerates early cerebral amyloid pathology

    Zhang J, Fang W, Liu H et al. · Signal transduction and targeted therapy · 2025

  166. 0.69

    Protective effect of melatonin against metabolic disorders and neuropsychiatric injuries in type 2 diabetes mellitus mice

    Gao X, Sun H, Wei Y et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024

  167. 0.69

    Long-term radiofrequency electromagnetic fields exposure attenuates cognitive dysfunction in 5xFAD mice by regulating microglial function

    Son Y, Park HJ, Jeong YJ et al. · Neural regeneration research · 2023

  168. 0.69

    Repetitive Transcranial Magnetic Stimulation-Mediated Neuroprotection in the 5xFAD Mouse Model of Alzheimer's Disease Through GABRG2 and SNAP25 Modulation

    Wang J, Zhou C, Huang Z et al. · Molecular neurobiology · 2025

  169. 0.69

    Chitosan/selenium nanoparticles Pickering emulsion prolong quercetin retention time to ameliorates cognitive disorder: Focus on restoring the metabolic disorder and gut microbiota

    Mei J, Shi X, Chen M et al. · Carbohydrate polymers · 2026

  170. 0.69

    A Novel Abeta B-cell epitope Vaccine, Abeta1-10 with carrier protein OVA and KLH reduce Abeta-induced neuroinflammation mediated neuropathology in mouse model of Alzheimer's disease

    Park JS, Choe K, Ahmad R et al. · Brain, behavior, and immunity · 2025

  171. 0.69

    Benign regulation of the gut microbiota: The possible mechanism through which the beneficial effects of manual acupuncture on cognitive ability and intestinal mucosal barrier function occur in APP/PS1 mice

    Hao X, Ding N, Zhang Y et al. · Frontiers in neuroscience · 2022

  172. 0.69

    Organophosphate Insecticide Malathion Induces Alzheimer's Disease-Like Cognitive Impairment in Mice: Evidence of the Microbiota-Gut-Brain Axis

    Cui J, Xiao S, Cao Y et al. · Environmental science & technology · 2024

  173. 0.69

    Structural characterization of a branched alpha-glucan from Pseudostellaria heterophylla and its neuroprotective effect against Alzheimer's disease via regulating the microbiota-gut-brain axis

    Chen L, Kang X, Deng W et al. · International journal of biological macromolecules · 2026

  174. 0.69

    Improvement of cognitive function in wild-type and Alzheimer s disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells

    Casares N, Alfaro M, Cuadrado-Tejedor M et al. · Frontiers in immunology · 2023

  175. 0.69

    Selective Targeting of Class I HDAC Reduces Microglial Inflammation in the Entorhinal Cortex of Young APP/PS1 Mice

    Wang C, Shen D, Hu Y et al. · International journal of molecular sciences · 2023

  176. 0.69

    Tranexamic Acid Improves Memory and Learning Abilities in Aging Mice

    Hiramoto K, Yamate Y, Matsuda K et al. · Journal of experimental pharmacology · 2020

  177. 0.69

    Novel Selenium Peptides Obtained from Selenium-Enriched Cordyceps militaris Alleviate Neuroinflammation and Gut Microbiota Dysbacteriosis in LPS-Injured Mice

    Wu S, Wu Q, Wang J et al. · Journal of agricultural and food chemistry · 2022

  178. 0.69

    2'-Fucosyllactose mitigates cognitive deficits in Alzheimer models: targeting amyloid pathology, oxidative stress, and synaptic plasticity

    Munni YA, Tran KN, Jeon SM et al. · Frontiers in pharmacology · 2025

  179. 0.68

    Chronic central-targeted Interleukin-6 overexpression promotes hippocampal and cortical neuropathology in the Tg2576 mouse model of Alzheimer's disease

    Canal C, Aguilar K, Comes G et al. · Alzheimer's research & therapy · 2026

  180. 0.68

    Ginsenoside Rg2 Ameliorates Alzheimer's Disease by Alleviating Neuroinflammation in APP/PS1 Mice

    Yeerkenbieke D, Guan Y, Cui J et al. · Current neuropharmacology · 2025

  181. 0.68

    Neuroprotection of macamide in a mouse model of Alzheimer's disease involves Nrf2 signaling pathway and gut microbiota

    Xia N, Xu L, Huang M et al. · European journal of pharmacology · 2024

  182. 0.68

    Progressive Hippocampal Neuroarchitecture Changes in the 5xFAD Alzheimer's Disease Mouse Model

    Jang H, Lee S, Kim YJ et al. · Journal of integrative neuroscience · 2025

  183. 0.68

    Combined Ionizing Radiation Caused Cognition and Non-Cognition Behavior Benefits and Modulated Microglial Activity in Wild-Type and Alzheimer's-like Transgenic Mice

    Kokhan VS, Levashova AI, Nesterov MS et al. · Biology · 2025

  184. 0.68

    Soluble beta-amyloid impaired the GABA inhibition by mediating KCC2 in early APP/PS1 mice

    Zhou Y, Cheng Y, Li Y et al. · Bioscience trends · 2021

  185. 0.68

    Regular Physical Exercise Modulates Iron Homeostasis in the 5xFAD Mouse Model of Alzheimer's Disease

    Belaya I, Kucharikova N, Gorova V et al. · International journal of molecular sciences · 2021

  186. 0.68

    Rhynchophylline alleviates cognitive deficits in multiple transgenic mouse models of Alzheimer's disease via modulating neuropathology and gut microbiota

    Zhong M, Xu QQ, Huang MQ et al. · Acta pharmacologica Sinica · 2025

  187. 0.68

    Long-term normalization of calcineurin activity in model mice rescues Pin1 and attenuates Alzheimer's phenotypes without blocking peripheral T cell IL-2 response

    Stallings NR, O'Neal MA, Hu J et al. · Alzheimer's research & therapy · 2023

  188. 0.67

    Effectiveness of Insulin-Induced umbilical cord stem cells on Seladin-1/APP/GFAP expression in rat hippocampal CA1/CA3 regions following chronic hypoxia

    Hassanzadeh G, Ashouri S, Kargar R et al. · Journal of molecular histology · 2025

  189. 0.67

    Homoharringtonine Inhibits Alzheimer's Disease Progression by Reducing Neuroinflammation via STAT3 Signaling in APP/PS1 Mice

    Jiang X, Wu Q, Zhang C et al. · Neuro-degenerative diseases · 2021

  190. 0.67

    Rosemary extract activates oligodendrogenesis genes in mouse brain and improves learning and memory ability

    Sasaki K, Becker J, Ong J et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024

  191. 0.67

    Modulation of Gut Microbiota and Neuroprotective Effect of a Yeast-Enriched Beer

    Cecarini V, Gogoi O, Bonfili L et al. · Nutrients · 2022

  192. 0.67

    Multi-Omics Integration Reveals Electroacupuncture Ameliorates Cognitive Impairment in Alzheimer's Disease via Gut-Brain Axis

    Zhang S, Liu X, Xu S et al. · Biomolecules · 2025

  193. 0.67

    Gut Microbiome rewiring via fecal transplants: Uncovering therapeutic avenues in Alzheimer's disease models

    Upadhyay P, Kumar S, Tyagi A et al. · BMC neuroscience · 2025

  194. 0.67

    IL-34 exacerbates pathogenic features of Alzheimer's disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice

    Ho A, Ngala B, Yamada C et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023

  195. 0.66

    Targeting MicroRNA-485-3p Blocks Alzheimer's Disease Progression

    Koh HS, Lee S, Lee HJ et al. · International journal of molecular sciences · 2021

  196. 0.66

    IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer's disease mouse model

    Lonnemann N, Hosseini S, Ohm M et al. · eLife · 2022

  197. 0.66

    17beta-Trenbolone Increases the Release of Lipocalin 2 via the Brain-Liver Axis and Causes Alzheimer's Disease-Like Symptoms in CSDS-Induced Mice

    Zuo X, Kuang X, Zhao Y et al. · Molecular neurobiology · 2025

  198. 0.66

    Acer truncatum Bunge seed oil attenuates learning and memory impairment in AD mouse model via modulating gut microbiota and metabolism

    Ren D, Chai X, Xiang C et al. · Frontiers in nutrition · 2026

  199. 0.66

    Effectiveness of electro-acupuncture for cognitive improvement on Alzheimer's disease quantified via PET imaging of sphingosine-1-phosphate receptor 1

    Wang L, Bi L, Qiu Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  200. 0.66

    Daily supplementation with egg yolk lipids from two eggs alleviated cognitive impairment in 5 x FAD mice by restoring neuronal and synaptic function and regulating gut microbiota

    Cheng L, Wang Y, Ma Y et al. · Food & function · 2026

  201. 0.66

    Glial cytokine modulation improves sleep and circadian disruption in female SAA knock-in mice of Alzheimer's-related pathology

    Macheda T, Hawkins MR, Johnson CE et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  202. 0.65

    Interplay of Neuroinflammation and Gut Microbiota Dysbiosis in Alzheimer's Disease Using Diffusion Kurtosis Imaging Biomarker in 3 x Tg-AD Mouse Models

    Palanivelu L, Chang CW, Li SJ et al. · ACS chemical neuroscience · 2025

  203. 0.65

    Engagement of CD300c by a Novel Monoclonal Antibody Ameliorates Behavioral Deficits in a 5xFAD Mouse Model of Alzheimer's Disease

    Lee S, Lim CK, Kim J et al. · Biomedicines · 2025

  204. 0.65

    Evaluation of microcurrent as an adjunct to donepezil therapy in an Alzheimer's disease mouse model: a pilot study

    Kim EH, Lee YJ, Moon YS et al. · Frontiers in aging neuroscience · 2025

  205. 0.65

    Bazi Bushen improves cognitive dysfunction in 5xFAD mice by targeting amyloid pathology, neuroinflammation and cellular senescence

    Huang H, Lu W, Huang Y et al. · Journal of ethnopharmacology · 2026

  206. 0.64

    Effects of ketogenic diet on cognitive functions of mice fed high-fat-high-cholesterol diet

    Lin DT, Kao NJ, Cross TWL et al. · The Journal of nutritional biochemistry · 2022

  207. 0.64

    Benign regulation of short-chain fatty acids: the underlying mechanism of the beneficial effects of manual acupuncture on cognitive ability and the intestinal mucosal barrier in APP/PS1 mice

    Ding N, Hao X, Zhang Y et al. · Frontiers in neuroscience · 2025

  208. 0.64

    Huanglian Jiedu decoction remodels the periphery microenvironment to inhibit Alzheimer's disease progression based on the "brain-gut" axis through multiple integrated omics

    Gu X, Zhou J, Zhou Y et al. · Alzheimer's research & therapy · 2021

  209. 0.64

    TERT activator compound alleviates cigarette smoke-induced cognitive deficits by modulating hippocampal inflammation and neurogenesis: A comprehensive study integrating Mendelian randomization

    Zheng Z, Chen C, Zhu S et al. · Experimental neurology · 2026

  210. 0.64

    AD-Like Neuropsychiatric Dysfunction in a Mice Model Induced by a Combination of High-Fat Diet and Intraperitoneal Injection of Streptozotocin

    Sun H, Gao X, Niu J et al. · eNeuro · 2024

  211. 0.63

    Buyang Huanwu Decoction Modulates the Gut Microbiota-C/EBPbeta/AEP Axis to Ameliorate Cognitive Impairment in Alzheimer's Disease Mice

    Liang J, Dong X, Yang J et al. · CNS neuroscience & therapeutics · 2025

  212. 0.63

    Acupuncture Effect Assessment in APP/PS1 Transgenic Mice: On Regulating Learning-Memory Abilities, Gut Microbiota, and Microbial Metabolites

    Yang B, He M, Chen X et al. · Computational and mathematical methods in medicine · 2022

  213. 0.63

    Treadmill exercise attenuates neuroinflammation in APP/PS1 mice via gut microbiota remodeling: Evidence from fecal microbiota transplantation

    Yuan S, Lin L, Liu J et al. · Life sciences · 2026

  214. 0.63

    Probiotic Bifidobacterium breve Prevents Memory Impairment Through the Reduction of Both Amyloid-beta Production and Microglia Activation in APP Knock-In Mouse

    Abdelhamid M, Zhou C, Ohno K et al. · Journal of Alzheimer's disease : JAD · 2022

  215. 0.63

    Effects of Qi-Fu-Yin on aging of APP/PS1 transgenic mice by regulating the intestinal microbiome

    Xiao QY, Ye TY, Wang XL et al. · Frontiers in cellular and infection microbiology · 2022

  216. 0.63

    H3K18 lactylation of senescent microglia potentiates brain aging and Alzheimer's disease through the NFkappaB signaling pathway

    Wei L, Yang X, Wang J et al. · Journal of neuroinflammation · 2023

  217. 0.63

    A ketogenic diet improves memory in females in the APOE4 mouse model of Alzheimer's disease

    Di Lucente J, Rutkowsky JM, Errico Provenzano A et al. · GeroScience · 2026

  218. 0.63

    Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer's disease

    Banik A, Amaradhi R, Lee D et al. · Journal of neuroinflammation · 2021

  219. 0.62

    Infiltrating Hematogenous Macrophages Aggregate Around beta-Amyloid Plaques in an Age- and Sex-Dependent Manner in a Mouse Model of Alzheimer Disease

    Kozyrev N, Albers S, Yang J et al. · Journal of neuropathology and experimental neurology · 2020

  220. 0.62

    Orthopedic Surgery Causes Gut Microbiome Dysbiosis and Intestinal Barrier Dysfunction in Prodromal Alzheimer Disease Patients: A Prospective Observational Cohort Study

    Liu F, Duan M, Fu H et al. · Annals of surgery · 2022

  221. 0.62

    Subcutaneous Administration of AMD3100 into Mice Models of Alzheimer's Disease Ameliorated Cognitive Impairment, Reduced Neuroinflammation, and Improved Pathophysiological Markers

    Gavriel Y, Rabinovich-Nikitin I, Ezra A et al. · Journal of Alzheimer's disease : JAD · 2020

  222. 0.62

    Lactate treatment improves brain biochemistry and cognitive function in transgenic Alzheimer's and wild-type mice

    Belhaj I, Amellem I, Tartanoglu CH et al. · Scientific reports · 2026

  223. 0.62

    D-methionine improves spatial navigation and attenuates oxidative stress and amyloid pathology in a sex-specific manner

    Peck MR, Chapman JE, Hill T et al. · Journal of Alzheimer's disease : JAD · 2026

  224. 0.62

    Targeting Neuroinflammation and Apoptosis: Cardamonin's Cognitive Benefits in Alzheimer's 5XFAD Mice

    Smail SW · Neurochemical research · 2024

  225. 0.62

    SPRY1 suppresses microglial fatty acid oxidation by retaining FATP3 on the endoplasmic reticulum in Alzheimer's disease

    Zhang YG, Li SY, Hu YZ et al. · Journal of neuroinflammation · 2026

  226. 0.60

    Soluble Epoxide Hydrolase Inhibition Improves Alzheimer's Disease Hallmarks: Correlation with Peripheral Inflammation and Gut Microbiota Modulation

    Jarne-Ferrer J, Grinan-Ferre C, Jora B et al. · Aging and disease · 2025

  227. 0.60

    Cigarette smoke-induced lung-brain barrier dysfunction drives neurocognitive impairment via inflammatory spill-over

    Yu X, Xiao H, Bao S et al. · Journal of neuroinflammation · 2025

  228. 0.59

    Anti-Alzheimers molecular mechanism of icariin: insights from gut microbiota, metabolomics, and network pharmacology

    Liu Y, Li H, Wang X et al. · Journal of translational medicine · 2023

  229. 0.59

    Osteoblastic Swedish mutant APP expedites brain deficits by inducing endoplasmic reticulum stress-driven senescence

    Pan JX, Sun D, Lee D et al. · Communications biology · 2021

  230. 0.59

    Inhibition of Soluble TNF Mitigates Traumatic Brain Injury as a Risk Factor for the Development of Amyloidogenic Proteins and Functional Deficits in 3xTg-AD Mice

    Poffenberger CN, Taylor MM, Larson K et al. · Journal of neurotrauma · 2026

  231. 0.59

    Supplementation of Seaweed Extracts to the Diet Reduces Symptoms of Alzheimer's Disease in the APPswePS1DeltaE9 Mouse Model

    Martens N, Zhan N, Yam SC et al. · Nutrients · 2024

  232. 0.59

    Cellulose-like chitosan microfibrils facilitate targeted release and enhance the prolonged residence time of quercetin-selenium nanoparticles for Alzheimer's disease treatment

    Fang C, Chen Q, Zheng G et al. · International journal of pharmaceutics · 2025

  233. 0.58

    Astrocytes upregulate interleukin-15 in response to neuroinflammation during Alzheimer's disease

    Shaw BC, Kaiser KE, Smith BC et al. · Journal of Alzheimer's disease : JAD · 2026

  234. 0.58

    Lacticaseibacillus rhamnosus CBT LR5 with skim milk alleviates scopolamine-induced cognitive impairment in mice

    Bae HJ, Kim SI, Kim SY et al. · Frontiers in microbiology · 2025

  235. 0.58

    A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies

    Yao Y, Kang SS, Xia Y et al. · Brain : a journal of neurology · 2021

  236. 0.57

    Enhancing cognitive memory function using Phyllanthus emblica polysaccharides via modulating autophagy and reshaping the gut microbiota

    Chen JD, Chen SY, Liao CC et al. · Food & function · 2025

  237. 0.57

    Exploring the gut-brain axis in alzheimer's disease treatment via probiotics: evidence from animal studies-a systematic review and meta-analysis

    Siripaopradit Y, Chatsirisakul O, Ariyapaisalkul T et al. · BMC neurology · 2024

  238. 0.57

    A novel multi-target compound mitigates amyloid plaques, synaptic deficits, and neuroinflammation in Alzheimer's disease models

    Lee Y, Han S, Lee J et al. · Archives of pharmacal research · 2025

  239. 0.57

    Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-beta clearance underlying vascular complications of Alzheimer's disease

    Fiala M, Hammock BD, Hwang SH et al. · Journal of Alzheimer's disease : JAD · 2025

  240. 0.57

    The Effect of Fat Intake with Increased Omega-6-to-Omega-3 Polyunsaturated Fatty Acid Ratio in Animal Models of Early and Late Alzheimer's Disease-like Pathogenesis

    Galeano P, de Ceglia M, Mastrogiovanni M et al. · International journal of molecular sciences · 2023

  241. 0.57

    Alzheimer's disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation

    Ramamoorthy K, Yoshimura R, Al-Juburi S et al. · Neurobiology of disease · 2022

  242. 0.57

    Near-infrared light reduces glia activation and modulates neuroinflammation in the brains of diet-induced obese mice

    Saieva S, Taglialatela G · Scientific reports · 2022

  243. 0.57

    Association of gut microbiota with sort-chain fatty acids and inflammatory cytokines in diabetic patients with cognitive impairment: A cross-sectional, non-controlled study

    Du Y, Li X, An Y et al. · Frontiers in nutrition · 2022

  244. 0.56

    Mechanism Explanation on Improved Cognitive Ability of D-Gal Inducing Aged Mice Model by Lactiplantibacillus plantarum MWFLp-182 via the Microbiota-Gut-Brain Axis

    Nie H, Wang X, Luo Y et al. · Journal of agricultural and food chemistry · 2024

  245. 0.56

    Multi-regional transcriptomic analysis reveals early nociceptive and neuroinflammatory alterations in APP/PS1 mice

    Sheng Z, Xu F, Yan Y et al. · Frontiers in immunology · 2026

  246. 0.56

    Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-beta and tau pathology

    Ries M, Watts H, Mota BC et al. · Brain : a journal of neurology · 2021

  247. 0.55

    Efficacy and Safety of a Brain-Penetrant Biologic TNF-alpha Inhibitor in Aged APP/PS1 Mice

    Ou W, Ohno Y, Yang J et al. · Pharmaceutics · 2022

  248. 0.55

    Alzheimer's disease/dementia-associated brain pathology in aging DPP6-KO mice

    Lin L, Petralia RS, Holtzclaw L et al. · Neurobiology of disease · 2022

  249. 0.55

    Endothelium-specific endoglin triggers astrocyte reactivity via extracellular vesicles in a mouse model of Alzheimer's disease

    Zhang P, Song C, Shi J et al. · Molecular neurodegeneration · 2025

  250. 0.55

    In Vivo Evaluation of Nose-to-Brain Delivery of Liposomal Donepezil, Memantine, and BACE-1 siRNA for Alzheimer's Disease Therapy

    Lee D, Shen AM, Shah M et al. · International journal of molecular sciences · 2024

  251. 0.55

    Analysis the alteration of systemic inflammation in old and young APP/PS1 mouse

    Liu L, Cao J, Huang C et al. · Experimental gerontology · 2021

  252. 0.54

    Preventive Effect of Indian Gooseberry (Phyllanthus emblica L.) Fruit Extract on Cognitive Decline in High-Fat Diet (HFD)-Fed Rats

    Chen YY, Chen SY, Lin JA et al. · Molecular nutrition & food research · 2023

  253. 0.54

    Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer's disease

    Gupta DP, Lee YS, Choe Y et al. · Molecular brain · 2023

  254. 0.54

    Effects of West Nile virus on behavioral and cognitive performance, cortical Abeta pathology, viral loads, and immune measures of middle-aged NL-G-F/E3 and NL-G-F/E4 mice

    O'Niel A, Parkins CJ, Pederson A et al. · Frontiers in aging neuroscience · 2025

  255. 0.53

    Lead-induced hypertension and cognitive dysfunction: brain amyloid pathology

    Zhang Y, Xu Y, Song Y et al. · European journal of medical research · 2025

  256. 0.53

    Differential Genotypic Effects of HSV-1 Infection on Cognitive Function and Pathology in the 5xFAD Mouse Model

    Lin K, Gu E, Ackerman S et al. · Cells · 2026

  257. 0.53

    Impaired spatial navigation and age-dependent hippocampal synaptic dysfunction are associated with chronic inflammatory response in db/db mice

    Al-Onaizi M, Al-Sarraf A, Braysh K et al. · The European journal of neuroscience · 2022

  258. 0.53

    Dysregulated glucose metabolism in the visual cortex of human subjects with mild cognitive impairment and Alzheimer's disease

    Mjaaseth UN, Hsu MF, Arballo J et al. · Frontiers in aging neuroscience · 2026

  259. 0.53

    Surgical removal of visceral adipose tissue has therapeutic benefit in male APP(NL-F) mice

    McFadden SA, Fang Y, Quinn K et al. · Frontiers in endocrinology · 2026

  260. 0.53

    Western diet-induced visceral adipose tissue inflammation promotes Alzheimer's disease pathology via microglial activation in a mouse model

    Lim JS, Kwak S, Yu MH et al. · Frontiers in aging neuroscience · 2025

  261. 0.52

    Ketone monoester alleviates cognitive impairment in a transgenic mouse model of Alzheimer's disease through innate immunological IFITM3 pathway

    Zhang T, Ruan J, Liu Z et al. · Brain, behavior, and immunity · 2025

  262. 0.52

    Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer's disease

    Badr A, Daily KP, Eltobgy M et al. · Brain, behavior, and immunity · 2024

  263. 0.51

    Sex-specific effects of chronic alcohol consumption across the lifespan in the transgenic Alzheimer's Disease (TgF344-AD) rat model

    Marsland P, Vore AS, Lutzke A et al. · Brain, behavior, and immunity · 2025

  264. 0.51

    Adolescent Binge Alcohol Enhances Early Alzheimer's Disease Pathology in Adulthood Through Proinflammatory Neuroimmune Activation

    Barnett A, David E, Rohlman A et al. · Frontiers in pharmacology · 2022

  265. 0.51

    Hydroxytyrosol Acetate Improves the Cognitive Function of APP/PS1 Transgenic Mice in ERbeta-dependent Manner

    Qin C, Hu S, Zhang S et al. · Molecular nutrition & food research · 2021

  266. 0.50

    E.coli-derived CsgA-peptides stimulate cytokine production in microglia and lead to transient changes in neocortical Abeta-levels in pre-plaque APP (SWE) /PS1 (DeltaE9) and wild type mice

    Mygind L, Jensen G, Neesgaard V et al. · Brain, behavior, & immunity - health · 2025

04biomarkers · cerebrospinal fluid130편

  1. 0.94

    The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum

    Bernier RA, Banks SJ, Panizzon MS et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2022

  2. 0.93

    Cerebrospinal fluid inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrum

    Ghanbarian E, Khorsand B, Petersen KK et al. · Journal of Alzheimer's disease : JAD · 2025

  3. 0.93

    Levels of Soluble Interleukin 6 Receptor and Asp358Ala Are Associated With Cognitive Performance and Alzheimer Disease Biomarkers

    Quillen D, Hughes TM, Craft S et al. · Neurology(R) neuroimmunology & neuroinflammation · 2023

  4. 0.93

    Inflammatory cytokine levels implicated in Alzheimer's disease moderate the effects of sex on verbal memory performance

    Caldwell JZK, Kinney JW, Ritter A et al. · Brain, behavior, and immunity · 2021

  5. 0.92

    Association of soluble tumor necrosis factor receptor 1 with tau pathology, brain atrophy, and cognitive decline: a longitudinal study

    Zhang Y, Sun L, Zhao Y et al. · BMC medicine · 2026

  6. 0.92

    Pro-inflammatory/Anti-Inflammatory Interleukin Imbalance in Iraqi Alzheimer's Patients: Implications for Post-Conflict Environmental Exposures

    Hoidy WH, Essa SM, Al-Saadi MH · The European journal of neuroscience · 2025

  7. 0.91

    Higher p-Cresol sulfate and tumor necrosis factor (TNF)-alpha levels are associated with cognitive improvement through increased TNF receptor 2 in individuals with mild cognitive impairment: A cross-sectional mediation analysis

    Azargoonjahromi A, Nasiri H · Journal of Alzheimer's disease reports · 2025

  8. 0.90

    CSF inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrum

    Ghanbarian E, Khorsand B, Petersen KK et al. · medRxiv : the preprint server for health sciences · 2024

  9. 0.90

    Interleukin-6 is associated with white matter hyperintensities and cognition independent of Alzheimer's disease plasma biomarkers-HABS-HD

    Dharmapuri A, Chaudhuri S, Contreras JA et al. · Journal of Alzheimer's disease : JAD · 2026

  10. 0.90

    Plasma profiling of B lymphocyte-associated cytokines in Alzheimer's disease

    Wang MT, Zhao RC, Huang M et al. · Journal of Alzheimer's disease : JAD · 2026

  11. 0.90

    TNF receptors are associated with tau pathology and conversion to Alzheimer's dementia in subjects with mild cognitive impairment

    Zhao A, Li Y, Deng Y · Neuroscience letters · 2020

  12. 0.90

    Prospective associations of interleukin-6 and APOE allele with cognitive decline in biracial community-dwelling older adults: The Chicago Health and Aging Project (CHAP)

    Ng TKS, Beck T, Desai P et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  13. 0.90

    Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study

    Brosseron F, Maass A, Kleineidam L et al. · Alzheimer's research & therapy · 2023

  14. 0.90

    TNF-alpha Levels Are Increased in Patients with Subjective Cognitive Impairment and Are Negatively Correlated with beta Amyloid-42

    Serafini S, Ferretti G, Monterosso P et al. · Antioxidants (Basel, Switzerland) · 2024

  15. 0.89

    Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial

    Kellar D, Register T, Lockhart SN et al. · Scientific reports · 2022

  16. 0.89

    Higher baseline levels of CSF inflammation increase risk of incident mild cognitive impairment and Alzheimer's disease dementia

    Contreras JA, Aslanyan V, Albrecht DS et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2022

  17. 0.89

    Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer's Disease

    de la Monte SM, Tong M, Hapel AJ · Biomedicines · 2023

  18. 0.89

    CSF neuroinflammatory biomarkers are associated with amyloid-beta42/40, tau pathology, and cognitive impairment across the Alzheimer's disease spectrum

    Alruwaili M, Turkistani AA, Shilbayeh SAR et al. · Immunologic research · 2026

  19. 0.89

    Plasma myeloperoxidase predicts cognitive decline in mild cognitive impairment: a multicenter longitudinal cohort study

    Sun W, Shan A, Wang P et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026

  20. 0.88

    Plasma IL-6 as a shared inflammatory marker of cognitive impairment across racially and ethnically diverse older adults: matched analyses from the HABS-HD study

    Misiura MB, Joseph TO, Cooper JA et al. · Frontiers in dementia · 2026

  21. 0.88

    Peripheral inflammatory biomarkers predict the deposition and progression of amyloid-beta in cognitively unimpaired older adults

    Oberlin LE, Erickson KI, Mackey R et al. · Brain, behavior, and immunity · 2021

  22. 0.88

    Inflammation, Cognition, and White Matter in Older Adults: An Examination by Race

    Boots EA, Castellanos KJ, Zhan L et al. · Frontiers in aging neuroscience · 2020

  23. 0.88

    The association of periodontal inflammation and inflammatory markers with cognitive dysfunction: A case-control study

    Buhlin K, Eriksdotter M, Jansson L et al. · Journal of periodontology · 2026

  24. 0.87

    Patterns of CSF Inflammatory Markers in Non-demented Older People: A Cluster Analysis

    Peng Y, Chen B, Chi L et al. · Frontiers in aging neuroscience · 2020

  25. 0.87

    Association of ApoE epsilon4 allele, homocysteine, and inflammatory factors (hs-CRP, IL-6, TNF-alpha) with cognitive dysfunction in Alzheimer's disease patients and development and validation of a predictive model

    Wang L, Sun Q · Neurological research · 2026

  26. 0.87

    Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition

    Flores-Aguilar L, Iulita MF, Orciani C et al. · Journal of neuroinflammation · 2021

  27. 0.86

    Brain derived beta-interferon is a potential player in Alzheimer's disease pathogenesis and cognitive impairment

    Wang Q, Yuan S, Wang C et al. · Alzheimer's research & therapy · 2024

  28. 0.86

    Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels

    Gonzalo R, Minguet C, Ortiz AM et al. · Annals of clinical and translational neurology · 2024

  29. 0.86

    The inflammatory profiling in a cohort of older patients suffering from cognitive decline and dementia

    Arosio B, Rossi PD, Ferri E et al. · Experimental gerontology · 2025

  30. 0.86

    Autoimmune antibodies and systemic inflammatory markers are prevalent and associated with cognition in individuals aged 90

    Farahmand G, Leiby AMC, Yu J et al. · Journal of Alzheimer's disease : JAD · 2025

  31. 0.85

    Blood biomarkers of amyloid and tau pathologies, brain degeneration, inflammation, and oxidative stress in early- and late-onset Alzheimer's disease

    Qin Q, Xia X, Qu J et al. · Journal of Alzheimer's disease : JAD · 2025

  32. 0.85

    CSF TNF alpha levels were associated with conversion from mild cognitive impairment to dementia

    Fu P, Peng F · PloS one · 2022

  33. 0.85

    CSF TNF-alpha Levels Were Associated with Longitudinal Change in Brain Glucose Metabolism Among Non-Demented Older People

    Fu P, Zhu B, Huang Y · Neuropsychiatric disease and treatment · 2021

  34. 0.85

    NFL strongly correlates with TNF-R1 in the plasma of AD patients, but not with cognitive decline

    Delaby C, Julian A, Page G et al. · Scientific reports · 2021

  35. 0.85

    Exploring molecular pathways in Alzheimer's disease neurodegeneration using biomarkers

    Mondal A, Gupta S, Bhattacharjee A et al. · Bioinformation · 2026

  36. 0.84

    The Mediating Role of Inflammation in the Relationship Between alpha-Synuclein and Cognitive Functioning

    Dabiri S, Ramirez Ruiz MI, Jean-Louis G et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2023

  37. 0.84

    Plasma IL-6 Levels as a Biomarker for Behavioral Changes in Alzheimer's Disease

    Yasuno F, Watanabe A, Kimura Y et al. · Neuroimmunomodulation · 2025

  38. 0.84

    No association between markers of systemic inflammation and endothelial dysfunction with Alzheimer's disease progression: a longitudinal study

    van Setten A, Uleman JF, Melis RJF et al. · GeroScience · 2025

  39. 0.84

    Neuroinflammation, cerebrovascular dysfunction and diurnal cortisol biomarkers in a memory clinic cohort: Findings from the Co-STAR study

    Daniilidou M, Holleman J, Hagman G et al. · Translational psychiatry · 2024

  40. 0.84

    Sex-specific associations of neurodegeneration and inflammatory biomarkers with intrinsic capacity in older adults: Findings from the 4-year longitudinal Multidomain Alzheimer's Prevention Trial (MAPT)

    de Assuncao Cortez Correa LC, Raffin J, Vellas B et al. · Maturitas · 2025

  41. 0.83

    Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia

    Gertje EC, Janelidze S, van Westen D et al. · Neurology · 2023

  42. 0.83

    Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's disease

    Hu WT, Ozturk T, Kollhoff A et al. · Nature communications · 2021

  43. 0.83

    Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people

    Clark C, Richiardi J, Marechal B et al. · Journal of neuroinflammation · 2022

  44. 0.83

    Association of inflammation-related plasma proteins with vascular cognitive burden and Alzheimer's disease: A multi-method study

    Ye Z, Teng B, Wang S et al. · Journal of Alzheimer's disease : JAD · 2026

  45. 0.83

    Risk factors for Alzheimer's disease and cognitive function before middle age in a U.S. representative population-based study

    Aiello AE, Momkus J, Stebbins RC et al. · Lancet regional health. Americas · 2025

  46. 0.82

    Circulating small extracellular vesicles in Alzheimer's disease: a case-control study of neuro-inflammation and synaptic dysfunction

    Singh R, Rai S, Bharti PS et al. · BMC medicine · 2024

  47. 0.82

    Plasma beta-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals

    Sun Q, Ni J, Wei M et al. · Frontiers in aging neuroscience · 2022

  48. 0.82

    Blood-brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease

    Bruno M, Bonomi CG, Ricci F et al. · European journal of neurology · 2024

  49. 0.82

    Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease

    Nordengen K, Kirsebom BE, Richter G et al. · Journal of neuroinflammation · 2023

  50. 0.81

    Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease

    Salai KHT, Wu LY, Chong JR et al. · Biomolecules · 2023

  51. 0.81

    Exploratory Analysis of Cerebrospinal Fluid IL-6 and IL-17A Levels in Subcortical Small-Vessel Disease Compared to Alzheimer's Disease: A Pilot Study

    Liakakis G, Vakrakou AG, Boufidou F et al. · Diagnostics (Basel, Switzerland) · 2025

  52. 0.81

    Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment

    Chai YL, Chong JR, Raquib AR et al. · Scientific reports · 2021

  53. 0.80

    Cerebrospinal fluid levels of tumour necrosis factor-alpha and its receptors are not associated with disease progression in Alzheimer's disease

    Aljuhani M · Frontiers in aging neuroscience · 2025

  54. 0.79

    Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes

    Pillai JA, Khrestian M, Bena J et al. · Frontiers in aging neuroscience · 2021

  55. 0.79

    Correlation between peripheral and central inflammatory and neuronal injury markers in mild cognitive impairment patients: the role of blood-brain barrier status

    Liu QF, Shi CN, Wu XM et al. · Translational psychiatry · 2026

  56. 0.79

    A Pilot randomized clinical trial of adapted tango to improve cognition and psychosocial function in African American women with family history of Alzheimer's disease (ACT trial)

    Wharton W, Jeong L, Ni L et al. · Cerebral circulation - cognition and behavior · 2021

  57. 0.78

    TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease

    Pillai JA, Bebek G, Khrestian M et al. · Frontiers in aging neuroscience · 2021

  58. 0.78

    The association between Alzheimer-associated neuronal thread protein (AD7c-NTP) and plasma inflammatory cytokine levels in individuals with cognitive impairment and demographically-matched controls

    Jin H, He J, Zhang W et al. · Journal of Alzheimer's disease : JAD · 2025

  59. 0.77

    Peripheral inflammation in a Canadian cohort of neurodegenerative conditions: Occurrence, determinants, and impact

    Seixas-Lima B, Rosa-Neto P, Phillips NA et al. · Journal of Alzheimer's disease : JAD · 2026

  60. 0.77

    Intersectional effects of race/ethnicity, sex, and APOE4 on plasma inflammatory profiles in Hispanic and non-Hispanic white adults

    Contreras JA, Ortega NE, Hayes CA et al. · Brain, behavior, & immunity - health · 2026

  61. 0.77

    Association between plasma cytokine levels and multiple neuroimaging modalities in mild cognitive impairment

    Nakamichi A, Kimura N, Hanaoka T et al. · Journal of Alzheimer's disease : JAD · 2025

  62. 0.76

    Associations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers - in cognitively unimpaired older adults

    Capogna E, Watne LO, Sorensen O et al. · Brain, behavior, and immunity · 2023

  63. 0.76

    Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment

    Chua XY, Chai YL, Chew WS et al. · Alzheimer's research & therapy · 2020

  64. 0.76

    Air pollution is associated with sex-specific longitudinal changes in astrocytic and neuroinflammatory processes linked to cognitive decline in Alzheimer's disease at-risk individuals

    Vilor-Tejedor N, Rodriguez-Fernandez B, Genius P et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  65. 0.76

    Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort

    Aksnes M, Aass HCD, Tiiman A et al. · Journal of Alzheimer's disease : JAD · 2022

  66. 0.76

    Association between inflammatory biomarkers and cognitive aging

    Fang Y, Doyle MF, Chen J et al. · PloS one · 2022

  67. 0.75

    Phenotypic alterations in peripheral blood B Lymphocytes of patients with Alzheimer's Disease

    Wang MT, Wang YR, Zeng GH et al. · The journal of prevention of Alzheimer's disease · 2025

  68. 0.75

    The long-term neuroprotective effect of MIND and Mediterranean diet on patients with Alzheimer's disease

    Liu X, Yang B, Liu Q et al. · Scientific reports · 2025

  69. 0.75

    The Associations of Cerebrospinal Fluid Ferritin with Neurodegeneration and Neuroinflammation Along the Alzheimer's Disease Continuum

    Pan R, Luo S, Huang Q et al. · Journal of Alzheimer's disease : JAD · 2022

  70. 0.75

    Sexual dimorphisms in innate immune activation markers in predementia Alzheimer's disease

    Knudtzon S, Nordengen K, Palhaugen L et al. · Brain communications · 2025

  71. 0.75

    Inflammatory Biomarkers Aid in Diagnosis of Dementia

    Erhardt EB, Adair JC, Knoefel JE et al. · Frontiers in aging neuroscience · 2021

  72. 0.74

    Associations between IL-1beta, IL-6, and TNFalpha polymorphisms and longitudinal trajectories of cognitive function in non-demented older adults

    Lawrence KA, Gloger EM, Pinheiro CN et al. · Brain, behavior, & immunity - health · 2024

  73. 0.73

    Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease

    Potter H, Woodcock JH, Boyd TD et al. · Alzheimer's & dementia (New York, N. Y.) · 2021

  74. 0.73

    Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer's Disease Pathology

    Riphagen JM, van Hooren RWE, Kenis G et al. · Journal of Alzheimer's disease : JAD · 2022

  75. 0.73

    A blunted T(H)17 cytokine signature in women with mild cognitive impairment: insights from inflammatory profiling of a community-based cohort of older adults

    Bachstetter AD, Lutshumba J, Winford E et al. · Brain communications · 2023

  76. 0.72

    Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort

    Foley KE, Winder Z, Sudduth TL et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  77. 0.72

    Pre-analytical characterization of CNS-derived extracellular vesicles from human saliva: effect of room temperature and cellular origin

    Licatini LM, Licatini LM, Haddadin FA et al. · Frontiers in neuroscience · 2026

  78. 0.72

    Association of Chronic Pain with Biomarkers of Neurodegeneration, Microglial Activation, and Inflammation in Cerebrospinal Fluid and Impaired Cognitive Function

    Sadlon A, Takousis P, Ankli B et al. · Annals of neurology · 2024

  79. 0.72

    Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease

    Aksnes M, Aass HCD, Tiiman A et al. · Translational neurodegeneration · 2021

  80. 0.72

    Association of multiple metabolic and cardiovascular markers with the risk of cognitive decline and mortality in adults with Alzheimer's disease and AD-related dementia or cognitive decline: a prospective cohort study

    Liu L, Gracely EJ, Zhao X et al. · Frontiers in aging neuroscience · 2024

  81. 0.72

    Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study

    Zuniga CH, Acosta BI, Menchaca R et al. · Alzheimer's research & therapy · 2025

  82. 0.71

    Instability in sleep architecture and intermittent hypoxia underlie cognitive impairment in patients with obstructive sleep apnea

    Sun Z, Shen T, Li M et al. · Sleep & breathing = Schlaf & Atmung · 2026

  83. 0.71

    Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study

    Tofiq A, Zetterberg H, Blennow K et al. · Journal of Alzheimer's disease : JAD · 2021

  84. 0.71

    Genetic predisposition to high circulating levels of interleukin 6 and risk for Alzheimer's disease. Discovery and replication

    Charisis S, Mourtzi N, Scott MR et al. · The journal of prevention of Alzheimer's disease · 2025

  85. 0.71

    Neuroimaging-derived biological brain age and its associations with glial reactivity and synaptic dysfunction cerebrospinal fluid biomarkers

    Cumplido-Mayoral I, Sanchez-Benavides G, Vilor-Tejedor N et al. · Molecular psychiatry · 2025

  86. 0.71

    Alzheimer's pathology is associated with altered cognition, brain volume, and plasma biomarker patterns in traumatic encephalopathy syndrome

    Asken BM, Tanner JA, Gaynor LS et al. · Alzheimer's research & therapy · 2023

  87. 0.71

    Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease

    Gonzales MM, Garbarino VR, Kautz T et al. · Research square · 2023

  88. 0.70

    An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum

    Van Hulle C, Jonaitis EM, Betthauser TJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021

  89. 0.69

    Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers

    Gokce M, Velioglu HA, Bektay MY et al. · Gerontology · 2023

  90. 0.69

    Potential Inflammatory Markers Related to the Conversion to Alzheimer's Disease in Female Patients With Late-Life Depression

    Pyo JH, Han SS, Kim MJ et al. · Biological psychiatry global open science · 2024

  91. 0.69

    Unusual expression of peripheral blood Alzheimer's markers, inflammatory cytokines, and cholinergic biomarkers in chronic kidney disease patients with cognitive dysfunction: Therapeutic impact of recombinant human erythropoietin (rHuEPO)

    Ganesan VK · Current research in translational medicine · 2026

  92. 0.69

    Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) study

    Sankhe K, Ruthirakuhan M, Andreazza AC et al. · International psychogeriatrics · 2026

  93. 0.68

    V-set and immunoglobulin domain containing 4 as a potential predictor of Alzheimer's disease and advanced aging

    Yang B, Teymur A, Tang C et al. · Journal of Alzheimer's disease : JAD · 2025

  94. 0.67

    Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial

    Gonzales MM, Garbarino VR, Kautz TF et al. · Nature medicine · 2023

  95. 0.67

    Longer sleep duration and neuroinflammation in at-risk elderly with a parental history of Alzheimer's disease

    Baril AA, Picard C, Labonte A et al. · Sleep · 2024

  96. 0.67

    An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer's Disease

    Chan HC, Ke LY, Lu HT et al. · Biomedicines · 2020

  97. 0.66

    GDF-11, GDF-15, Jag-1, and leptin in neuronal-derived extracellular vesicles as aging-related biomarkers to identify individuals at risk of Alzheimer's dementia: A pilot study

    Lanzillotta S, Boccardi V, Zulli B et al. · Neurobiology of disease · 2026

  98. 0.66

    Pro-inflammatory cytokine genetic variants show variable susceptibility to mild cognitive impairment, alzheimer's disease and frontotemporal dementia in South India

    Mallika AP, Sulajamani JP, Sivasankara MP et al. · Neurogenetics · 2025

  99. 0.66

    Modulation of Amyloid-beta and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin(R) and Donepezil

    Alvarez XA, Winston CN, Barlow JW et al. · Journal of Alzheimer's disease : JAD · 2022

  100. 0.65

    Plasma Biomarkers in Neurodegenerative Dementias: Unrevealing the Potential of Serum Oxytocin, BDNF, NPTX1, TREM2, TNF-alpha, IL-1 and Prolactin

    Olgun Y, Poyraz CA, Bozluolcay M et al. · Current Alzheimer research · 2024

  101. 0.65

    Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity

    Carvalho DZ, St Louis EK, Przybelski SA et al. · Frontiers in aging neuroscience · 2022

  102. 0.65

    Contributions of Cardiovascular Burden, Peripheral Inflammation, and Brain Integrity on Digital Clock Drawing Performance in Non-Demented Older Adults

    Dion C, Tanner JJ, Libon DJ et al. · Journal of Alzheimer's disease : JAD · 2023

  103. 0.65

    A cross-sectional examination of a family history of Alzheimer's disease and ApoE epsilon 4 on physical fitness, molecular biomarkers, and neurocognitive performance

    Tsai CL, Erickson KI, Sun HS et al. · Physiology & behavior · 2021

  104. 0.65

    The association of specific and cumulative exposure to infectious agents with cognitive impairment in older Hispanic adults

    Rangel GA, Munoz BA, Ramirez M et al. · Journal of Alzheimer's disease reports · 2025

  105. 0.64

    Association between aging-related biomarkers and longitudinal trajectories of intrinsic capacity in older adults

    Lu WH, Guyonnet S, Martinez LO et al. · GeroScience · 2023

  106. 0.64

    Sex Differences in Metabolic Indices and Chronic Neuroinflammation in Response to Prolonged High-Fat Diet in ApoE4 Knock-In Mice

    Mattar JM, Majchrzak M, Iannucci J et al. · International journal of molecular sciences · 2022

  107. 0.64

    Low TGF-beta1 plasma levels are associated with cognitive decline in Down syndrome

    Grasso M, Fidilio A, L'Episcopo F et al. · Frontiers in pharmacology · 2024

  108. 0.63

    Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer's disease

    Shen H, Han C, Yang Y et al. · Brain and behavior · 2021

  109. 0.63

    Associations of adverse childhood experiences, inflammation, and cognition in older Black adults

    Rose DK, Drouin SM, Thibeadeaux D et al. · Psychoneuroendocrinology · 2025

  110. 0.63

    Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer's disease: a potential early sign of AD

    Goikolea J, Gerenu G, Daniilidou M et al. · Alzheimer's research & therapy · 2022

  111. 0.62

    Prenatal immune origins of brain aging differ by sex

    Goldstein JM, Konishi K, Aroner S et al. · Molecular psychiatry · 2025

  112. 0.61

    Heterogeneity of cerebral atrophic rate in mild cognitive impairment and its interactive association with proteins related to microglia activity on longitudinal cognitive changes

    Tang J, Cao Z, Lei M et al. · Archives of gerontology and geriatrics · 2024

  113. 0.61

    Associations of obstructive sleep apnea with A/T/N biomarkers, neuroimaging abnormalities, neurodegenerative progression, and CPAP-related changes in Alzheimer's disease

    Zheng W, Zhou Y, Lu M et al. · Sleep medicine · 2026

  114. 0.61

    TNFR-1 and GDF-15 Are Associated With Plasma Neurofilament Light Chain and Progranulin Among Community-Dwelling Older Adults: A Secondary Analysis of the MAPT Study

    Giudici KV, de Souto Barreto P, Guyonnet S et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2023

  115. 0.60

    Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive Disorder

    Feng V, Lanctot K, Herrmann N et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2023

  116. 0.60

    Sex differences in a murine model of Cerebral Amyloid Angiopathy

    Maniskas ME, Mack AF, Morales-Scheihing D et al. · Brain, behavior, & immunity - health · 2021

  117. 0.60

    Sleep duration and biomarkers of inflammation in African American and white participants with a parental history of Alzheimer's disease

    Pak VM, Paul S, Swieboda D et al. · Alzheimer's & dementia (New York, N. Y.) · 2022

  118. 0.59

    Perivascular spaces in Alzheimer's disease are associated with inflammatory, stress-related, and hypertension biomarkers

    Sibilia F, Sheikh-Bahaei N, Mack WJ et al. · bioRxiv : the preprint server for biology · 2023

  119. 0.57

    Plasma inflammation-related biomarkers are associated with intrinsic capacity in community-dwelling older adults

    Lu WH, Gonzalez-Bautista E, Guyonnet S et al. · Journal of cachexia, sarcopenia and muscle · 2023

  120. 0.57

    Comparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer's disease

    Barros-Aragao FGQ, Pinheiro TL, Pinto TP et al. · Brain, behavior, & immunity - health · 2025

  121. 0.56

    Searching for New Possible Peripheral Biomarkers of Cognitive Decline in Down Syndrome: The Role of IL-18 Pathway and its Interaction with TGF-beta1 and TNF-alpha

    Grasso M, Fidilio A, L'Episcopo F et al. · Neuromolecular medicine · 2026

  122. 0.55

    Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study

    Salvado G, Larsson V, Cody KA et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  123. 0.54

    Relationship between cytomegalovirus antibody levels and cognitive performance is dependent on age and genetic risk

    Vacher M, Lee S, Price P et al. · BMC neurology · 2025

  124. 0.53

    Interrogating the plasma proteome of repetitive head impact exposure and chronic traumatic encephalopathy

    Saloner R, Casaletto KB, Rayaprolu S et al. · Molecular neurodegeneration · 2025

  125. 0.51

    Brain Amyloid-beta Peptide Is Associated with Pain Intensity and Cognitive Dysfunction in Osteoarthritic Patients

    Wen CH, Kang HY, Chan JYH · International journal of molecular sciences · 2024

  126. 0.51

    A novel composite biomarker score for the identification of cognitive impairment in patients with heart failure: a pilot study

    Hoyer-Kimura C, Palmer J, Gopalan R et al. · Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2025

  127. 0.51

    Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults

    Albrecht DS, Sagare A, Pachicano M et al. · Brain, behavior, and immunity · 2021

  128. 0.51

    Characterization of cognitive decline in long-duration type 1 diabetes by cognitive, neuroimaging, and pathological examinations

    Shah HS, DeSalvo MN, Haidar A et al. · JCI insight · 2025

  129. 0.51

    APOE epsilon4-associated downregulation of the IL-7/IL-7R pathway in effector memory T cells: Implications for Alzheimer's disease

    Zhang YJ, Cheng Y, Tang HL et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  130. 0.50

    Psychological and neurobiological mechanisms involved in the relationship between loneliness and cognitive decline in older adults

    Dabiri S, Mwendwa DT, Campbell A · Brain, behavior, and immunity · 2024

05mci · scores109편

  1. 0.94

    Associations between systemic inflammatory markers and cognitive decline in patients with early-stage Alzheimer's disease: a retrospective clinical study

    Liu Y, Li Y, Zheng P et al. · Frontiers in neurology · 2026

  2. 0.94

    Inflammatory Cytokines and Cognition in Alzheimer's Disease and Its Prodrome 이 논문

    Seong SJ, Kim KW, Song JY et al. · Psychiatry investigation · 2024

  3. 0.91

    Reduced serum IL-6 as a potential peripheral marker of amnestic mild cognitive impairment: A pilot study

    Castro MM, Pavon RA, Moroni AD et al. · Medicina clinica · 2026

  4. 0.90

    Randomized controlled trial of Bushen Yinao pill combined with conventional therapy on intestinal flora and cognitive function in older patients with Alzheimer's disease

    Wang W, Zhang J, Li C · International journal of psychiatry in medicine · 2025

  5. 0.90

    Investigating the association between inflammation mediated by mushroom consumption and mild cognitive impairment in Chinese older adults

    Chen L, Qiu R, Wang B et al. · Food & function · 2024

  6. 0.90

    Association between inflammatory biomarkers and the cognitive response to a multidomain intervention: secondary longitudinal analyses from the MAPT study

    Gonzalez-Bautista E, Soto M, Abellan van Kan G et al. · GeroScience · 2025

  7. 0.90

    An inflammatory fingerprint in mild cognitively impaired patients is reversed by physical and cognitive training

    Desiato G, Bosco P, Cintoli S et al. · Brain, behavior, & immunity - health · 2025

  8. 0.90

    Does Gotu kola supplementation improve cognitive function, inflammation, and oxidative stress more than multicomponent exercise alone? - a randomized controlled study

    Phoemsapthawee J, Ammawat W, Prasertsri P et al. · Journal of exercise rehabilitation · 2022

  9. 0.90

    A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias

    Haroon J, Jordan K, Mahdavi K et al. · Medicine · 2024

  10. 0.90

    Vitamin D and inflammatory cytokines association in mild cognitive impaired subjects

    Kumar A, Verma A, Chaurasia RN · Neuroscience letters · 2023

  11. 0.90

    IL-6 Enhances the Negative Impact of Cortisol on Cognition among Community-Dwelling Older People without Dementia

    Koutentaki E, Basta M, Antypa D et al. · Healthcare (Basel, Switzerland) · 2023

  12. 0.90

    Decreased Netrin-1 in Mild Cognitive Impairment and Alzheimer's Disease Patients

    Ju T, Sun L, Fan Y et al. · Frontiers in aging neuroscience · 2021

  13. 0.89

    Plasma Cytokines Profile in Subjects with Alzheimer's Disease: Interleukin 1 Alpha as a Candidate for Target Therapy

    Mahdavi M, Karima S, Rajaei S et al. · Galen medical journal · 2021

  14. 0.89

    Relationship between cortisol, Interleukin-6 and homocysteine in Alzheimer's disease

    Yeram N, Dalvi S, Mankeshwar R et al. · Qatar medical journal · 2021

  15. 0.89

    Analysis of Correlation between Serum Inflammatory Factors and Cognitive Function, Language, and Memory in Alzheimer's Disease and Its Clinical Significance

    Lu Y, Li J, Hu T · Computational and mathematical methods in medicine · 2022

  16. 0.89

    Characteristics of Dysregulated Proinflammatory Cytokines and Cognitive Dysfunction in Late-Life Depression and Amnestic Mild Cognitive Impairment

    Nie J, Fang Y, Chen Y et al. · Frontiers in immunology · 2021

  17. 0.89

    Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease

    Karima S, Aghamollaii V, Mahmoodi Baram S et al. · Journal of Alzheimer's disease : JAD · 2023

  18. 0.88

    Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer's Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial

    Chen H, Liu S, Ge B et al. · The journal of prevention of Alzheimer's disease · 2021

  19. 0.88

    Correlations between SHBG, Sex Hormones, Inflammation, and Neurocognitive Decline in Alzheimer's Disease: A Retrospective Study

    Jin J, Lu L, Hua K et al. · Current Alzheimer research · 2024

  20. 0.88

    Correlation of serum complement factor 5a level with inflammatory response and cognitive function in patients with Alzheimer's disease of different severity

    Li Z, Wu H, Luo Y et al. · BMC neurology · 2023

  21. 0.88

    The effect of physical exercise with cognitive training on inflammation and Alzheimer's disease biomarkers of Mild Cognitive Impairment patients

    Katsipis G, Tzekaki EE, Andreadou EG et al. · Neuroscience applied · 2024

  22. 0.88

    A Mixed-Effects Model of Associations Between Interleukin-6 and Hippocampal Volume

    Harrell ER, Bui C, Newman SD · The journals of gerontology. Series A, Biological sciences and medical sciences · 2022

  23. 0.88

    The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer's Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement

    Lewis JE, Reginald McDaniel H, Woolger JM et al. · Journal of Alzheimer's disease : JAD · 2023

  24. 0.88

    Correlation of early cognitive dysfunction with inflammatory factors and metabolic indicators in patients with Alzheimer's disease

    Xin Y, Zhang L, Hu J et al. · American journal of translational research · 2021

  25. 0.88

    Comparative assessment of donepezil memantine and sodium oligomannate on cognitive decline and neuroinflammation in early Alzheimer's disease

    Deng X, Zeng Y, Ding D · Pakistan journal of pharmaceutical sciences · 2026

  26. 0.87

    A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial

    Rashidi-Ranjbar N, Churchill NW, Jerkic M et al. · Journal of Alzheimer's disease : JAD · 2026

  27. 0.87

    Adherence to the Mediterranean diet, inflammatory biomarkers and cognitive status in older Italian adults

    Grasso M, L'Episcopo F, Fidilio A et al. · Frontiers in nutrition · 2026

  28. 0.87

    Alterations in Immune Responses Are Associated with Dysfunctional Intracellular Signaling in Peripheral Blood Mononuclear Cells of Men and Women with Mild Cognitive Impairment and Alzheimer's disease

    Vasantharekha R, Priyanka HP, Nair RS et al. · Molecular neurobiology · 2024

  29. 0.87

    A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer's disease

    Millar CL, Iloputaife I, Baldyga K et al. · EBioMedicine · 2025

  30. 0.86

    Efficacy evaluation and metabolomics analysis of Huanglian Jiedu decoction in combination with donepezil for Alzheimer's disease treatment

    Xu M, Yue Y, Huang J · Journal of pharmaceutical and biomedical analysis · 2023

  31. 0.86

    The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug

    Marr C, McDowell B, Holmes C et al. · Journal of Alzheimer's disease : JAD · 2024

  32. 0.86

    Oral and Periodontal Health Status, Peripheral Immune Dysregulation, and Cognitive Impairment in Alzheimer's Disease: A Clinical and Immunological Study

    Ochnik M, Zborowski J, Leszek J et al. · International journal of molecular sciences · 2025

  33. 0.85

    Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment

    Jing X, Wang L, Song M et al. · Scientific reports · 2024

  34. 0.85

    Inflammation levels in type 2 diabetes mellitus patients with mild cognitive impairment: Assessment followed by amelioration via dapagliflozin therapy

    Zhang W, Sun C, Huang Y et al. · Journal of diabetes and its complications · 2025

  35. 0.85

    Effects of Sport Stacking on Neuropsychological, Neurobiological, and Brain Function Performances in Patients With Mild Alzheimer's Disease and Mild Cognitive Impairment: A Randomized Controlled Trial

    Yang Z, Zhang W, Liu D et al. · Frontiers in aging neuroscience · 2022

  36. 0.85

    Central and Peripheral Inflammation in Mild Cognitive Impairment in the Context of Alzheimer's Disease

    Schmidt-Morgenroth I, Michaud P, Gasparini F et al. · International journal of molecular sciences · 2023

  37. 0.85

    Influence of CurQfen((R))-curcumin on cognitive impairment: a randomized, double-blinded, placebo-controlled, 3-arm, 3-sequence comparative study

    Das SS, Gopal PM, Thomas JV et al. · Frontiers in dementia · 2023

  38. 0.85

    Porphyromonas gingivalis in Alzheimer's disease: Association with salivary lactoferrin and inflammatory response

    Antequera D, Carrero L, Romualdi D et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026

  39. 0.84

    Resistance training's impact on blood biomarkers and cognitive function in older adults with low and high risk of mild cognitive impairment: a randomized controlled trial

    Vints WAJ, Gokce E, Seikinaite J et al. · European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2024

  40. 0.84

    Inflammation and the pathological progression of Alzheimer's disease are associated with low circulating choline levels

    Judd JM, Jasbi P, Winslow W et al. · Acta neuropathologica · 2023

  41. 0.84

    Food anthocyanins decrease concentrations of TNF-alpha in older adults with mild cognitive impairment: A randomized, controlled, double blind clinical trial

    do Rosario VA, Fitzgerald Z, Broyd S et al. · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2021

  42. 0.84

    27-hydroxycholesterol causes cognitive deficits by disturbing Th17/Treg balance and the related immune responses in mild cognitive impairment patients and C57BL/6J mice

    Wang T, Feng W, Ju M et al. · Journal of neuroinflammation · 2023

  43. 0.84

    Clinical values of serum C5a in Alzheimer's disease patients with different dementia stages

    Yang C, Wu X, Feng J et al. · Neuroscience letters · 2024

  44. 0.84

    Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial

    Lin PY, Cheng C, Satyanarayanan SK et al. · Brain, behavior, and immunity · 2022

  45. 0.83

    Handgrip strength, tumor necrosis factor-alpha, interlukin-6, and visfatin levels in oldest elderly patients with cognitive impairment

    Huang HH, Chang JCY, Liu HC et al. · Experimental gerontology · 2020

  46. 0.83

    Predicting the Beneficial Effects of Cognitive Stimulation and Transcranial Direct Current Stimulation in Amnestic Mild Cognitive Impairment with Clinical, Inflammation, and Human Microglia Exposed to Serum as Potential Markers: A Double-Blind Placebo-Controlled Randomized Clinical Trial

    Alcala-Lozano R, Carmona-Hernandez R, Ocampo-Romero AG et al. · International journal of molecular sciences · 2025

  47. 0.83

    Consumption of ultra-processed foods is associated with cognitive status in elderly patients

    Grasso M, L'Episcopo F, Olvera-Moreira MA et al. · Frontiers in nutrition · 2026

  48. 0.82

    MicroRNA-511-3p regulates Abeta(1)(-)(40) induced decreased cell viability and serves as a candidate biomarker in Alzheimer's disease

    Wang T, Zhao W, Liu Y et al. · Experimental gerontology · 2023

  49. 0.82

    IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment

    Toppi E, Sireno L, Lembo M et al. · Frontiers in immunology · 2022

  50. 0.82

    Exposure to coal dust exacerbates cognitive impairment by activating the IL6/ERK1/2/SP1 signaling pathway

    Cai F, Xue S, Zhou Z et al. · The Science of the total environment · 2024

  51. 0.82

    miR‑660‑5p ameliorates neuronal damage in Alzheimer's disease via targeting APP

    Gong P, Su X, Fang Y · Neurogenetics · 2026

  52. 0.81

    Bacterial DNAemia in Alzheimer's Disease and Mild Cognitive Impairment: Association with Cognitive Decline, Plasma BDNF Levels, and Inflammatory Response

    Giacconi R, D'Aquila P, Balietti M et al. · International journal of molecular sciences · 2022

  53. 0.81

    Exercise-associated changes in leptin and irisin relate to cognitive function in older adults stratified by cognitive impairment

    Gabr SA, Salama ME, Alzahrani AH et al. · Scientific reports · 2026

  54. 0.81

    Adiponectin and Inflammatory Marker Levels in the Elderly Patients with Diabetes, Mild Cognitive Impairment and Depressive Symptoms

    Gorska-Ciebiada M, Ciebiada M · International journal of molecular sciences · 2024

  55. 0.81

    The effects of dexmedetomidine on the cognitive function of mild cognitive impairment (MCI) rats

    Zhou Q, Xie D, Chen T et al. · Annals of translational medicine · 2022

  56. 0.81

    Exercise-Mediated Alteration of miR-192-5p Is Associated with Cognitive Improvement in Alzheimer's Disease

    Qin Z, Han X, Ran J et al. · Neuroimmunomodulation · 2022

  57. 0.80

    Inflammatory biomarkers and lipid metabolism parameters in women with mild cognitive impairment and dementia

    Zorkina Y, Abramova O, Ushakova V et al. · Women & health · 2023

  58. 0.80

    Flurbiprofen axetil alleviates the effect of formalin-induced inflammatory pain on the cognitive function of rats with mild cognitive impairment through the AMPKalpha/NF-kappaB signaling pathway

    Huang L, Zheng X, Zhang Y et al. · Annals of translational medicine · 2022

  59. 0.80

    Role of Inflammatory Cytokines in the Conversion of Mild Cognitive Impairment to Dementia: A Prospective Study

    Romero-Sevilla R, Lopez-Espuela F, Fuentes JM et al. · Current Alzheimer research · 2022

  60. 0.79

    The Role of Nutrition and Inflammation on Cognition in a High-Risk Group for Alzheimer's Disease

    Jackson JM, Bay AA, Barter JD et al. · Journal of Alzheimer's disease reports · 2020

  61. 0.78

    Dietary (Poly)phenol Intake, Inflammatory Biomarkers, and Mild Cognitive Impairment in Italian Adults

    Grasso M, L'Episcopo F, Toscano G et al. · Antioxidants (Basel, Switzerland) · 2026

  62. 0.78

    Clinical outcomes and anti-inflammatory mechanisms of nucleus basalis of Meynert deep brain stimulation in Alzheimer's disease

    Chen Y, Du T, Lian T et al. · Frontiers in neurology · 2026

  63. 0.76

    The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease

    Culjak M, Perkovic MN, Uzun S et al. · Current Alzheimer research · 2020

  64. 0.75

    Intelectin-1 and systemic inflammation indices as potential biomarkers in alzheimer's disease

    Ozkaya AL, Gurbuzer N, Mercantepe F et al. · Metabolic brain disease · 2026

  65. 0.75

    Cross-sectional assessment of mild cognitive impairment in pre-dialysis chronic kidney disease and its association with inflammation and changes seen on MRI: what the eyes cannot see

    Pires LA, Almeida ALMd, Paraizo MdA et al. · Jornal brasileiro de nefrologia · 2022

  66. 0.75

    Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population

    Abuelezz NZ, Nasr FE, Abdel Aal WM et al. · Experimental gerontology · 2022

  67. 0.75

    Efficacy of personalized acupuncture combined with accelerated deep transcranial magnetic stimulation in mild cognitive impairment: A randomized controlled trial

    Xia J, Wu X, Wang Z et al. · Integrative medicine research · 2026

  68. 0.74

    Periodontitis and incident cognitive decline and dementia: A 15-year prospective cohort study of older men residing in Northern Ireland

    Farsi DN, Abadalkareem R, Linden GJ et al. · Journal of Alzheimer's disease : JAD · 2026

  69. 0.74

    MCP-1 levels in astrocyte-derived exosomes are changed in preclinical stage of Alzheimer's disease

    Wang T, Yao Y, Han C et al. · Frontiers in neurology · 2023

  70. 0.74

    A Preliminary Finding: N-butyl-phthalide Plays a Neuroprotective Role by Blocking the TLR4/HMGB1 Pathway and Improves Mild Cognitive Impairment Induced by Acute Cerebral Infarction

    Zhou H, Li S, Huang C et al. · Journal of integrative neuroscience · 2024

  71. 0.74

    Moderate aerobic training modulates cytokines and cortisol profiles in older adults with cognitive abilities

    Alghadir AH, Gabr SA, Al-Momani M et al. · Cytokine · 2021

  72. 0.73

    GuiLingJi ameliorates mild cognitive impairment by targeting unsaturated fatty acid metabolism to inhibit GPR120/NF-kappaB mediated neuroinflammation

    Shi J, Ni L, Yu S et al. · Frontiers in pharmacology · 2026

  73. 0.72

    Effects of folic acid supplementation on cognitive function and inflammation in elderly patients with mild cognitive impairment: A systematic review and meta-analysis of randomized controlled trials

    Wang M, Fang M, Zang W · Archives of gerontology and geriatrics · 2024

  74. 0.72

    Exploring the Changes in Mild Cognitive Impairment Blood-Based Biomarkers after Local Antibiotic Periodontal Treatment in Diabetic Patients: Secondary Analysis of Data from a Randomized Controlled Trial

    Ramadhani A, Tanaka A, Minagawa K et al. · European journal of dentistry · 2025

  75. 0.71

    Adherence to the MIND diet and the odds of mild cognitive impairment in generally healthy older adults: The 3-year DO-HEALTH study

    Sager R, Gaengler S, Willett WC et al. · The journal of nutrition, health & aging · 2024

  76. 0.71

    Promising benefits of six-month Phaeodactylum tricornutum microalgae supplementation on cognitive function and inflammation in healthy older adults with age-associated memory impairment

    Goodbody E, Maury J, Doolan A et al. · Frontiers in aging · 2025

  77. 0.70

    Inflammation-mediated regional brain alterations associated with mild cognitive impairment in knee osteoarthritis

    Li C, Hao C, Zhou K et al. · Arthritis research & therapy · 2025

  78. 0.70

    Factors Associated with Apathy in Alzheimer's Disease: A Cross-Sectional Analysis of the Texas Alzheimer's Research and Care Consortium (TARCC) Study

    Teixeira AL, Salem H, Martins LB et al. · Journal of Alzheimer's disease : JAD · 2022

  79. 0.68

    Elucidating the role of peripheral monocyte nicotinic acetylcholine receptors and inflammation in cognitive outcomes in older adults

    Kohn JN, Ang G, Pruitt C et al. · Biogerontology · 2025

  80. 0.68

    The Role of Inflammation and Psycho-Behavioral Factors as Mediators Between Acculturation and Time to Incident Dementia Among Older Mexican Americans

    Nianogo RA, Hays RD, Gong Y et al. · Journal of Alzheimer's disease : JAD · 2024

  81. 0.68

    Poor Diet, Long Sleep, and Lack of Physical Activity Are Associated with Inflammation among Non-Demented Community-Dwelling Elderly

    Basta M, Belogianni C, Yannakoulia M et al. · Healthcare (Basel, Switzerland) · 2022

  82. 0.68

    The Effect of Guilingji Capsules on Vascular Mild Cognitive Impairment: A Randomized, Double-Blind, Controlled Trial

    Zhang H, Chen H, Pei H et al. · Evidence-based complementary and alternative medicine : eCAM · 2022

  83. 0.68

    Probing gut-brain links in Alzheimer's disease with rifaximin

    Suhocki PV, Ronald JS, Diehl AME et al. · Alzheimer's & dementia (New York, N. Y.) · 2022

  84. 0.66

    Cholesterol profiling reveals 7beta-hydroxycholesterol as a pathologically relevant peripheral biomarker of Alzheimer's disease

    Ha J, Kwon GE, Son Y et al. · Psychiatry and clinical neurosciences · 2024

  85. 0.65

    Resistance exercise effects on hippocampus subfield volumes and biomarkers of neuroplasticity and neuroinflammation in older adults with low and high risk of mild cognitive impairment: a randomized controlled trial

    Vints WAJ, Seikinaite J, Gokce E et al. · GeroScience · 2024

  86. 0.64

    Effect of Probiotic Supplementation in Older Individuals with Mild Cognitive Impairment and Alzheimer's Disease: A Randomized, Placebo-Controlled, Triple-Blind Clinical Trial

    Medeiros EB, de Oliveira Monteiro I, Kluwe-Schiavon B et al. · Probiotics and antimicrobial proteins · 2026

  87. 0.64

    Intraoperative dexmedetomidine for prevention of postoperative delirium in elderly patients with mild cognitive impairment

    Xin X, Chen J, Hua W et al. · International journal of geriatric psychiatry · 2021

  88. 0.62

    Serum SIRT3 Levels and Their Relationship With Alzheimer Disease Pathological Markers in Individuals With Mild Cognitive Impairment

    Du J, An Z, Niu X et al. · Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2026

  89. 0.61

    Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer's disease in mild cognitive impairment patients

    Qian XH, Liu XL, Chen Sd et al. · Frontiers in immunology · 2022

  90. 0.61

    Different peripheral expression patterns of the nicotinic acetylcholine receptor in dementia with Lewy bodies and Alzheimer's disease

    Costantini E, Carrarini C, Borrelli P et al. · Immunity & ageing : I & A · 2023

  91. 0.61

    Effects of Hydrogen Gas Inhalation on Community-Dwelling Adults of Various Ages: A Single-Arm, Open-Label, Prospective Clinical Trial

    Rahman MH, Bajgai J, Sharma S et al. · Antioxidants (Basel, Switzerland) · 2023

  92. 0.60

    Preoperative Microbiomes and Intestinal Barrier Function Can Differentiate Prodromal Alzheimer's Disease From Normal Neurocognition in Elderly Patients Scheduled to Undergo Orthopedic Surgery

    Duan M, Liu F, Fu H et al. · Frontiers in cellular and infection microbiology · 2021

  93. 0.60

    The investigation of peripheral inflammatory and oxidative stress biomarkers in dementia with Lewy Bodies, compared with Alzheimer's Disease, and mild cognitive impairment

    Yu Y, Shen H, Qin Q et al. · Neuroscience · 2025

  94. 0.59

    The impact of physical activity on blood inflammatory cytokines and neuroprotective factors in individuals with mild cognitive impairment: a systematic review and meta-analysis of randomized-controlled trials

    Ma C, Lin M, Gao J et al. · Aging clinical and experimental research · 2022

  95. 0.59

    Peripheral inflammation mediates the association between triglyceride-glucose index and cognitive impairment in comorbid major depressive disorder and type 2 diabetes: Translational implications for Alzheimer's disease risk via neuroinflammatory pathways

    Yuan Q, He S, Elhassan MAM et al. · Journal of affective disorders · 2026

  96. 0.59

    Association between T-tau protein and Abeta42 in plasma neuronal-derived exosomes and cognitive impairment in patients with permanent atrial fibrillation and the role of anticoagulant therapy and inflammatory mechanisms

    Du M, Wang X, Ma F et al. · Journal of cardiac surgery · 2022

  97. 0.59

    Dietary inflammatory index and its association with serum cytokines in mexican older adults with mild cognitive impairment and dementia

    Garrido-Dzib AG, Bravo-Armenta E, Rubio-Zapata H et al. · Psychoneuroendocrinology · 2026

  98. 0.58

    Relationships among tumor necrosis factor-alpha levels, beta-amyloid accumulation, and hippocampal atrophy in patients with late-life major depressive disorder

    Ho SK, Hsiao IT, Lin KJ et al. · Brain and behavior · 2024

  99. 0.58

    Regulated upon activation, normal T cell expressed and secreted (RANTES) levels in the peripheral blood of patients with Alzheimer's disease

    Vacinova G, Vejrazkova D, Rusina R et al. · Neural regeneration research · 2021

  100. 0.57

    Exosomal miR-223-3p, associated with NLRP3-related neuroinflammation, as a potential biomarker for mild cognitive impairment in patients with type 2 diabetes mellitus

    Zhang H, Liang B, Chang Y et al. · Journal of Alzheimer's disease : JAD · 2026

  101. 0.56

    Neuropsychiatric Symptoms are Related to Blood-biomarkers in Major Neurocognitive Disorders

    Marques-Aleixo I, Sampaio A, Bohn L et al. · Current aging science · 2024

  102. 0.56

    Reduced Blood Choline in Obesity Is Associated with Metabolic and Alzheimer's Biomarkers

    Winslow W, Judd JM, Tallino S et al. · Aging and disease · 2025

  103. 0.56

    Serum oxidized low density lipoprotein serves as a mediator for the inverse relationship between serum d-ribose and cognitive performance in type 2 diabetic patients

    Lu Y, Jiang H, Zhang H et al. · Free radical biology & medicine · 2021

  104. 0.55

    Time restricted eating through self-regulatory behaviors for metabolic and cognitive health in mild cognitive impairment: Feasibility and acceptability findings from the TEMPO trial

    Smith PJ, Ingle KK, Nakamura Z et al. · Journal of Alzheimer's disease : JAD · 2026

  105. 0.55

    Effect of desalted Salicornia europaea L. ethanol extract (PM-EE) on the subjects complaining memory dysfunction without dementia: a 12 week, randomized, double-blind, placebo-controlled clinical trial

    Lee WJ, Shin YW, Kim DE et al. · Scientific reports · 2020

  106. 0.53

    Actigraphy Analysis of Sleep Associates with Salivary IL-6 Concentration in Institutionalized Older Individuals

    Valle VID, Mafla-Espana MA, Silva J et al. · Diseases (Basel, Switzerland) · 2023

  107. 0.53

    Plasma cytokines profile in patients with Alzheimer's and Parkinson's Disease: a comparative study in terms of inflammation

    Shateri S, Khatami SH, Haghbin Toutounchi A et al. · The International journal of neuroscience · 2025

  108. 0.52

    Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease

    Fiorillo A, Gallego JJ, Casanova-Ferrer F et al. · International journal of molecular sciences · 2023

  109. 0.50

    The effects of different types of exercises on cognition in older persons with mild cognitive impairment: A systematic review and meta-analysis

    Akalp K, Ferreira JP, Soares CM et al. · Archives of gerontology and geriatrics · 2024

06network pharmacology · molecular docking69편

  1. 0.88

    An integrative study on the effects of Lingguizhugan decoction in treating Alzheimer's disease rats through modulation of multiple pathways involving various components

    Wang Z, Zhang HT, Li SY et al. · Computers in biology and medicine · 2025

  2. 0.88

    Mechanism of Atractylodis Rhizoma in improving cognitive dysfunction in Alzheimer's disease by regulating the cAMP/CREB/BDNF pathway

    Xu X, Zhao Y, Ma H et al. · International immunopharmacology · 2026

  3. 0.87

    Curcumin and Glycyrrhiza glabra Synergistically Attenuate Alzheimer's Pathology via TLR4/NF-kappaB-Mediated Anti-inflammatory and Redox Modulation in a D-Gal/Sodium Nitrite-Induced Mouse Model

    Liu S, Yan J, Dong J · Neurochemical research · 2026

  4. 0.86

    Integrating Network Pharmacology and Component Analysis to Study the Potential Mechanisms of Qi-Fu-Yin Decoction in Treating Alzheimer's Disease

    Lei X, Xu H, Wang Y et al. · Drug design, development and therapy · 2023

  5. 0.86

    Integrating serum pharmacology, network pharmacology, and molecular biology analysis to reveal the mechanisms of Baihe Dihuang decoction in treating Alzheimer's disease

    Liang X, Ning T, Wang Y et al. · Frontiers in microbiology · 2026

  6. 0.85

    Structural identification and anti-neuroinflammatory effect of a heteropolysaccharide ATP50-3 from Acorus tatarinowii rhizome

    Yu Q, Qiu X, Zhong J et al. · International journal of biological macromolecules · 2024

  7. 0.84

    Erjingwan and Alzheimer's disease: research based on network pharmacology and experimental confirmation

    Xu Y, Zhang J, Li X · Frontiers in pharmacology · 2024

  8. 0.83

    Modified Sanjia Powder ameliorates cognitive impairment and exerts neuroprotective effects in 5 x FAD mice: insights from quantitative proteomics

    Wang Y, Liu C, Zheng X et al. · Frontiers in nutrition · 2025

  9. 0.83

    Salvianolic acid a inhibits neuroinflammation and ameliorates Alzheimer's disease pathology via the p38 MAPK/NF-kappaB pathway based on network pharmacology and experimental validation

    Xiao S, Han Y, Yan J et al. · International immunopharmacology · 2026

  10. 0.83

    Qi Fu Yin ameliorates neuroinflammation through inhibiting RAGE and TLR4/NF-kappaB pathway in AD model rats

    He C, Yu W, Yang M et al. · Aging · 2023

  11. 0.82

    Anti-inflammatory and antioxidant effects of fenugreek in preventing mice model of Alzheimer's disease

    Xiong L, Li Q, Zhou X et al. · Journal of Alzheimer's disease reports · 2025

  12. 0.82

    Zhinao Capsule Improved Sleep and Memory Disorders in APP/PS1 Mice via cAMP/PKA/CREB Signaling Pathway Modulation

    Xi H, Xie W, Yang Y et al. · Drug design, development and therapy · 2025

  13. 0.82

    Targeting TLR4/NF-kappaB/NLRP3 signaling with 6-hydroxyflavanone mitigates amyloid-beta-induced Alzheimer's disease in mice

    Rakshit D, Nema M, Mishra A · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026

  14. 0.82

    Effect of Cerebralcare Granule(R) combined with memantine on Alzheimer's disease

    Yang M, Zhang X, Qiao O et al. · Journal of ethnopharmacology · 2024

  15. 0.81

    Danggui Shaoyao San and disassembled prescription: neuroprotective effects via AMPK/mTOR-mediated autophagy in mice

    Cheng X, Dai Y, Shang B et al. · BMC complementary medicine and therapies · 2024

  16. 0.81

    Combined with network pharmacology, the therapeutic effect and mechanism of coumarins from Chimonanthus praecox extract in the treatment of Alzheimer's disease were investigated

    Zhu S, Li Y, Lin C et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2026

  17. 0.81

    Gegen Qinlian tablets delay Alzheimer's disease progression via inhibiting glial neuroinflammation and remodeling gut microbiota homeostasis

    Wang L, Lu Y, Liu J et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024

  18. 0.81

    PI3K-Akt signaling pathway based on network pharmacology for the anti-Alzheimer's disease effect of licorice stem flavonoids

    Pei H, He L, Shi M et al. · Aging · 2023

  19. 0.80

    Integrative network pharmacology, machine learning, and experimental validation identify the TLR4/NF-kappaB/NLRP3 axis as a potential mechanism underlying the therapeutic effects of Lingguizhugan decoction in Alzheimer's disease

    Hu D, Li D, He L et al. · Journal of ethnopharmacology · 2026

  20. 0.80

    Multi-target neuroprotection of Atractylodes macrocephala ethyl acetate extract against Alzheimer's disease: from bioactivity-guided screening to mechanistic validation

    Sun T, Li Z, Xiao B et al. · Journal of ethnopharmacology · 2026

  21. 0.80

    Elucidating the Neuroprotective Mechanism of 5,7-Dimethoxyflavone and 5,7',4'-Trimethoxyflavone Through In Silico Target Prediction and in Memory-Impaired Mice

    Mohamed Yusof NIS, Ramasamy K, Mohd Fauzi F · Neurochemical research · 2025

  22. 0.79

    Shuangxia Decoction attenuates sleep disruption in 5xFAD mice through neuroinflammation inhibition: An integrative analysis of transcriptomic and molecular biology investigations

    Wang J, Pan H, Tang H et al. · Journal of ethnopharmacology · 2025

  23. 0.79

    Integrating network pharmacology analysis and pharmacodynamic evaluation for exploring the active components and molecular mechanism of moutan seed coat extract to improve cognitive impairment

    Wang Y, Wu X, Yang K et al. · Frontiers in pharmacology · 2022

  24. 0.79

    Quercetagitrin Ameliorates Alzheimer-Like Pathologies Associated with TNFalpha/NFkappaB Pathway in APP/PS1 Mice

    Yuan C, Lv S, Han Y et al. · ACS omega · 2025

  25. 0.78

    Yangxue Qingnao Wan ameliorates cognitive impairment in scopolamine-induced AD mice via modulating neuropeptide signaling pathways and suppressing neuroinflammation

    Zhang X, Yang J, Xiao M et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026

  26. 0.78

    Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer's disease

    Wang P, Dong YL, Li SS et al. · Journal of Alzheimer's disease : JAD · 2025

  27. 0.78

    Neuroprotective effects of Shenghui decoction via inhibition of the JNK/p38 MAPK signaling pathway in an AlCl(3)-induced zebrafish (Danio rerio) model of Alzheimer's disease

    Lu H, Tan A, Zhang Y et al. · Journal of ethnopharmacology · 2024

  28. 0.78

    Huang-Lian-Jie-Du decoction alleviates cognitive deficits in Alzheimer's disease model 5xFAD mice by inhibiting Trem2/Dap12 signaling pathway

    Pang RK, Shi J, Peng XY et al. · Chinese medicine · 2025

  29. 0.78

    Neuroprotective Mechanism of Polygonatum sibiricum Polysaccharides in Alzheimer's Disease: Highlighting Role of PI3K-AKT Signalling Pathway and Leptin Receptor

    Zhang X, Zhang SP, Li C et al. · Chinese journal of integrative medicine · 2026

  30. 0.78

    Integrated metabolomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue tang in treating Alzheimer's disease

    Tong P, Li X, Li S et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026

  31. 0.77

    Analyses of neurotoxicity following multiple metal exposures among adults living along the Yangtze River in Anhui Province, China: In vitro experiments with mild cognitive impairment integrating community population cohort

    Bian C, Wang W, Yao Z et al. · Ecotoxicology and environmental safety · 2026

  32. 0.76

    Epimedium attenuates neuroinflammation and ameliorates Alzheimer's disease through a KAT2B-dependent mechanism

    Gao J, Song ML, Liu J et al. · Frontiers in medicine · 2026

  33. 0.75

    Mechanistic study on ligustilide modulation of the TLR4/NF-kappaB pathway in ameliorating Scopolamine-Induced cognitive impairment

    Zhang Q, Gao M, Xu Z et al. · Metabolic brain disease · 2025

  34. 0.75

    Kaixin San Jiawei granule improves cognitive function and alleviates neuronal damage in Alzheimer's disease via multi-component and multi-target mechanisms

    Liu W, Zhao Y, Liu T et al. · Frontiers in pharmacology · 2025

  35. 0.73

    Network pharmacology and molecular docking integrated strategy to investigate the pharmacological mechanism of palmatine in Alzheimer's disease

    Pei H, Zeng J, Chen W et al. · Journal of biochemical and molecular toxicology · 2022

  36. 0.73

    Metabolomics and network pharmacology based study of the potential of Brassica rapa L. extract BREE-Ea for the treatment of Alzheimer's disease

    Miao J, Huang Y, Yi Q et al. · Food & function · 2025

  37. 0.73

    Polygalacic acid attenuates cognitive impairment by regulating inflammation through PPARgamma/NF-kappaB signaling pathway

    Zhao T, Jia J · CNS neuroscience & therapeutics · 2024

  38. 0.72

    Jiajian Shuyu pills effectively ameliorate cognitive impairment via regulating the inflammation of microglia in an Alzheimer's disease mouse model

    Chen Y, Zhu Y, Tan Z et al. · Journal of ethnopharmacology · 2025

  39. 0.72

    Tianma Formula Alleviates Dementia via ACER2-Mediated Sphingolipid Signaling Pathway Involving Abeta

    Lin H, Wu S, Weng Z et al. · Evidence-based complementary and alternative medicine : eCAM · 2021

  40. 0.72

    Dual Mechanisms of Cognitive Function and Pathological Improvements by the Selective S1PR1/5 Modulator Siponimod in 3xTg-AD Mice

    Tang C, Ding Y, Yang S et al. · Molecular neurobiology · 2025

  41. 0.71

    Zexieyin formula attenuates Alzheimer's disease via suppressing A1 astrocyte activation: A serum pharmacochemistry and network pharmacology study

    Zhou S, Sun M, Song Z et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025

  42. 0.71

    Calcaratarin D exerts neuroprotective effects in Alzheimer's disease mouse model by inhibiting CERT-mediated NF-kappaB pathway

    Pan JZ, Yu MY, Tian MZ et al. · Experimental neurology · 2026

  43. 0.70

    Synapsin 1 Ameliorates Cognitive Impairment and Neuroinflammation in Rats with Alzheimer's Disease: An Experimental and Bioinformatics Study

    Ma W, Lu K, Liang HM et al. · Current Alzheimer research · 2023

  44. 0.70

    Integrating network pharmacology and experimental validation to uncover the mechanisms of Ganoderma lucidum in ameliorating neuroinflammation in Alzheimer's disease

    Sheng F, Yu JM, Yang Q et al. · The Journal of pharmacy and pharmacology · 2026

  45. 0.70

    Neuroinflammation mediated repurposing of clemastine for Alzheimer's disease through network pharmacology, molecular dynamics, and experimental validation studies

    Soni S, Sarkar S, Tripathi P et al. · Inflammopharmacology · 2026

  46. 0.68

    Integrated analysis strategies reveal the pharmacodynamic substances and action mechanisms of Huangqi San in the treatment of Alzheimer's disease

    Xu Y, Li N, Li X et al. · Journal of pharmaceutical and biomedical analysis · 2026

  47. 0.68

    Neuroprotective effect of the traditional decoction Tian-Si-Yin against Alzheimer's disease via suppression of neuroinflammation

    Zhou L, Yang C, Liu Z et al. · Journal of ethnopharmacology · 2024

  48. 0.67

    Integrated Network Pharmacology, Molecular Docking, and Experimental Validation Elucidating the Therapeutic Mechanism of Idesia polycarpa Crude Oil in Aluminum Chloride-Induced Alzheimer's Rat Models

    Chang W, Chen Y, Kan J et al. · Food science & nutrition · 2026

  49. 0.66

    The Therapeutic Potential of Dalbergia pinnata (Lour.) Prain Essential Oil in Alzheimer's Disease: EEG Signal Analysis In Vivo, SH-SY5Y Cell Model In Vitro, and Network Pharmacology

    Qin S, Fang J, He X et al. · Biology · 2024

  50. 0.65

    Unraveling the anti-neuroinflammatory mechanisms of Cervus cucumis polypeptide injection in Alzheimer's disease: insights from network pharmacology, molecular docking, molecular dynamics simulation, and experimental validation

    Fu X, Huang J, Liu Y et al. · Frontiers in aging neuroscience · 2026

  51. 0.65

    Danggui Shaoyao San ameliorates neuroinflammation in a D-galactose-induced Alzheimer's disease rat model by suppressing the JAK2/STAT3 pathway and modulating Th17/Treg -related immune dysregulation

    Fu G, Tang S, Sun X et al. · Frontiers in cell and developmental biology · 2026

  52. 0.65

    A network pharmacology and in silico approach to target NEU1-mediated microglial activation in neuroinflammation: Validation in an LPS-induced mouse model

    Alzarea SI, Alsaidan OA, Qasim S et al. · Computers in biology and medicine · 2025

  53. 0.64

    Homotherapy for heteropathy of Alzheimer's disease and anemia through reducing the expression of toll-like receptor and TNF by steamed Panax notoginseng

    Mengnan L, Xianwen Y, Shuyan Z et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023

  54. 0.64

    Elucidating the Role of Trem2 in Lipid Metabolism and Neuroinflammation

    Zhao C, Qi W, Lv X et al. · CNS neuroscience & therapeutics · 2025

  55. 0.64

    The Crosstalk Between Sepsis-Associated Encephalopathy and Alzheimer's Disease: Identifying Potential Biomarkers and Therapeutic Targets for Cognition

    Wang Z, Zhang Z, Shi J et al. · Molecular neurobiology · 2025

  56. 0.62

    Extract of Tinospora sinensis alleviates LPS-induced neuroinflammation in mice by regulating TLR4/NF-kappaB/NLRP3 signaling pathway

    Xie Y, Fang C, Lu L et al. · Journal of ethnopharmacology · 2025

  57. 0.62

    Integrated identification and validation of HSP90AA1 as a therapeutic target of Astragalus membranaceus in Alzheimer's disease

    Xie M, Niu X, Shi L · Neuroscience · 2026

  58. 0.61

    Modified Kai-Xin-San ameliorates cognitive impairment in Alzheimer's disease model mice by regulating neuroinflammation and synaptic dysfunction

    Liu XY, Wang K, Zhong JJ et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026

  59. 0.59

    Network pharmacology analysis reveals neuroprotective effects of the Qin-Zhi-Zhu-Dan Formula in Alzheimer's disease

    Xu W, Ren B, Zhang Z et al. · Frontiers in neuroscience · 2022

  60. 0.59

    Integrating serum pharmacochemistry and network pharmacology to reveal the active constituents and mechanism of Corydalis Rhizoma in treating Alzheimer's disease

    Lyu Y, Wang Y, Guo J et al. · Frontiers in aging neuroscience · 2023

  61. 0.58

    Integrating network pharmacology, UPLC-Q-TOF-MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease

    Shen ZJ, Fu YB, Hou JL et al. · Chinese medicine · 2022

  62. 0.57

    Pterostilbene targets microglia-mediated neuroinflammation for Alzheimer's therapy

    Chen F, Lv X, Xiang K et al. · The Journal of nutritional biochemistry · 2026

  63. 0.57

    Network Proximity Analysis Deciphers the Pharmacological Mechanism of Osthole against D-Galactose Induced Cognitive Disorder in Rats

    Wang X, Fu X, Luo X et al. · Molecules (Basel, Switzerland) · 2023

  64. 0.55

    Potential modulation of microglial ferroptosis by Linggui Zhugan decoction in Alzheimer's disease through IL-17 and TNF pathways

    Tang P, Zhao D, Lin H et al. · International immunopharmacology · 2025

  65. 0.54

    Molecular mechanism of Epimedium in the treatment of vascular dementia based on network pharmacology and molecular docking

    Xie C, Tang H, Liu G et al. · Frontiers in aging neuroscience · 2022

  66. 0.54

    Differential Expression of GABA Receptor-Related Genes in Alzheimer's Disease and the Positive Regulatory Role of Aerobic Exercise-From Genetic Screening to D-gal-induced AD-like Pathology Model

    Liu Y, Peng H, Liu Q et al. · Neuromolecular medicine · 2024

  67. 0.53

    Agnuside enhances neuronal survival and cognitive function by modulating PI3K/AKT/mTOR signaling in Aluminium Chloride induced Alzheimer's disease

    Gnanarajan R, Uvarajan D, Ravichandran N et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2025

  68. 0.51

    Integrated comparative metabolomics and network pharmacology approach to uncover the key active ingredients of Polygonati rhizoma and their therapeutic potential for the treatment of Alzheimer's disease

    Wang F, Chen H, Hu Y et al. · Frontiers in pharmacology · 2022

  69. 0.51

    Protective effect and mechanism of Zhuang medicine Tinosporae Radix on LPS-induced neuroinflammation

    Wang J, Xie Y, Wang S et al. · Journal of ethnopharmacology · 2025

07review · neurodegenerative69편

  1. 0.84

    Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL-1beta drives amplified responses in primed astrocytes and neuronal network dysfunction

    Lopez-Rodriguez AB, Hennessy E, Murray CL et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021

  2. 0.83

    Factor H's Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer's Disease Treatment

    Hasantari I, Nicolas N, Alzieu P et al. · International journal of molecular sciences · 2024

  3. 0.82

    Nanoligomers targeting NF-kappaB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy

    Wahl D, Risen SJ, Osburn SC et al. · Journal of neuroinflammation · 2024

  4. 0.80

    Vorinostat ameliorates cognitive impairment and Tau pathology in an AAV-P301L-Tau-induced tauopathy mouse model: insights into neuroinflammation and PI3K/AKT/GSK3beta signaling

    Shi Z, Cheng X, Zhang C et al. · International immunopharmacology · 2026

  5. 0.79

    Alzheimer's Disease-Like Pathology Triggered by Porphyromonas gingivalis in Wild Type Rats Is Serotype Dependent

    Diaz-Zuniga J, More J, Melgar-Rodriguez S et al. · Frontiers in immunology · 2020

  6. 0.79

    The Periodontal Pathogen Fusobacterium nucleatum Exacerbates Alzheimer's Pathogenesis via Specific Pathways

    Wu H, Qiu W, Zhu X et al. · Frontiers in aging neuroscience · 2022

  7. 0.78

    Microcurrent Therapy Mitigates Neuronal Damage and Cognitive Decline in an Alzheimer's Disease Mouse Model: Insights into Mechanisms and Therapeutic Potential

    Kim EH, Lee WS, Kwon DR · International journal of molecular sciences · 2024

  8. 0.78

    Restoring regulatory T-cell dysfunction in Alzheimer's disease through ex vivo expansion

    Faridar A, Thome AD, Zhao W et al. · Brain communications · 2020

  9. 0.77

    IL-1beta and TNF-alpha play an important role in modulating the risk of periodontitis and Alzheimer's disease

    Wang RPH, Huang J, Chan KWY et al. · Journal of neuroinflammation · 2023

  10. 0.76

    Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone-Pyridylhydrazone Copper(II) Complex

    Choo XY, McInnes LE, Grubman A et al. · International journal of molecular sciences · 2022

  11. 0.76

    Extracellular vesicles from human-induced pluripotent stem cell-derived neural stem cells alleviate proinflammatory cascades within disease-associated microglia in Alzheimer's disease

    Madhu LN, Kodali M, Upadhya R et al. · Journal of extracellular vesicles · 2024

  12. 0.76

    Double stranded RNA drives innate immune responses, sickness behavior and cognitive impairment dependent on dsRNA length, IFNAR1 expression and age

    McGarry N, Murray CL, Garvey S et al. · bioRxiv : the preprint server for biology · 2021

  13. 0.75

    Human amniotic mesenchymal stromal cell-derived extracellular vesicles reprogram microglia and prevent neurodegeneration in experimental models of Alzheimer's disease

    Papait A, Natale F, Silini AR et al. · Translational neurodegeneration · 2026

  14. 0.75

    Top-down engineered micron-cell derived nanovesicles encapsulating curcumin targeting the 3R strategy (remove, remodel, repair) for Alzheimer's disease therapy

    Chu J, Hu H, Xu W et al. · Materials today. Bio · 2025

  15. 0.75

    Gastrodin Alleviates Tau Pathology by Targeting the Alzheimer's Risk Gene FERMT2, Reversing the Reduction in Brain Viscoelasticity

    Wang L, Li B, Tang Z et al. · CNS neuroscience & therapeutics · 2025

  16. 0.74

    Aberrantly activated TAK1 links neuroinflammation and neuronal loss in Alzheimer's disease mouse models

    Sai K, Nakanishi A, Scofield KM et al. · Journal of cell science · 2023

  17. 0.74

    Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer's disease mouse model

    Zelek WM, Bevan RJ, Nimmo J et al. · Brain : a journal of neurology · 2025

  18. 0.73

    Hepcidin deficiency impairs hippocampal neurogenesis and mediates brain atrophy and memory decline in mice

    Bai X, Wang B, Cui Y et al. · Journal of neuroinflammation · 2024

  19. 0.73

    Potential application of human neural crest-derived nasal turbinate stem cells for the treatment of neuropathology and impaired cognition in models of Alzheimer's disease

    Lim JY, In Park S, Park SA et al. · Stem cell research & therapy · 2021

  20. 0.72

    Targeting Pro-Inflammatory Interleukin-1 Beta Signaling to Modulate Neuroinflammatory Processes Associated with Cognitive Decline in Dementia with Lewy Bodies

    Alam JJ, Germann UA, Maruff P · Cells · 2026

  21. 0.72

    Edaravone Dexborneol mitigates pathology in animal and cell culture models of Alzheimer's disease by inhibiting neuroinflammation and neuronal necroptosis

    Xu C, Mei Y, Yang R et al. · Cell & bioscience · 2024

  22. 0.70

    Exploring the role of tocotrienol-rich fraction (TRF) in ameliorating neuroinflammation

    Tan JY, Retinasamy T, Lee VLL et al. · Inflammopharmacology · 2026

  23. 0.70

    Porphyromonas gingivalis outer membrane vesicles drive neuroinflammation via TGM2-mediated mitochondria-associated endoplasmic reticulum membranes

    Zhang P, Zhu Q, Zhang K et al. · BMC oral health · 2026

  24. 0.70

    Sesamol Mitigates Chronic Iron Overload-Induced Cognitive Impairment and Systemic Inflammation via IL-6 and DMT1 Regulation

    Wang Y, Zhang Y, Wang X et al. · Molecular nutrition & food research · 2023

  25. 0.69

    Modified Korean MIND Diet: A Nutritional Intervention for Improved Cognitive Function in Elderly Women through Mitochondrial Respiration, Inflammation Suppression, and Amino Acid Metabolism Regulation

    Kang EY, Kim DY, Kim HK et al. · Molecular nutrition & food research · 2023

  26. 0.69

    Dexmedetomidine Exerts Multi-level Effects to Ameliorate Alzheimer's Disease Pathology in the Adult Zebrafish Brain

    Nazli D, Poyraz YK, Can K et al. · Molecular neurobiology · 2026

  27. 0.69

    Innate immune memory mediates increased susceptibility to Alzheimer's disease-like pathology in sepsis surviving mice

    De Sousa VL, Araujo SB, Antonio LM et al. · Brain, behavior, and immunity · 2021

  28. 0.69

    Beta-hydroxybutyrate (BHB) elicits concentration-dependent anti-inflammatory effects on microglial cells which are reversible by blocking its monocarboxylate (MCT) importer

    Garcia C, Banerjee A, Montgomery C et al. · Frontiers in aging · 2025

  29. 0.68

    Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer's Disease Hallmarks

    Grinan-Ferre C, Jarne-Ferrer J, Bellver-Sanchis A et al. · International journal of molecular sciences · 2024

  30. 0.68

    Small extracellular vesicles carrying miRNA34 in Alzheimer's disease: effects on oxidative stress, neuroinflammation, cognitive function, and mitochondrial/ferroptosis-related protein regulation

    Celik H, Celik O, Aydin S et al. · Gene · 2026

  31. 0.68

    Modulation of Mitochondrial Dynamics by Loganic Acid Ameliorates Alzheimer's Disease Pathology: Evidence from In Vitro and In Vivo Studies

    Panda SR, Soni U, Panja P et al. · ACS chemical neuroscience · 2026

  32. 0.67

    TNF-alpha-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2(R47H) rats

    Ren S, Breuillaud L, Yao W et al. · The Journal of biological chemistry · 2021

  33. 0.67

    The Effects of Fibrinogen's Interactions with Its Neuronal Receptors, Intercellular Adhesion Molecule-1 and Cellular Prion Protein

    Sulimai N, Brown J, Lominadze D · Biomolecules · 2021

  34. 0.67

    Physcion Mitigates LPS-Induced Neuroinflammation, Oxidative Stress, and Memory Impairments via TLR-4/NF-small ka, CyrillicB Signaling in Adult Mice

    Ahmad S, Choe K, Badshah H et al. · Pharmaceuticals (Basel, Switzerland) · 2024

  35. 0.67

    Intranasal Delivery of BACE1 siRNA and Berberine via Engineered Stem Cell Exosomes for the Treatment of Alzheimer's Disease

    Sun C, Sha S, Shan Y et al. · International journal of nanomedicine · 2025

  36. 0.67

    Untargeted metabolomics reveals intervention effects of wine-processed Schisandra chinensis polysaccharide on Alzheimer's disease mice

    Wu L, Guo X, Gao Y et al. · International journal of biological macromolecules · 2024

  37. 0.66

    Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer's disease

    Apodaca LA, Baddour AAD, Garcia CJ et al. · Alzheimer's research & therapy · 2021

  38. 0.65

    TNF-alpha and IFN-gamma impair neural oscillations and induce neurodegeneration by microglial nitric oxide, metabolic and oxidative stress

    Malorny N, Chausse B, Khodaie B et al. · Journal of neuroinflammation · 2026

  39. 0.65

    Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia

    Akif A, Nguyen TTM, Liu L et al. · Fluids and barriers of the CNS · 2025

  40. 0.64

    Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia

    Akif A, My Nguyen TT, Liu L et al. · Research square · 2024

  41. 0.64

    Increased cytokine gene expression and cognition risk associated with androgen deprivation therapy

    Verma S, Kushwaha PP, Shankar E et al. · The Prostate · 2022

  42. 0.64

    A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer's Disease Mice Models

    Jarne-Ferrer J, Grinan-Ferre C, Bellver-Sanchis A et al. · Pharmaceuticals (Basel, Switzerland) · 2022

  43. 0.63

    IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease

    Brigas HC, Ribeiro M, Coelho JE et al. · Cell reports · 2021

  44. 0.63

    A Virus-Like-Particle-Based Conjugate Vaccine Targeting the Microtubule Binding Region of Tau Protein

    McFall-Boegeman H, Talbot C, Montalbano M et al. · ACS omega · 2026

  45. 0.63

    Gadd45A-mediated autophagy regulation and its impact on Alzheimer's disease pathogenesis: Deciphering the molecular Nexus

    Althobaiti NA, Al-Abbas NS, Alsharif I et al. · Biochimica et biophysica acta. Molecular basis of disease · 2024

  46. 0.62

    Neuroinflammatory Stress Preferentially Impacts Synaptic MAPK Signaling and Mitochondria in Excitatory Neurons

    Espinosa-Garcia C, Srivastava U, Kumar P et al. · bioRxiv : the preprint server for biology · 2025

  47. 0.60

    Lipid-conjugated siRNA targeting SARM1 enables CNS silencing and mitigates alzheimer-like phenotypes

    Cai Y, Hou Q, Cheng Z et al. · Bioorganic chemistry · 2026

  48. 0.59

    GRK5 Deficiency in the Hippocampus Leads to Cognitive Impairment via Abnormal Microglial Alterations

    Shen H, Zhang T, Ji Y et al. · Molecular neurobiology · 2023

  49. 0.59

    Neuroprotective roles of SGLT2 and DPP4 inhibitors: Modulating ketone metabolism and suppressing NLRP3 inflammasome in T2D induced Alzheimer's disease

    Sim AY, Kim JY, Lee YH et al. · Experimental neurology · 2025

  50. 0.58

    Therapeutic Intervention of Neuroinflammatory Alzheimer Disease Model by Inhibition of Classical Complement Pathway with the Use of Anti-C1r Loaded Exosomes

    Richards T, Perron JC, Patel K et al. · Research square · 2023

  51. 0.57

    Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age

    McGarry N, Murray CL, Garvey S et al. · Brain, behavior, and immunity · 2021

  52. 0.57

    Somatostatin-induced modulation of microglial activity contributes to mitigating Alzheimer's disease pathology

    Jung H, Hyun G, Kim S et al. · Brain, behavior, and immunity · 2026

  53. 0.57

    Therapeutic Effects of miR-29b-Enriched Nanovesicles on Mitochondrial Injury and Neuroinflammatory Processes in Alzheimer's Disease

    Gonullu S, Dalkilinc E, Celik O et al. · Neurotoxicity research · 2026

  54. 0.57

    Deciphering the Association of Epstein-Barr Virus and Its Glycoprotein M Peptide with Neuropathologies in Mice

    Rani A, Patra P, Verma TP et al. · ACS chemical neuroscience · 2024

  55. 0.55

    KIT-13, a novel plasmalogen derivative, attenuates neuroinflammation and amplifies cognition

    Hossain MS, Mawatari S, Honsho M et al. · Frontiers in cell and developmental biology · 2024

  56. 0.55

    P2X(7)R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes

    Beltran-Lobo P, Hughes MM, Troakes C et al. · Brain, behavior, and immunity · 2023

  57. 0.54

    Role of pro-inflammatory cytokines in Alzheimer's disease and neuroprotective effects of pegylated self-assembled nanoscaffolds

    Rani V, Verma R, Kumar K et al. · Current research in pharmacology and drug discovery · 2023

  58. 0.54

    Therapeutic relevance of an EU-GMP certified Cannabis sativa L. strain in a dual in vivo model of cognitive impairment and chronic neuropathic pain

    Costachescu I, Gogu RM, Stanciu GD et al. · Frontiers in pharmacology · 2026

  59. 0.54

    Abeta oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer's disease

    Salvadores N, Moreno-Gonzalez I, Gamez N et al. · Acta neuropathologica communications · 2022

  60. 0.53

    Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis

    Tsitsou-Kampeli A, Suzzi S, Kenigsbuch M et al. · Cell reports. Medicine · 2023

  61. 0.53

    Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids

    Sharma S, Gilberto VS, Rask J et al. · ACS chemical neuroscience · 2024

  62. 0.53

    Proteomic Signature and mRNA Expression in Hippocampus of SAMP8 and SAMR1 Mice during Aging

    Reale M, Costantini E, Aielli L et al. · International journal of molecular sciences · 2022

  63. 0.53

    Delta133p53alpha Protects Human Astrocytes from Amyloid-beta Induced Senescence and Neurotoxicity

    Ungerleider K, Beck JA, Lissa D et al. · Neuroscience · 2022

  64. 0.53

    Probiotic Bifidobacterium breve MCC1274 Protects against Oxidative Stress and Neuronal Lipid Droplet Formation via PLIN4 Gene Regulation

    Bernier F, Kuhara T, Xiao J · Microorganisms · 2023

  65. 0.52

    BDNF Protects Against Neuronal Damage Induced by TNF and beta-Amyloid Peptides by Targeting JNK Activation

    Ramirez-Olvera A, Almazan JL, Perez-Martinez L et al. · Neurochemical research · 2026

  66. 0.52

    Neutrophils from Alzheimer's disease mice fail to phagocytose debris and show altered release of immune modulators with age

    Kays M, Kelly A, McGinnis F et al. · Frontiers in immunology · 2025

  67. 0.51

    Neuroinflammatory stress preferentially impacts synaptic MAPK signaling and mitochondria in excitatory neurons

    Espinosa-Garcia C, Srivastava U, Kumar P et al. · Molecular neurodegeneration advances · 2026

  68. 0.51

    TLR2- and TLR3-activated microglia induce different levels of neuronal network dysfunction in a context-dependent manner

    Schilling S, Chausse B, Dikmen HO et al. · Brain, behavior, and immunity · 2021

  69. 0.50

    Neuronal Necroptosis Drives Neuroinflammation and Cognitive Decline Independent of Neuronal Cell Death

    Thadathil N, Wolf NA, Wolf R et al. · Aging and disease · 2025

08activity · ache67편

  1. 0.86

    Baicalin-Myricetin-Coated Selenium Nanoparticles Mitigate Pathology in an Abeta1-42 Mice Model of Alzheimer's Disease

    Perez Gutierrez RM, Tellez Gomez J, Mota Flores JM et al. · Pharmaceuticals (Basel, Switzerland) · 2025

  2. 0.80

    Design, synthesis, and investigation of anti-Alzheimer's activity and molecular mechanisms of phosphatidylserine derivatives

    Lin Y, Lin X, Zhu J et al. · European journal of medicinal chemistry · 2026

  3. 0.80

    Attenuation of spatial memory in 5xFAD mice by targeting cholinesterases, oxidative stress and inflammatory signaling using 2-(hydroxyl-(2-nitrophenyl)methyl)cyclopentanone

    Ullah R, Ali G, Subhan F et al. · International immunopharmacology · 2021

  4. 0.79

    Neuroprotective, Antioxidant and Anti-Inflammatory Effect of Greek Pomegranate Seed Oil on N2a Neuroblastoma Cells and Mild Cognitive Impairment Patients

    Tzekaki EE, Katsipis G, Chatzikostopoulos A et al. · Biology · 2025

  5. 0.79

    Demethyleneberberine attenuates combined cognitive and metabolic dysfunctions in an insulin-resistance-induced Alzheimer's disease rat model: Synthesis, in-silico and in-vivo insights

    Kaur A, Singh S, Singh M et al. · Experimental neurology · 2026

  6. 0.79

    An orally administered quinolinium molecule mitigates neuropathology of Alzheimer's disease through modulation of mitochondrial dysfunction and neuroinflammation

    He J, Ran M, Tam KY · Brain research · 2025

  7. 0.78

    Taxifolin-Functionalized Rivastigmine Liposomal Nanoformulation: A Synergistic Approach for Alzheimer's Disease Management

    M M, Kaliyaperumal R · Pharmaceutical nanotechnology · 2026

  8. 0.77

    Ameliorative effect of vanillin on scopolamine-induced dementia-like cognitive impairment in a mouse model

    Anand A, Khurana N, Ali N et al. · Frontiers in neuroscience · 2022

  9. 0.77

    Anti-Alzheimer effects of the newly synthesized cationic compounds as multi-target dual hAChE/hBuChE inhibitor: An in silico, in vitro, and in vivo approach

    Karami H, Soltani S, Wolber G et al. · BioImpacts : BI · 2025

  10. 0.77

    Nanogel Delivery of Plumbagin from Nepenthes Khasiana Attenuates Neuroinflammation and Cognitive Decline in Alzheimer's Mice Models

    Zhang X, Zhang X · Applied biochemistry and biotechnology · 2026

  11. 0.77

    Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer's Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways

    El-Nashar HAS, Abbas H, Zewail M et al. · Pharmaceuticals (Basel, Switzerland) · 2022

  12. 0.77

    Development and evaluation of multi-functionalized sialic acid conjugated asiatic acid nanoconstruct to mitigate cognitive deficits in Alzheimer's disease

    Halder T, Saha B, Dhas N et al. · Drug development research · 2024

  13. 0.77

    A comprehensive investigation of Clerodendrum Infortunatum Linn. using LC-QTOF-MS/MS metabolomics as a promising anti-alzheimer candidate

    Atef F, Abdelkawy MA, Eltanany BM et al. · Scientific reports · 2025

  14. 0.77

    Molecular networking-guided investigation of the secondary metabolome of four Morus species and their in vivo neuroprotective potential for the mitigation of Alzheimer's disease

    Hegazi NM, Mohamed TA, Salama A et al. · Food & function · 2024

  15. 0.76

    Orthosiphon aristatus (Blume) Miq. Extracts attenuate Alzheimer-like pathology through anti-inflammatory, anti-oxidative, and beta-amyloid inhibitory activities

    Chiang KH, Cheng TJ, Kan WC et al. · Journal of ethnopharmacology · 2024

  16. 0.76

    Discovery of novel 5-(2-hydroxyphenyl)-2-phthalide-3(3H)-pyrazolones as balanced multifunctional agents against Alzheimer's disease

    Cong S, Shi Y, Yu G et al. · European journal of medicinal chemistry · 2023

  17. 0.76

    Design, synthesis, and preclinical evaluation of novel 1-benzylpiperidine derivatives as multitarget agents against Alzheimer's disease

    Ramachandran AK, Govindula A, Ranadive N et al. · European journal of pharmacology · 2025

  18. 0.76

    Innovative Test Strip-Based Colorimetric Sensors Integrated With Affinity Chromatography: Acetylcholinesterase Inhibitor Screening Breakthrough in Lycium Barbarum Leaves

    Sa Y, Yuan H, Ma J et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026

  19. 0.75

    ZRMQ-22, a novel DYRK1A inhibitor, attenuates neuroinflammation and cognitive impairments in LPS-induced mice: a potential strategy for Alzheimer's disease

    Ren M, Chen H, Li Z et al. · RSC medicinal chemistry · 2026

  20. 0.75

    Avanafil mediated dual inhibition of IKKbeta and TNFR1 in an experimental paradigm of Alzheimer's disease: in silico and in vivo approach

    Chowdari Gurram P, Satarker S, Kumar G et al. · Journal of biomolecular structure & dynamics · 2023

  21. 0.75

    Ameliorative effect of scopolamine-induced cognitive dysfunction by Fufangmuniziqi formula: The roles of alkaloids, saponins, and flavonoids

    Zhao X, Hu X, Xie Q et al. · Journal of ethnopharmacology · 2024

  22. 0.74

    Endogenous extraction yielded high quality sulforaphane from broccoli sprouts unveils potent antioxidant and anti-Alzheimer's activities

    Uthaman SK, Kang WS, Park JY et al. · Heliyon · 2025

  23. 0.74

    Structural optimization of naturally derived Ar-turmerone, as novel neuroinflammation suppressors effective in an Alzheimer mouse model

    Zhou W, Chang Y, Xiao Q et al. · Bioorganic & medicinal chemistry · 2025

  24. 0.72

    In vitro and in vivo biological evaluation of newly synthesized multi-target 20(R)-panaxadiol derivatives for treating Alzheimer's disease

    Pang L, Li J, Liu Z et al. · European journal of medicinal chemistry · 2022

  25. 0.71

    Depolymerized peanut skin-derived proanthocyanidins alleviate cognitive dysfunction by inhibiting Abeta42 aggregation in Alzheimer's disease

    Liu H, Zhang Z, Li X et al. · Food research international (Ottawa, Ont.) · 2025

  26. 0.69

    A novel nasal mucosal peptide-modified co-delivery system for ginsenoside Rg1, Rb1, and notoginseng saponin R1 in the amelioration of AD

    Li Y, Hu C, Xia C et al. · Journal of nanobiotechnology · 2026

  27. 0.69

    Enhanced cognitive function in mice through intranasal delivery of sinapic acid via chitosan-coated solid lipid nanoparticles

    Prabakaran A, Rakshit D, Patel I et al. · International journal of pharmaceutics · 2025

  28. 0.68

    Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer's agents: Design, synthesis, in vitro biological evaluation, in vivo and in silico studies

    Sang Z, Bai P, Ban Y et al. · Bioorganic chemistry · 2022

  29. 0.68

    Synergistic Neuroprotection in Tauopathic Mice via Green-Synthesized Silver Nanoparticles Co-delivering Methylene Blue and Moringa oleifera

    Elbermawy Y, El-Desouky S, Arafa RK et al. · Molecular neurobiology · 2025

  30. 0.67

    Discovery of novel deoxyvasicinone derivatives with benzenesulfonamide substituents as multifunctional agents against Alzheimer's disease

    Dong S, Xia J, Wang F et al. · European journal of medicinal chemistry · 2024

  31. 0.67

    Behavioral, neurochemical, and biochemical investigations of coumarin derivatives in modulating neuroinflammation, cholinergic dysfunction, and cytokine responses: In Vivo studies for potential Alzheimer's disease therapy

    Herbet M, Wicha-Komsta K, Pawlowski K et al. · Behavioural brain research · 2026

  32. 0.67

    In Vitro and In Vivo Evaluation of Kai-Xin-San Polysaccharides: Antioxidant, Anti-Inflammatory, and Anti-Alzheimer's Disease Activities

    Xiong Y, Zhou L, Zhang M et al. · Current neuropharmacology · 2025

  33. 0.67

    A novel carbamate-based hybrid derivative with anti-neuroinflammatory properties as a selective butyrylcholinesterase inhibitor for Alzheimer's disease therapy

    Liu X, Xu J, Yu C et al. · Bioorganic chemistry · 2025

  34. 0.67

    Design, synthesis and evaluation of novel L-tryptophan derivatives as multifunctional agents with cholinesterase inhibition, anti-beta-amyloid aggregation, anti-inflammatory, antioxidant and neuroprotection properties against Alzheimer's disease

    Yu H, Chen Y, Li H et al. · Bioorganic chemistry · 2025

  35. 0.67

    BDNF Loaded Amino Acid-Catecholamine Hybrid Nanoparticles as Curative Agents Against Cognitive Decline in Alzheimer's Disease

    Panda HS, Dhokne MD, Thakur S et al. · Small (Weinheim an der Bergstrasse, Germany) · 2025

  36. 0.67

    Design and development of 1,5-diarylpyrazole-based multitarget-directed ligands as dual COX-2/HDAC6 inhibitors for Alzheimer's disease therapy: Molecular dynamics and experimental insights

    Abdelrahman KS, Soltan OM, Abo Mansour HE et al. · European journal of medicinal chemistry · 2026

  37. 0.67

    A novel phosphodiesterase 5 inhibitor, RF26, improves memory impairment and ameliorates tau aggregation and neuroinflammation in the P301S tauopathy mouse model of Alzheimer's disease

    El-Desouky S, Abdel-Halim M, Fathalla RK et al. · Experimental neurology · 2025

  38. 0.66

    Amaryllidaceae, Lycopodiaceae Alkaloids and Coumarins-A Comparative Assessment of Safety and Pharmacological Activity

    Herbet M, Widelski J, Piatkowska-Chmiel I et al. · Journal of clinical medicine · 2022

  39. 0.66

    Integrated computational, pharmacological and molecular investigations of piperitone in mitigating Alzheimer disease pathology by targeting cholinesterases, beta-secretase and neuroinflammation

    Anwer R, Ullah I, Khan AU et al. · Inflammopharmacology · 2026

  40. 0.65

    "Behavioral and Neuroinflammatory Evaluation of a Novel Isoxazole-5-One Derivative in Animal Models of Alzheimer's Disease via TNF-alpha, COX-2, IL-6, and NF-kappaB Modulation"

    Gohar N, Abbas M, Masaud SM et al. · ACS omega · 2026

  41. 0.65

    Ellagic acid improves the symptoms of early-onset Alzheimer's disease: Behavioral and physiological correlates

    Jha AB, Chaube UJ, Jha AB · Heliyon · 2024

  42. 0.65

    AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy

    Liu X, Xu J, Zheng S et al. · Pharmacological research · 2025

  43. 0.65

    Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease

    Liu D, Zhang H, Wang Y et al. · European journal of medicinal chemistry · 2022

  44. 0.65

    Intra-nasal Delivery of Quercetin-Loaded Nanostructured Lipid Carriers (NLCs) in the Management of Alzheimer's Disease: Formulation, In Vitro and In Vivo assessment

    Satpathy B, Rajwar TK, Mishra A et al. · Molecular neurobiology · 2025

  45. 0.65

    Amelioration of cognition by hesperidin-conjugated cobalt oxide nanoparticles

    Behera A, Satpathy B, Sahoo RK et al. · Scientific reports · 2024

  46. 0.64

    Modified Low-Temperature Extraction Method for Isolation of Bletilla striata Polysaccharide as Antioxidant for the Prevention of Alzheimer's Disease

    Lin YW, Fang CH, Liang YJ et al. · International journal of molecular sciences · 2021

  47. 0.63

    Valine conjugated polymeric nanocarriers for targeted co-delivery of rivastigmine and quercetin in rat model of Alzheimer disease

    Kaboli Z, Hosseini MJ, Sadighian S et al. · International journal of pharmaceutics · 2023

  48. 0.63

    Insights of Valacyclovir in Treatment of Alzheimer's Disease: Computational Docking Studies and Scopolamine Rat Model

    Patel P, Faldu K, Borisa A et al. · Current neurovascular research · 2022

  49. 0.61

    Effects and mechanism of extracts rich in phenylpropanoids-polyacetylenes and polysaccharides from Codonopsis Radix on improving scopolamine-induced memory impairment of mice

    Xie Q, Hu X, Zhao X et al. · Journal of ethnopharmacology · 2024

  50. 0.60

    Design, Synthesis, and Biological Evaluation of Piperazine and N-Benzylpiperidine Hybrids of 5-Phenyl-1,3,4-oxadiazol-2-thiol as Potential Multitargeted Ligands for Alzheimer's Disease Therapy

    Waiker DK, Verma A, Akhilesh et al. · ACS chemical neuroscience · 2023

  51. 0.60

    Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics

    Grinan-Ferre C, Jarne-Ferrer J, Bellver-Sanchis A et al. · CNS neuroscience & therapeutics · 2024

  52. 0.60

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer's Disease

    Sun Y, Xu L, Shao H et al. · Journal of medicinal chemistry · 2022

  53. 0.60

    The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease

    Carles A, Hoffmann M, Scheiner M et al. · CNS neuroscience & therapeutics · 2024

  54. 0.59

    Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease

    Liu T, Chen S, Du J et al. · European journal of medicinal chemistry · 2022

  55. 0.59

    5alpha-Epoxyalantolactone from Inula macrophylla attenuates cognitive deficits in scopolamine-induced Alzheimer's disease mice model

    Ma R, Feng XY, Tang JJ et al. · Natural products and bioprospecting · 2024

  56. 0.58

    Protective effects of the natural polyphenol garcinol from Garcinia indica mitigates aluminium chloride-induced Alzheimer's-like neurodegeneration in Drosophila melanogaster

    Kandasamy K, Narasimhamoorthi SP, Arulselvan P et al. · 3 Biotech · 2026

  57. 0.57

    Chromone derivatives suppress neuroinflammation and improve mitochondrial function in the sporadic form of Alzheimer's disease under experimental conditions

    Pozdnyakov DI, Zolotych DS, Rukovitsyna VM et al. · Iranian journal of basic medical sciences · 2022

  58. 0.57

    Discovery of novel substituted (Z)-N'-hydroxy-3-(3-phenylureido)benzimidamide derivatives as multifunctional molecules targeting pathological hallmarks of Alzheimer's disease

    Shankar G, Praveen Kumar C, Yadav M et al. · European journal of medicinal chemistry · 2024

  59. 0.57

    Synthesis and Biological Evaluation of Benzimidazole Derivatives as Potential Neuroprotective Agents in an Ethanol-Induced Rodent Model

    Imran M, Shah FA, Nadeem H et al. · ACS chemical neuroscience · 2021

  60. 0.56

    Paeoniflorin inhibits pyruvate dehydrogenase kinase 3 and promotes BDNF activity by modulating neuronal activity and TNF-alpha

    Pinky, Anwar S, Neha et al. · Brain research · 2025

  61. 0.56

    Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of Alzheimer's disease

    Liu Y, Ma C, Li Y et al. · European journal of medicinal chemistry · 2024

  62. 0.56

    Urolithin A exhibits a neuroprotective effect against Alzheimer's disease by inhibiting DYRK1A activity

    Tu HJ, Su CJ, Peng CS et al. · Journal of food and drug analysis · 2023

  63. 0.55

    Discovery of Novel Tryptanthrin Derivatives with Benzenesulfonamide Substituents as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease

    Wang G, Du J, Ma J et al. · Pharmaceuticals (Basel, Switzerland) · 2023

  64. 0.54

    The Tragedy of Alzheimer's Disease: Towards Better Management via Resveratrol-Loaded Oral Bilosomes

    Abbas H, Gad HA, Khattab MA et al. · Pharmaceutics · 2021

  65. 0.52

    Synthesis, in silico Studies and Pharmacological Evaluation of a New Series of Indanone Derivatives as Anti-Parkinsonian and Anti-Alzheimer's Agents

    Bansal R, Singh R, Rana P · Current computer-aided drug design · 2023

  66. 0.52

    Neuroprotective triterpenoids from Astragalus membranaceus stems and leaves: Anti-inflammatory and anti-apoptotic mechanisms for memory improvement via in vivo and in vitro models

    Cheng YG, Li JL, Li P et al. · Bioorganic chemistry · 2025

  67. 0.51

    Design, molecular Docking, synthesis and evaluation of xanthoxylin hybrids as dual inhibitors of IL-6 and acetylcholinesterase for Alzheimer's disease

    Kaur S, Bansal Y · Bioorganic chemistry · 2022